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A welcome from the Chairman 
 
 
Welcome to the 14th International Symposium on Cells of the Hepatic Sinusoid in Tromsø, Norway, 
Aug 31 - Sep 4, 2008!  The International Scientific Committee has prepared for a scientific program 
that promises interesting presentations and discussions. I believe that the motto of the Symposium: 
"Integrating basic and clinical hepatology" will be clearly reflected throughout the scientific program. 
For the first time since these symposia were initiated in 1977, we will bring up a proposal of 
establishing a formalized society. The preparation towards transforming the series of symposia into a 
society has been taken care of by Prof. Hidekazu Tsukamoto on behalf of the International Scientific 
Committee. Please be present during the business meeting (Tuesday Sep 2, 12.20 - 13.00) when this 
issue will be discussed. The 15th ISCHS in Coronado, California, USA, Aug 29 - Sep 1, 2010, will also 
be presented during the business meeting. 
 
The Local Organizing Committee has worked hard to establish optimal logistics and an interesting 
social program. The Committee realizes that it is hard to control weather, but the planning of the rest of 
the meeting events has been down to the detail. 
 
I believe this Symposium will enable plentiful scientific and social communication that will spur ideas 
and collaborations within the topic of liver sinusoidal cells. 
 
I also want to thank The Norwegian Research Council, The University of Tromsø, The City 
Government of Tromsø, and Olympus Norway for their generous sponsoring of this symposium. 
 














SUNDAY August 31, 2008 
 
15:00 Registration at Rica Ishavs Hotel 
19:30 Welcoming remarks: Tromsø City Hall 
19:45 Welcome reception in the Tromsø City Hall 
 
MONDAY September 1, 2008 
  Abstract 
08:30 Bård Smedsrød Welcome  
08:45 Eddie Wisse: Differences in sinusoids and sinusoidal cells in rat, mouse, rabbit, pig and human liver (key note) #1  
 
Session I Liver sinusoidal endothelial cells: Endocytosis 
Chair Eddie Wisse and Bård Smedsrød 
09:30 Peter McCourt Liver sinusoidal endothelial cells - mega-endocytes (tutorial) #2 
10:00 Sergij Goerdt Molecular biology of hepatic sinusoidal endothelium (tutorial) #3 
10:30 Coffee break 
 
Session II Liver sinusoidal endothelial cells: Endocytosis and comparative biology 
Chair Masaya Oda and Clark Anderson 
11:00  Clark Anderson FcγRIIb2 expression in endothelium of liver and placenta (tutorial) #4 
11:30 Trond Berg Endocytosis and recycling of immune complexes mediated by the FcgammaRIIb2 in rat liver sinusoidal endothelial cells #5 
11:50 Clive Crossley Invertebrate analogues of hepatic sinusoidal scavenger systems (tutorial) #6 
12:20 Montserrat Martin-Armas 
Uptake of oligonucleotides by scavenger endothelial cells in the 
Atlantic cod (Gadus morhua, L.) #7 
12:40 Vijay K. Kalra 
Hypoxia inducible factor (HIF-1α) and related miRNAs in the 
regulation of ethanol induced inflammatory genes in liver 
sinusoidal endothelial cells 
#8 
13:00 Iñigo Martinez The influence of oxygen tension on the structure and function of isolated liver sinusoidal endothelial cells #9 
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13:15  Jaione Simon-Santamaria 
Age-related changes in scavenger-receptor mediated endocytosis in 
rat liver sinusoidal endothelial cells. #10 
13:30 Lunch at Rica Ishavs Hotel 
 
Session III Liver sinusoidal endothelial cells: Cytoskeleton 
Chair Robert McCuskey and David LeCouteur 
14:30  David LeCouteur Old age and the hepatic sinusoid (tutorial) #11 
15:00  Robert McCuskey Age-related dysfunction in the hepatic microcirculation #12 
15:20  Robin Fraser Atherosclerosis, lipoproteins and the liver sieve #13 
15:40  Masaya Oda 
Different expressions of Aquapoint-1 in normal and cirrhotic 
human liver – Demonstrating the capillarization of hepatic 
sinusoids 
#14 
16:00 Coffee break 
 
Session IV Liver sinusoidal endothelial cells: Cytoskeleton continued 
16:30 Frederic Saltel Implication of cortactin, a regulator of actin cytoskeleton assembly, in the control of fenestration in liver sinusoidal endothelial cells #15 
16:50 Katsuhiko Enomoto Involvement of signaling of VEGF and TGF-β in differentiation of sinusoidal endothelial cells during culture of fetal rat liver cells #16 
17:10 Beatriz Arteta 
Integrin LFA-1 enables colon carcinoma cells to upregulate 
sinusoidal endothelial cell mannose receptor via interleukin-1 
dependent mechanism: implications on anti-tumor immunity 





TUESDAY September 2, 2008 
 
Session V Kupffer cells 
Chair Hartmut Jaeschke and Laura Nagy 
09:00  Laura Nagy Innate immune responses and alcoholic liver disease: Role of Kupffer cells (tutorial) #18 
09:30  Takashi Yamamoto Kinetics and replacement of Kupffer cells after bone marrow transplantation in mice and rats #19 
09:50  Nicolas Lanthier High fat feeding induces hepatic insulin resistance and preferential distribution of Kupffer cells around lipid loaded hepatocytes #20 
10:10  Joan Clária Arachinodate 5-lipoxygenase modulates hepatocyte fatty acid uptake and microsomal triglyceride transfer protein activity #21 
10:30 Coffee break 
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Session V Kupffer cells continued 
11:00  Daniela Gärtner Cross talk between PGE2- and IL-6-mediated signaling pathways in cultured rat Kupffer cells #22 
11:20  Hartmut Jaeschke The inflammatory response during drug-induced liver injury: Toxicity versus regeneration #23 
11:40  Maria K. Dahle Cecal ligation and puncture sepsis is associated with a shift in adenylyl cyclase expression in sinusoidal liver cells #24 
12:00 – 13:00 Business meeting 
13:00 – 14:00 Lunch at Rica Ishavs Hotel 
 
18:00-23:30: Excursion: Boat to Sommarøya, and dinner there 
 
WEDNESDAY September 3, 2008 
 
Session VI Stellate cells: Signaling and gene regulation 
Chair Kenjiro Wake and Jelena Mann 
09:00  Norifumi Kawada Splanchnic vitamin A-storing cell system and organ fibrogenesis (tutorial) #25 
09:30 Erica Novo 
Modulation of human hepatic stellate cells chemotaxis by 
intracellular ROS generation and c-Jun N-terminal kinase 
activation 
#26 
09:50 Gunter Maubach Cysteine cathepsins in hepatic stellate cells #27 
10:10 Hidekazu Tsukamoto Canonical Wnt signaling and hepatic stellate cells #28 
10:30 Ilse Bockx 
Proliferation of hepatic stellate cells in rats with acute hepatitis is 
independent on vagal innervation via muscarinic acetylcholine 
receptor subtype 2 
#29 
10:50 Coffee break 
 
Session VII Stellate cells: Signaling and gene regulation continued 
Chair Haruki Senoo and Hidekazu Tsukamoto 
11:20  Jelena Mann Epigenetic regulation of hepatic stellate cells (tutorial) #30 
11:50 Yoshihiro Mezaki Rat hepatic stellate cells acquire retinoid responsiveness after activation in vitro #31 
12:10 Kiwamu Yoshikawa Involvement of ADRP and TIP47 in lipid droplets formation of hepatic stellate cells #32 
12:30 Richard George Ruddell 
Hepatic stellate cells express Tim-2: A possible mediator of 
ferritin-induced NfκB activation and proinflammatory gene 
expression 
#33 
12:50 Keisuke Nagatsuma 
Cellular distribution of lecithin: retinol acyltransferase (LRAT) and 




13:30 – 14:30 Lunch at Rica Ishavs Hotel 
 
14:30 –15:30  Poster session 
 
Session VIII Stellate cells: Modulators of liver fibrosis 
Chair Trond Berg and Kenichi Ikejima 
15:30  Michele Pritchard 
Expression of the transcription factor, early growth response (Egr)-
1, is a critical regulator of carbontetrachloride-induced fibrosis in 
mice 
#35 
15:50 Noriko Yamaguchi Vitamin E suppressed the proliferation and induced apoptosis of ”activated” hepatic stellate cells #36 
16:10 Peter Witters Blood platelets in cholestatic liver disease #37 
16:30 Tomohiro Ogawa Study on a rabbit model of steatohepatitis that develops liver cirrhosis #38 
16:50 Kenichi Ikejima C-reactive protein minimizes experimental hepatic fibrosis by inhibiting transactivation of hepatic stellate cells #39 
17:10  Soichi Kojima Detection and prevention of hepatic fibrosis targeting TGF-β activation reaction #40 
 
20:00 Conference dinner at Rica Ishavs Hotel 
 
THURSDAY September 4, 2008 
 
Session IX Stellate cells: comparative morphology and methods 
Chair Norifumi Kawada and Soichi Kojima 
09:00  Haruki Senoo Extracellular matrix in sinusoidal wall of frozen mammoths #41 
09:20 Mitsutaka Miura 
A study of morphological changes in lamprey liver during the 
course of metamorphosis with special reference to hepatic stellate 
cells 
#42 
09:40 Anna Nakamura Cryopreservation for long-tem storage of human primary cultured hepatic stellate cells #43 
10:00 Coffee break 
8
 
Session X Immunology/Tumor Biology 
Chair Makoto Naito and Fernando Vidal-Vanaclocha 
10:30  Percy Knolle Immunobiology of liver sinusoidal endothelial cells (tutorial) #44 
11:00  Fernando Vidal-Vanaclocha The prometastatic environment of the liver (tutorial) #45 
11:30 Aritz Lopategi 
Nerve growth factor expression by hepatic parenchymal and non-
parenchymal cells during metastatic colorectal development in 
human and murine liver 
#46 
11:50  Tatyana Korolenko Tumor-associated macrophages in experimental murine tumors #47 
 












DIFFERENCES IN SINUSOIDS AND SINUSOIDAL CELLS IN RAT, MOUSE, RABBIT, 
PIG AND HUMAN LIVER 
 
E Wisse1, 3, G Koek1, F Braet3, B De Geest2, and P Frederik1 
Departments of Pathology (EM unit), Surgery and Internal Medicine, University of Maastricht1, Center for 
Molecular and Vascular Biology, University of Leuven2 and Australian Key Centre for Microscopy and 
Microanalysis, University of Sydney, Australia3. 
 
In order to study the morphology of hepatic sinusoidal cells, it is obligatory to use the better 
resolution and higher magnification of electron microscopes (TEM and SEM). As a result, it is necessary 
to apply perfusion-fixation to preserve fine cellular detail. With this approach, it has been possible to 
distinguish four different types of sinusoidal cells and study their function, topography, interaction and 
behaviour in experiments and disease. Structural and functional differences between endothelial cells 
and Kupffer cells were not well distinguished in textbooks and publications written before the year 1970. 
EM observations made clear that the sinusoid is a microenvironment special to the hepatic lobule, 
responsible for a specific segment of liver function. Endothelial endocytosis and filtration by fenestrae; 
endotoxin clearance, phagocytosis, and secretion of biologically active products by Kupffer cells; fat-
storing cell storage of vitamin A and collagen synthesis, and the killing of invading tumor cells by pit 
cells (NK cells) were described and confirmed in numerous experiments, mostly performed in rats. Some 
of the functions found in situ, were extended with in vitro observations, obtained after isolation, 
purification and culture of the different types of sinusoidal cells. In as much as the in vitro results posed 
the question whether they equalled in vivo conditions, the question was also asked whether observations 
in the rat liver are relevant for other species, including the healthy and diseased human liver. Indeed, the 
histology and fine structure of many organs, tissues and cells does not differ much when different 
species, including Homo sapiens, are compared. This appeared also true for a comparative EM study of 
well-fixed livers of the animal species mentioned in the title of this abstract. Sinusoids and their cells 
showed remarkable resemblance. 
In the present survey, we will show details of sinusoids and sinusoidal cells, for which whole 
livers or wedge biopsies (appr. 1 x 1 x 1 cm) were fixed by perfusion- or injection-fixation seconds after 
laparotomy. In the case of wedge biopsies, glutaraldehyde was injected from different sides into the 
tissue. Discoloration and hardening of the tissue indicated well-perfused and well-fixed areas. After 
postfixation in osmium, dehydration in ethanol series and embedding in Epon, these tissues showed in 
many cases an almost perfect quality of fixation. Differences in the structure of the sinusoids and their 
cells in rats, mice, rabbits, pigs and human livers are subtle and only concern details, suggesting that 
differences in function could also be assumed minimal. 
Rat fenestrae in ultrathin plastic sections in TEM have an average size of 147 ± 0.9 nm in 
centrolobular areas, whereas periportal fenestrae measured 175 ± 1.0 nm. Fenestrae in mice (C57BL/6) 
have an average diameter of 141 ± 5.4 nm, whereas three rabbit strains showed different size 
distributions of fenestrae: NZW rabbits 103 ± 1.3 nm, DB rabbits measured 124 ± 3.4 nm, whereas FdB 
rabbits measured 105 ± 2.6 nm. In both mice and rabbit strains, a large size of fenestrae correlated well 
with good transgene expression of hepatocytes after adenoviral gene transfer, small fenestrae showed the 
opposite effect. Adenoviral capsules measure 93 ± 0.29 nm with protruding, flexible fibers of 30 nm. In 
well-fixed human liver biopsies, taken from livers without specific liver pathology, the diameter of 
fenestrae was 107 ± 1.5 nm, in a group of 12 patients undergoing liver surgery for colon cancer 
metastasis, the diameter of fenestrae was found to be 103 nm ± 0,15 nm, suggesting that adenoviral gene 
transfer vectors will be unsuccessful in the transfection of human liver parenchymal cells. This might 
explain the unsuccessful clinical attempts. 
During this investigation a few other details of endothelial and other cells came to light and will 
be presented. These concern defenestration centers, saccular SER and coated pits near sieve plates, 
transendothelial channels and fenestrae labyrinths. 
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Abstract #1
LIVER SINUSOIDAL ENDOTHELIAL CELLS - MEGA-ENDOCYTES 
 
Peter McCourt  
Department of Cell Biology and Histology, Institute of Medical Biology, University of Tromsoe, Tromsoe, Norway 
 
Every day the body turns over enormous amounts of biological molecules vital for the maintenance of 
life. Liver sinusoidal endothelial cells (LSEC) play a pivotal role in this removal/recycling process, 
daily clearing gram amounts (i.e. > 20 times their own weight) of spent connective tissue molecules 
(e.g. hyaluronan and denatured collagen) and waste products (e.g. atherogenic lipids, coagulation 
products and damaged proteins) from the circulation, and recycling them to energy and new building 
blocks (1). LSEC are thus a central player in homeostasis and are clearly not a sedate endothelium with 
filter holes, simply connecting the portal and central veins in the mammalian liver lobule. 
 
This endocytosis of such a wide range of different macromolecules is actually mediated by only a few 
categories of endocytosis receptor; namely the mannose receptor, the Fc-gamma receptor and the LSEC 
scavenger receptors stabilin-2 and its homologue stabilin-1 (1-4). Mannose and scavenger receptors are 
traditionally regarded as pattern recognition receptors (PRRs) in macrophages. Interestingly, this 
"endocytic profile" appears to be preserved in the LSEC analogues of all vertebrates (albeit in other 
organs in some non-mammals; (5)), and possibly in insects as well.  Furthermore, LSEC are also 
exceptionally richly equipped with early and late endosomes and lysosomes (6) to degrade all the 
material internalised by this massive uptake. LSEC also use their massive endocytic capacity to recruit 
circulating lysosomal enzymes, via the mannose receptor, thus reducing their own need to devote 
resources to enzyme synthesis (7). 
 
The aim of this tutorial is summarise the known endocytic pathways mediated by LSEC to maintain 
homeostasis, plus describe some preliminary studies indicating the wider role LSEC has in keeping our 
insides clean.  
 
1. Smedsrod B. Clearance function of scavenger endothelial cells. Comp Hepatol 2004;3 Suppl 1:S22. 
2. Malovic I, Sorensen KK, Elvevold KH, et al. The mannose receptor on murine liver sinusoidal 
endothelial cells is the main denatured collagen clearance receptor. Hepatology 2007;45:1454-1461. 
3. McCourt PA, Smedsrod BH, Melkko J, Johansson S. Characterization of a hyaluronan receptor on 
rat sinusoidal liver endothelial cells and its functional relationship to scavenger receptors. Hepatology 
1999;30:1276-1286. 
4. Politz O, Gratchev A, McCourt PA, et al. Stabilin-1 and -2 constitute a novel family of fasciclin-like 
hyaluronan receptor homologues. Biochem J 2002;362:155-164. 
5. Seternes T, Sorensen K, Smedsrod B. Scavenger endothelial cells of vertebrates: a nonperipheral 
leukocyte system for high-capacity elimination of waste macromolecules. Proc Natl Acad Sci U S A 
2002;99:7594-7597. 
6. Wisse E. An ultrastructural characterization of the endothelial cell in the rat liver sinusoid under 
normal and various experimental conditions, as a contribution to the distinction between endothelial 
and Kupffer cells. J Ultrastruct Res 1972;38:528-562. 
7. Elvevold, K., Simon-Santamaria, J., Hasvold, H., et al. Liver sinusoidal endothelial cells depend on 
mannose receptor mediated recruitment of lysosomal enzymes for normal degradation capacity. 









FCγRIIB2 EXPRESSION IN ENDOTHELIUM OF LIVER AND PLACENTA 
 
CL Anderson, JM Robinson, S Mohanty, LP Ganesan, J Kim 
The Ohio State University College of Medicine; Columbus, Ohio, USA 
 
Fc receptors for IgG (FcγR) are expressed in the endothelium (EC) of the body at only two sites, the liver 
sinusoids (LSEC) and the placental villus; and at both sites the FcγR is of the same special sort, namely, 
FcγRIIb2.  Such expression presents three striking features.  First, FcγRIIb2 is the only FcγR of many (8 
FcγR genes in man; 4 in mouse) that transduces an inhibitory signal; the others are agonists.  Is this 
compatible with the simple function of immune complex (IC) disposal or does it suggest a different 
activity?  Second, FcγRIIb2 at these two sites is apparently unopposed by an interacting agonistic 
receptor as it is at all other sites of expression in the body.  Have we missed finding an agonist receptor 
or does the receptor cluster with itself upon IC engagement?  Third, the isoform expressed is the 
truncated ‘b2’ isoform found in macrophages rather than the longer ‘b1’ isoform found in B 
lymphocytes.  Is this important?  So far the function of FcγRIIb2 at both of these sites is unknown.   
Despite the similarities in FcγRIIb2 expression, one must be wary of carrying too far the parallel 
between EC of both liver and placenta, for the EC at the two sites are distinctive in many respects.     
Having analyzed in depth the expression and function of FcγRIIb2 in the placenta EC, we are extending 




ENDOCYTOSIS AND RECYCLING OF IMMUNE COMPLEXES MEDIATED BY THE 
FcγRIIb2 IN RAT LIVER ENDOTHELIAL CELLS 
 
Seyed Ali Mousavi, Marita Sporstøl Fønhus and Trond Berg. 
Department of Molecular Biosciences, P.O. Box 1041 University of Oslo, Blindern, Oslo 
 
Introduction: Liver sinusoidal endothelial cells (LSECs) are equipped with receptors that mediate 
endocytosis of harmful molecules from blood.  The receptors in question are, among others, scavenger 
receptors (ScR), mannose receptors and Fc-receptors. Earlier studies showed that an IC (DNP-BSA in 
complex with rabbit anti DNP-IgG) is removed almost mainly by the liver following intravenous 
injection in rats. Kupffer cells and LSECs are responsible for the uptake.  The antigen (DNP-BSA) is a 
ligand for ScRs and was found to reach the lysosomes and degraded more rapidly than the IC1.  
Methods and Results: Four different classes of FcγRs have been identified in rodents (FcγRI-IV)2. RT-
PCR and western blot analyses indicated that LSECs express only the FcγRIIb. As expected, a 
monoclonal antibody against FcγRIIb prevented binding of 125I-ICs completely. Two splice variants exist 
for FcγRIIb3 (FcγRIIb1 and FcγRIIb2); only FcγRIIb2 is able to mediate endocytosis of ICs. Using a 
deglycosylation analysis of FcγRIIb isoforms revealed that only the FcγRIIb2 is expressed in LSECs.  By 
measuring binding of a monoclonal antibody against rat FcγRIIb to LSECs it was found that each cell 
expressed about 500,000 receptors. The cells internalise both ICs and antigens effectively, but the 
antigens (e.g. DNP-BSA) are degraded much more rapidly than the ICs, compatible with the in vivo data. 
IC was also found to be internalized at a slower rate than the Ag. Two reasons for these differences are 
suggested:  First, the ICs seemed to be associated with detergent-resistant membranes on cross-linking 
before internalization via clathrin-coated pits, secondly the ICs were found to be recycled to the plasma 
membrane to a very large extent. Both these incidents will of course delay receptor-ligand transport to 
later endocytic compartments.   
Discussion and Conclusion: The present data shows that the ICs are degraded, albeit at a lower rate 
than the Ag. What happens to the receptor? It was found that during four hours the cells internalise ICs 
corresponding to about 5 pools of FcγRIIb in the cells. Moreover, western blot analysis performed before 
and after incubation of the cells in presence of saturating concentrations of ICs over night did not reduce 
receptor concentration. These results are compatible with the finding that cross-linking of FcγRIIb does 
not lead to tyrosine phosphorylation. In conclusion, the FcγRIIb2 in LSECs effectively removes ICs 
from the circulation. It is perpetually available to mediate endocytosis of IC, as it is not downregulated. 
Maybe the FcγRIIb2 in LSECs, similar to its role in dendritic cells, is able to present antigen to B cells. 
References: (1) Johansson AG, Løvdal T, Magnusson KE, Berg T and Skogh T: Hepatology 1996; 
24:169-175. (2) Nimmerjahn F and Ravetch JV: Advances in Immunology 2007; 96:179-204. (3) 
Miettinen HM, Rose JK and Mellman I: Cell 1989; 58:317-327.  
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Abstract #5
INVERTEBRATE ANALOGUES OF HEPATIC SINUSOIDAL SCAVENGER SYSTEMS 
 
Dr. A. Clive Crossley 
IASOS, University of Tasmania, Private Bag 77, Hobart, Australia, 7000. 
 
Cells specialised for receptor-mediated endocytosis comprise an important part of invertebrate soluble 
waste management and innate immune systems. These cells can be visualised using the same vital dyes 
used in classical methods for identifying cells of the vertebrate RES, such as lithium carmine. 
Ultrastructural, molecular and genetic analyses reveal many analogies between invertebrate and 
vertebrate scavenger systems such as those of the hepatic sinusoid, including distinct processing systems 
for insoluble and soluble materials. In insects the pinocytic scavenger cells are termed nephrocytes, and 
are distinct from circulating and fixed phagocytic macrophages. Nephrocytes are central to homeostasis 
of the blood by recycling foreign, disfunctional or surplus proteins and metals. They are also important 
in innate immunity, responsible for bacteriolysis and uptake of viruses. Nephrocytes can be maintained 
in vitro allowing analysis of endocytic processes, independently of macrophage phagocytosis, and their 
large size facilitates microscopy. Nephrocytes show infolding of the plasma membrane, which increases 
the surface available for coated vesicle endocytosis, and have an extraordinarily active endocytic system. 
Receptor-mediated endocytosis is coupled to a rapid ligand-detachment and membrane-recycling system 
of tubular elements, and an active lysosomal degradation system. Unlike hepatic sinusoidal endothelial 
cells, nephrocytes are sheathed in a basal lamina, and a have podocyte, rather than a fenestrated, 
configuration. The podocyte structure allows filtration of lymph before it reaches vesicular receptors, 
and resembles the primary urine filter seen in the glomerular cells of the mammalian kidney. Insect 
nephrocytes have scavenger receptors for uptake of formaldehyde treated albumen, collagen, and 
hyaluronan, but no mannose receptor. The insect receptors appear not to be homologous with vertebrate 
scavenger endothelial cell receptors. However, as in scavenger endothelial cells, energy derived from 
endocytic catabolism is returned to the blood as lactate. Genetic analysis of Drosophila has revealed the 
sequence of genes controlling differentiation of heart, nephrocytes, and haemopoietic tissue from 





UPTAKE OF OLIGONUCLEOTIDES BY SCAVENGER ENDOTHELIAL CELLS IN THE 
ATLANTIC COD (Gadus morhua, L.)  
 
Montserrat Martin-Armas1, Bård Smedsrød1, Tore Seternes2 
1 Department of Cell Biology and Histology, Institute of Medical Biology. 2 Department of Marine Biotechnology, 
The Norwegian College of Fishery Science. University of Tromsø, N-9037 
Tromsø, Norway 
 
Introduction: The term ‘scavenger endothelial cells’ (SECs) was introduced by Smedsrød et al. in 1999. 
It describes a specialized type of endothelium that is highly and uniquely active in endocytosis of an 
array of waste macromolecules and colloids. In land-based vertebrates (mammals, birds, reptiles and 
amphibians) SECs make up the liver sinusoidal endothelial cells (LSECs). In bony fish SECs are located 
in heart (endocardium) or kidney (kidney sinusoids), but not in liver. In the Atlantic cod, SECs line the 
inner aspects of the chambers of the heart. Studies in our laboratory have shown that Atlantic cod SECs 
share the high endocytic capacity and specificity that characterize their mammalian counterpart. These 
cells eliminate a broad spectrum of own and foreign waste material, including LPS.  
The elimination of blood borne DNA fragments by mammalian LSECs has been previously shown by 
others. Fragments of DNA, especially bacterial DNA may act as immunomodulators. The immune 
stimulatory effects of bacterial DNA are a consequence of the presence of unmethylated CpG 
dinucleotides in particular base contexts, termed CpG motifs. In the present study we describe the 
elimination of DNA oligonucleotides from the circulation by SECs in the Atlantic cod.  
Methods: Radiolabelled and FITC-CpG-oligonucleotides were injected intravenously into Atlantic cod. 
The radioactivity was measured and organ sections were studied to elucidate the site(s) of accumulation 
after different time points. Co-injection of radiolabelled oligonucleotides with excess amounts of 
formaldehyded-serum albumin (FSA, a much used test ligand to study scavenger-mediated endocytosis) 
was performed to determine the possible uptake of oligonucleotides via the scavenger receptor. 
Primary cultures of heart SECs were prepared to investigate the route of cellular uptake of the 
oligonucleotides. We also tested the effect that pre-incubation with CpG-oligonucleotides, has on the 
endocytosis via the mannose- and scavenger-receptors by checking in vitro uptake of radiolabelled FSA, 
mannan and α-chains of collagen. 
Results and conclusion: The results suggest that intravenously injected radiolabelled FITC-
oligonucleotides accumulate mainly in the heart of Atlantic cod. Intravenously injected FITC-
oligonucleotides were found concentrated in vesicles of heart SECs. Moreover, studies using in vitro 
cultures of cod SECs revealed efficient uptake of FITC-oligonucleotides after incubation for 1h. 
Injection of surplus amounts of FSA along with radiolabelled oligonucleotides diverted the accumulation 
of radioactivity from heart to liver and intestines. This indicates that uptake of these oligonucleotides in 
heart is scavenger receptor mediated. Additionally, in vitro studies showed that incubation of 
oligonucleotides in the presence of excess amounts of scavenger receptor ligands, such as FSA and 
hyaluronan, inhibits the uptake by Atlantic cod SECs. These observations strengthen the notion that 
endocytosis of CpG in cod SECs is a scavenger receptor mediated process. 
Preincubation for 24 h of SECs with CpG-oligonucleotides (5 and 20 µg/ml) selectively down-regulated 
the scavenger receptor mediated endocytosis in SECs, while only marginal effects were noted on 
endocytosis via the mannose receptor. In conclusion, Atlantic cod SECs are the main elimination site of 
blood borne oligonucleotides and this elimination occurs via the scavenger receptor. Moreover, SECs 
cultured in the presence of CpG-oligonucleotides exhibit a profoundly reduced scavenger receptor 




HYPOXIA INDUCIBLE FACTOR (HIF-1α) AND RELATED miRNAs IN THE 
REGULATION OF ETHANOL INDUCED INFLAMMATORY GENES IN LIVER 
SINUSOIDAL ENDOTHELIAL CELLS (LSECs)  
 
Vijay K. Kalra1, Samantha Yeligar1 and Hidekazu Tsukamoto2  
Department of Biochemistry and Molecular Biology1, and Pathology2, Research Center for Alcoholic Liver and 
Pancreatic Diseases, University of Southern California Keck School of Medicine, Los Angeles, CA 90033, USA  
 
Chronic ethanol consumption leads to liver inflammation and injury. Studies have shown that high blood 
alcohol levels are accompanied by hypoxia and activation of HIF-1α in the liver. To delineate the role of 
HIF-1α in regulating inflammatory genes in LSECs, rats were fed ethanol (9-15 gm/kg/day) by 
intragastric feeding for 9 weeks. Sinusoidal endothelial cells were isolated from the liver, which were 
>95% pure as assessed by LSEC markers. RNA was isolated from LSECs derived from control (C-
LSEC) and ethanol fed rats (E-LSEC) followed by qRT-PCR. We show that the mRNA expression of 
chemokine genes (MCP-1, RANTES and MIP-2), vasoconstrictor molecule (ET-1) and HIF-1α 
increased 2-4-fold in E-LSEC vs. C-LSEC. Cultured rat LSECs, (which do not express fenestrae,) that 
were treated with ethanol (50-100mm) showed upregulation in the expression of the same genes as well 
as HIF-1α, as was observed in E-LSEC. Next, we examined whether the effect of ethanol was similar or 
different in endothelial cells derived from other vascular beds. Treatment of human dermal 
microvascular endothelial cells (HDMVECs) or cell line with ethanol resulted in increased mRNA 
expression of MCP-1, RANTES, MIP, ET-1 and HIF-1α. Thus, we used HDMVECs for ease of 
transfection and for mechanistic cell signalling studies. We examined whether ET-1 expression was 
regulated by HIF-1α, as hypoxia is known to regulate the expression of ET-1 via HIF-1α. We observed 
that ethanol caused a time-dependent increase in the expression of HIF-1α protein. Transfection of 
HDMVECs with wt-ET-1-luc plasmid (-669 bp) or truncated ET-1 promoter-luc plasmid (-176 bp) 
showed several fold increase in ET-1 promoter activity, which was attenuated when the hypoxia 
response element was mutated in the ET-1 promoter. Furthermore, silencing of HIF-1α protein with 
siRNA in HDMVECs attenuated ethanol-mediated ET-1 expression along with other genes. 
Electrophoretic mobility shift assay (EMSA) and chromatin immunoprecipitation (ChIP) analysis 
support the role of HIF-1α in the ethanol mediated transcription of ET-1 in response to ethanol. 
 
Since ethanol increased the HIF-1α mRNA and protein levels in LSECs, we hypothesized that HIF-1α 
related microRNAs (miRNAs) may play a role in HIF-1α mRNA expression and concomitantly HIF-1α 
regulated genes. We isolated miRNA from E-LSEC and C-LSEC. Several putative HIF-1α miRNAs 
were identified including miR-20, miR-155, miR-199, miR-17-3p and miR-203. The expression levels of 
miR-155, miR-199 and miR-17-3p, as determined by qRT-PCR, were significantly reduced while the 
expression of miR-20 increased significantly in E-LSEC as compared to C-LSEC. Data will be presented 
on the cell signalling pathways for the expression of specific HIF-1α related miRNAs and their 
functions. These studies show for the first time that ethanol activates ET-1 via HIF-1α, independent of 
hypoxia. The ethanol mediated release of ET-1 may activate HSCs and exaggerate vasoconstriction and 
hepatic blood flow, and inflammation in the liver. Supported by NIH-P50-AA11999, R24-AA12885 and 
training grant (T32-AA07578) fellowship to SY.  
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THE INFLUENCE OF OXYGEN TENSION ON THE STRUCTURE AND FUNCTION OF 
ISOLATED LIVER SINUSOIDAL ENDOTHELIAL CELLS 
 
Martinez I*, Nedredal GI§, Øie CI, Warren A **, Johansen O*, Le Couteur DG** and Smedsrød 
B* 
* Department of Cell Biology and Histology, IMB, Department of Medicine, IKM, Department of Orthopaedic 
Surgery, IKM, and §Surgical Research Lab, IKM, University of Tromsø, Norway. 
** Centre for Education and Research on Ageing and the ANZAC Research Institute, Concord RG Hospital and 
University of Sydney, Australia.  
 
Background: Liver sinusoidal endothelial cells (LSECs) are specialized scavenger cells, with crucial 
roles in maintaining hepatic and systemic homeostasis. Under normal physiological conditions, the 
oxygen tension encountered in the hepatic sinusoids is in general considerably lower than the oxygen 
tension in the air; therefore cultivation of freshly isolated LSECs under more physiologic conditions with 
regard to oxygen would expect to improve cell survival, structure and function. In this study LSECs 
were isolated from rats and cultured under either 5% (normoxic) or 20% (hyperoxic) oxygen tensions, 
and several morpho-functional features were compared. 
Results: Cultivation of LSECs under normoxia, as opposed to hyperoxia improved the survival of 
LSECs and scavenger receptor-mediated endocytic activity, reduced the production of the pro-
inflammatory mediator, interleukin-6 and increased the production of the anti-inflammatory cytokine, 
interleukin-10. On the other hand, fenestration, a characteristic feature of LSECs disappeared gradually 
at the same rate regardless of the oxygen tension. Expression of the cell-adhesion molecule, ICAM-1 at 
the cell surface was slightly more elevated in cells maintained at hyperoxia. Under normoxia, 
endogenous generation of hydrogen peroxide was drastically reduced whereas the production of nitric 
oxide was unaltered. Culture decline in high oxygen-treated cultures was abrogated by administration of 
catalase, indicating that the toxic effects observed in high oxygen environments is largely caused by 
endogenous production of hydrogen peroxide. 
Conclusions: Viability, structure and many of the essential functional characteristics of isolated LSECs 
are clearly better preserved when the cultures are maintained under more physiologic oxygen levels. 
Endogenous production of hydrogen peroxide is to a large extent responsible for the toxic effects 
observed in high oxygen environments. 
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AGE-RELATED CHANGES IN SCAVENGER-RECEPTOR MEDIATED ENDOCYTOSIS 
IN RAT LIVER SINUSOIDAL ENDOTHELIAL CELLS 
 
Jaione Simon-Santamaria1, Ivana Malovic1, Alessandra Warren2, Ana Oteiza1, David LeCouteur2, 
Bård Smedsrød1, Peter McCourt1, Karen Kristine Sørensen1  
1Department of Cell Biology and Histology, Institute of Medical Biology, University of Tromsoe, Tromsoe, 
Norway; 2Centre for Education and Research on Ageing, University of Sydney and Concord RG Hospital, Sydney, 
NSW, Australia 
 
In spite of the generally accepted notion that liver sinusoidal endothelial cells (LSECs) play a pivotal 
role in the clearance of waste substances from the circulation via different types of scavenger receptors, 
very little is known about the effect of ageing on the activity of these receptors. Recently, distinct age-
related morphological changes have been described in the liver sinusoids of human, rat, mouse and 
baboons (1-5). These changes have been named pseudocapillarization because they resemble those 
occurring in cirrhosis, including loss of fenestrae, thickening of the endothelium, and formation of basal 
lamina and collagen deposits in the Space of Disse. The aim of this study was to compare scavenger-
receptor-mediated endocytosis in LSECs from young and old rats and determine if it is associated to the 
morphological changes seen in pseudocapillarization.  
Hybrid F344/BN F1 rats, aged 4-8 months and 26-30 months of age, were chosen as animal model to 
avoid the effect of inbreeding and homozygocity on ageing. Freshly isolated LSECs in monolayer 
cultures were incubated for 2 hours at 37°C under serum free conditions with different concentrations of 
radiolabelled formaldehyde-treated serum albumin (FSA), a ligand for the LSEC scavenger receptors. 
All experiments commenced 2 hours after seeding, and the average cell density was equal in cultures 
from young and old rats. Parallel cultures of LSEC were fixed at similar time points for Scanning 
Electron Microscopy (SEM) analysis of culture quality and cell fenestration (using the Image-J 
software). Liver tissues from old and young rats were also subjected to light and transmission electron 
microscopy (TEM) for analysis of liver sinusoidal morphology in this rat strain.  
Main results and conclusions: 1) With increasing concentrations of FSA there was a significant 
reduced endocytic capacity in LSECs from old rats compared to in cells from young individuals. 2) 
Morphometrical analysis of SEM images showed a marked porosity reduction in LSEC from old animals 
compared to young animals. 3) A significant correlation between LSEC porosity and endocytosis was 
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OLD AGE AND THE HEPATIC SINUSOID 
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Morphological changes in the hepatic sinusoid with old age are increasingly recognized. These 
include thickening and defenestration of the liver sinusoidal endothelial cell, sporadic deposition of 
collagen and basal lamina in the extracellular space of Disse and increased numbers of fat engorged, 
non-activated stellate cells. In addition, there is endothelial upregulation of von Willebrands factor and 
ICAM-1 with reduced expression of caveolin-1. These changes have been termed age-related 
pseudocapillarization. The effects of old age on Kupffer cells are inconsistent but impaired 
responsiveness is likely. There are functional implications of these aging changes in the hepatic 
sinusoid. There is reduced sinusoidal perfusion, which will impair the hepatic clearance of highly 
extracted substrates. Blood clearance of a variety of waste macromolecules takes place in LSEC. 
Previous studies indicated either that aging had no effect, or reduced the endocytic capacity of LSEC. 
However, a recent study in mice showed reduced endocytosis in pericentral regions of the liver lobules. 
Reduced endocytosis may increase systemic exposure to potential harmful waste macromolecules such 
as advanced glycation end products Loss of fenestrations leads to impaired transfer of lipoproteins 
from blood to hepatocytes. This provides a mechanism for impaired chylomicron remnant clearance 
and post-prandial hyperlipidemia associated with old age. Given the extensive range of substrates 
metabolized by the liver, age-related changes in the hepatic sinusoid and microcirculation have 
important systemic implications for aging and age-related diseases. 
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AGE-RELATED DYSFUNCTION IN THE  HEPATIC MICROCIRCULATION  
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Smedsrød2 
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Ageing of the liver is associated with an impaired metabolism of drugs and potential adverse drug 
interactions and susceptibility to toxins.  Reduced hepatic blood flow is suspected to be the cause.  As a 
result, we examined  age-related alterations in hepatic microcirculation and their causes.  Livers of 
C57Bl/6 mice were examined at 0.8 (pre-pubertal), 3 (young), 14 (mature) and 27 (senescent) months of 
age using  in vivo and electron microscopic methods.  The results demonstrated a 14% reduction  in the 
numbers of perfused sinusoids between 0.8 and 27 month mice associated with 35% reduction in 
sinusoidal blood flow measured by a Laser Doppler flowmeter. This was accompanied by a hepatic 
microvascular inflammatory response evidenced by a 5-fold increase in leukocyte adhesion in 27 month 
mice, up-regulated expression of ICAM-1, and increases in intrahepatic macrophages.  Sinusoidal 
diameter decreased 6-10%.  Evidence of sinusoidal endothelial cell (LSEC) dysfunction was seen as 
early as 14 months when there was a 3-fold increase  in the numbers of swollen LSEC.  The endocytosis 
of the FITC-FSA, a ligand for the scavenger receptor on LSEC was suppressed at 14 months and further 
reduced at 27 months. This could be mimicked in young animals by injecting advanced glycosylated 
end-products (AGEs). The sinusoidal endothelium in 27 month old mice exhibited early capillarization 
with reduced fenestration together with deposition of basal laminae and collagen in the Space of Disse.  
In conclusion, the results suggest  that leukocyte accumulation in the sinusoids and narrowing of 
sinusoidal lumens reduce sinusoidal blood flow in aged livers due to early capillarization and 
dysfunction of SEC perhaps resulting from increased circulating AGEs during aging.  This study was 
supported by the National Institute Health/ National Institute of Aging, grant No.  R21 AG-02582, and 
the Norwegian Research Council, grant No. 153483/V50. 
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ATHEROSCLEROSIS, LIPOPROTEINS AND THE LIVER SIEVE 
 
Fraser R, Day WA, Dobbs BR, Jamieson HA, Cogger VC, Hilmer SN, Warren A, Le Couteur DG, 
University of Otago, Christchurch, New Zealand and University of Sydney, Concord, Australia 
 
Atherosclerosis, localized thickenings or plaques of the intima of arteries from cholesterol deposition 
and cellular hyperplasia causing thrombosis and obstruction, is a major killer due to ischaemic heart 
failure, strokes, gangrenous feet and aortic aneurysm.  In 1976 in Tokyo, at the third International 
Symposium on Atherosclerosis, we first presented data confirming that the fenestrated liver sinusoidal 
endothelial cells (LSEC) filtered chylomicrons and their remnants (intestinal lipoproteins transporting 
cholesterol) according to their size.1 We postulate, with implications in atherogenesis, that sieving 
controls the balance between exogenous (dietary) and endogenous (hepatic-synthesized) cholesterol in 
tandem with hepatocyte receptor-mediated uptake.2 
The possibility that the size and composition of chylomicrons influences atherogenesis had long 
intrigued us.3 Chylomicrons, in cholesterol-fed and atherosclerotic-prone New Zealand white rabbits 
increased in diameter from about 50-100nm to 100-800 nm as triglycerides were added to the cholesterol 
in their diet,4 as well as increasing the ratio of free to esters of cholesterol.5  Zilversmit and others have 
shown chylomicron lipids, especially the esters of cholesterol and retinol are the major lipids in 
atherosclerotic plaques.6 
Despite fat of dietary origin in early fatty plaques, Wissler’s group showed that the concurrent 
hyperplasia of the arterial smooth muscle cells (SMC), at least in tissue culture, was triggered not by 
chylomicrons, but by low density lipoproteins transporting liver-synthesized cholesterol.7 It is known 
that dietary cholesterol, if it enters the hepatocytes, inhibits their synthesis of cholesterol.2 
Florén in 1984 demonstrated that in vitro hepatocytes bound chylomicron-cholesterol, but in vivo large 
native chylomicrons did not bind, this only occurring when smaller chylomicron remnants entered the 
hepatic circulation. He suggested this was due to “steric hindrance” of chylomicron-uptake.8 Wisse’s 
seminal hypothesis in 1970, that the 100nm pores or fenestrae of the LSEC endothelium might filter 
chylomicrons, explains this “steric hindrance”.9 In 1978 both our group and Naito and Wisse published 
to confirm this sieving, as shown by comparing the sizes of chylomicrons in the sinusoidal lumen 
compared to the space of Disse, as well as the trapping of radio- labeled chylomicrons and remnants of 
small size within the liver. 10, 11 
Since then our major research thrust has been testing the hypothesis that a low porosity liver sieve 
predisposes to post-prandial hyperlipidaemia (consisting especially of chylomicrons and their 
remnants, but also of liver synthesized cholesterol in LDL, since the latter’s synthesis would not be 
switched off by dietary cholesterol2).  These experiments confirmed a low porosity in species of high 
sensitivity to dietary cholesterol (e.g. NZ white rabbits12 and chickens13).  In rats and primates with 
higher porosity sieves, the effects of drugs such as nicotine,14 excess alcohol,15 and various pro-
atherogenic-diseases, such as diabetes16 which reduce their porosity, lead to hyperlipoproteinaemia.     
Rabbit sub-species with differing porosities (which were shown to differ in ability to sieve a 70-90nm 
adenovirus) might in future make interesting experimental subjects if fed cholesterol.17 
The new millennium heralded a change of direction, as instigated by our Sydney colleagues with their 
interest in old age 18.  Coronary artery disease and post-prandial hyperlipidaemia increase with age19 
and we found that these correlated with a decrease in sinusoidal porosity in many species including 
humans.20, 21,  Whether this decrease is purely an age factor, or is related to long-term diets, toxins or 
concurrent disease states, has yet to be determined.  It has also been shown that the semi-starvation of 
the Methuselah diet increases porosity and also leads to longevity,22 while some detergents or 
surfactants decrease porosity and increase atherosclerosis.23   
Our dream is to find an enjoyable lifestyle or a safe drug to increase LSEC porosity and longevity. 




DIFFERENT EXPRESSIONS OF AQUAPORIN-1 IN NORMAL AND CIRRHOTIC 
HUMAN LIVER – DEMONSTRATING THE CAPILLARIZATION OF HEPATIC 
SINUSOIDS 
Oda, M.1) and Yokomori, H.2) 
1) Organized Center of Clinical Medicine and Dept. of Internal Medicine, Sanno Hospital, International University 
of Health & Welfare, Tokyo, Japan 107-0052 2) Dept. of Internal Medicine, Kitasato Medical Center Hospital, 
Saitama, Japan 364-8501   
In liver cirrhosis, defenestration of hepatic sinusoidal endothelial cells concomitant with extensive 
collagen deposition in the space of Disse causes an increase in peripheral portal microvascular 
resistance, leading to portal hypertension. In general, aquaporins (AQPs) are key regulators in water 
channels, contributing to the control of microcirculation by regulating water transport across the 
microvascular endothelial cells. A couple of immunohistochemical studies have been directed to the 
localizations of AQPs in the hepatobiliary system in mammals. However, little is known about the 
localizations of AQPs in the hepatic microvascular system including sinusoids and about their alterations 
in liver cirrhosis. The aim of the present study is to clarify the immunohistochemical and 
immunoelectron microscopic expressions of AQP-1 in the microvessels in normal human liver and 
primary biliary cirrhosis (PBC). 
As human normal liver samples (controls), wedged liver biopsy specimens were obtained from normal 
portions of the livers of 10 patients who underwent surgical resection for metastatic liver carcinoma (8 
colonic carcinomas, 2 gastric carcinomas). Fifteen wedged liver biopsy specimens of PBC patients (5 
cases each of stage I-II and stage III) and 5 samples of cirrhotic livers removed from PBC stage IV 
patients for liver transplantation were subjected to the following studies. Immuno-staining was 
performed on the serial 5 µm sections of control and PBC liver tissues fixed in PLP solution. For 
immunohistochemistry, semi-thin liver sections were incubated overnight at 4°C with anti-AQP-1 rabbit 
polyclonal antibody as primary antibody, followed by incubation with peroxidase-conjugated anti-rabbit 
IgG antibody according to the Envision method for light microscopy. For immunoelectron microscopy, 
semi-thin liver sections were incubated with anti-AQP-1 antibody as above followed by incubation with 
1.4nm colloidal gold-conjugated anti-rabbit IgG antibody for 40 min at room temperature. Then the 
ultrathin sections were observed by transmission electron microscopy. Western blotting was conducted 
using fresh control and PBC liver tissues. For histochemical in situ hybridization (ISH), human AQP-1 
RNA probes were used with a CSA system. By focusing on the microvascular system in control liver 
tissue, the immunoperoxidase-positive reaction products showing the presence of AQP-1 were found to 
be mainly localized along the endothelial lining cells in the portal venules, hepatic arterioles and arterial 
capillaries in the portal tract, while these AQP-1 expressions were hardly detected in the hepatic 
sinusoids. By immunoelectron microscopy, the electron dense immuno reactive gold particles showing 
the presence of AQP-1 were evident on the plasma membranes of endothelial cells in the microcirculator 
vasculature except hepatic sinusoids as above. In PBC stage I-II liver tissue, AQP-1 distributions on the 
microvascular vessels were similar to those in control liver tissue. On the contrary, AQP-1 was 
aberrantly expressed on the sinusoidal endothelial lining cells in the periportal zone and in the periphery 
of the regenerating hepatic nodules circumscribed with the fibrotic septa in PBC stage IV cirrhotic liver 
tissue. By immunoelectron microscopy, the immunoreactive gold particles specifically demonstrating the 
existence of AQP-1 were proved on the endothelial cell plasma membranes of hepatic sinusoids 
surrounded not only with excessive collagen fibers in the perisinusoidal space of Disse, but also with the 
basement membranes just beneath the sinusoidal endothelial cell linings. Overexpressions of AQP-1 at 
protein and mRNA levels were demonstrated by Western blot and ISH, respectively.  
In conclusion, AQP-1 protein molecules were proved to be aberrantly expressed on the plasma 
membranes of sinusoidal endothelial cells (SECs) in cirrhotic liver of PBC. These new findings indicate 
that AQP-1 would induce the transformation of the fenestrated SEFs into “the defenestrated capillary 
endothelial cells” in association with excessive collagen deposition in the perisinusoidal space, further 
increasing the defenestrated sinusoidal microvascular resistance, and thus contributing to the progression 
of portal hypertension in PBC.  
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IMPLICATION OF CORTACTIN, A REGULATOR OF ACTIN CYTOSKELETON 
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Liver sinusoidal endothelial cells (LSECs) possess fenestrae, open pores approximately 100 to 200 nm in 
diameter, arranged in sieve plates. Alterations in their number or diameter in liver diseases have 
important implications for hepatic microcirculation and function. Sieve plates and fenestrae are clearly 
delineated by cytoskeleton elements, including actin and microtubules. In addition, from the use of actin 
binding drugs, which stabilize or disassemble actin microfilaments, it was learned that actin dynamics 
govern the appearance of these structures. Although decades of studies using SEM approaches have 
characterized sieve plates and fenestrae at the ultrastructural level, much remains to be discovered on the 
mechanisms by which these structures form.  
 
Since cortactin constitutes an important molecular scaffold for actin assembly of cytoskeletal structures 
involved in cellular processes such as endocytosis, adhesion, migration and invasion, we sought to 
explore its role in the formation of fenestrae. We first developed an in vitro assay, which, by measuring 
the cell surface occupied by fenestrae though IRM (Interference Reflection Microscopy) enables us to 
study their dynamics. Next, we examine cortactin expression and subcellular distribution in LSEC. 
Immunohistochemical staining for cortactin in liver tissue sections revealed an intense staining in LSEC. 
Cortactin was also detected by immunofluorescence in primary LSEC isolated from mice livers. In these 
cells, cortactin presented an unusual pattern, which manifested by colocalization of the protein with the 
microtubule network. Consequently, cortactin was found excluded from sieve plates areas. 
 
LSEC brought in culture de-differentiate, a process associated with cytoskeleton remodelling and loss of 
fenestration. Dedifferentiation induced the dissociation of cortactin from microtubules and its 
relocalization to the cytosol, where the protein was found evenly distributed after 3 days of culture. 
Cytochalasin D treatment restored the fenestration status and this was accompanied by relocalization of 
cortactin to microtubules. Profibrogenic cytokines are known to alter LSEC characteristics. The 
dedifferentiation process and the relocalisation of cortactin were accelerated upon TGF-β1 treatment and 
delayed in the presence of SB-431542, an inhibitor of Alk-5 TGF-β1 type I receptor. Analysis of TGF-
β1 signalling pathways are in progress to determine how TGF-β1 affects cortactin localization and 
especially whether TGF-β1 is responsible for post-translational modifications of coractin. 
 
Altogether, the correlation between cortactin subcellular localisation and the fenestration status of LSEC, 
combined with the known function of cortactin in cytoskeletal organization, identify cortactin as a prime 
candidate to explain the dynamics of LSEC fenestrae. 
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INVOLVEMENT OF SIGNALING OF VEGF AND TGF-β1 IN DIFFERENTIATION OF 
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Introduction: Embryonic development of the liver is closely associated with vascular organization. Our 
previous study showed that the maturation of sinusoidal endothelial cell (SEC) occurred between E13.0 
to E15.0 of the fetal rat liver. However, little is known about the mechanisms of SEC differentiation 
during liver development. To investigate factors related to the differentiation of SEC, we examined the 
effects of VEGF and SB-431542 (an inhibitor of TGF-β1 receptor kinase; ALK-5) on the cultured fetal 
rat liver cells. Appearance of the endothelial cell sheets with fenestration structures and expression of the 
maturation markers of SEC, SE-1 and stabilin-2, were examined during the culture.  
Materials and Methods: Frozen sections obtained from E13.5 to 21.5 fetal rat livers were stained with 
antibodies against SE-1 and stabilin-2. Whole liver cells from E13.5 rat fetus were cultured in EBM-2 
medium containing VEGF and/or SB-431542 for 4 and 7days. Endothelial sheet formation and 
expression of the two markers in the cultured cells were investigated. Phosphorylation of Smads, the 
down-stream molecules of TGF-β1, was examined. 
Results and Conclusions: SE-1 and stabilin-2 were co-expressed in SEC in the late stage of liver 
development (E15.5-17.5), although stabilin-2 was expressed in almost all vascular endothelial cells in 
the early stage. After culturing E13.5 fetal liver cells for 7 days under the presence of VEGF, 
proliferated-endothelial sheets were observed. But cells of the sheets expressed neither SE-1 nor stabilin-
2. Under the presence of both VEGF and SB-431542, the endothelial sheets became to express stabilin-2 
and contained some SE-1 co-expressing cells. These findings suggest that VEGF plays a role in the 
endothelial sheet formation, and block of TGF-β1 signaling may involve in differentiation of SEC.  
The present study indicates that co-expression of SE-1 and stabilin-2 is an adequate marker for the 
differentiated-SEC. Signaling of VEGF and TGF-β1 is involved in differentiation of SEC in culture of 
fetal rat liver cells. Further analysis on genes related to the SEC differentiation is currently in progress 
using the DNA micro array. 
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Interleukin-1 (IL-1) up-regulates the endocytic activity of mannose receptor (ManR) expressed by 
liver sinusoidal endothelial cells (LSEC), a 175 kDa transmembrane glycoprotein involved in 
homeostatic processes and endogenous defence. ManR binds and uptakes mannosylated molecules, C-
terminal procollagen peptides and denatured collagen from blood, and contributes to the clearance of 
circulating infectious agents, but also to the adhesion of cancer cells to liver sinusoid endothelial cells 
(LSEC). Interestingly, ManR is involved in antigen uptake, processing and presentation to T cells by 
LSEC and it has been suggested that this process diminishes local immune response of the liver under 
physiological conditions. However, at present it is unknown how expression and function of ManR are 
regulated during the hepatic microvascular infiltration of metastatic cancer cells. Furthermore, the 
possible contribution of ManR to the regulation of anti-tumor immunity during hepatic metastasis 
development is also unknown.  
We examined ManR regulation during C26 colorectal cancer cell interaction with LSEC, and its 
immunological implications in the hepatic metastasis microenvironment. Expression and activity of 
ManR were determined by both immunohistochemistry and labelled mannan or ovalbumin uptake. Anti-
ManR antibodies were used to suppress ManR activity in primary cultured LSEC. Anti-IL-1 receptor 
type I antibody, IL-1 receptor antagonist and IL-1beta converting enzyme inhibitor were used to analyze 
the role of IL-1 in the regulation of ManR. 
ManR expression and endocytic activity concomitantly increased in LSEC upon direct interaction 
with metastatic C26 cells in vitro and in vivo. The mechanism involved three steps: (1) activation of 
LFA-1-expressing cancer cells by intercellular adhesion molecule (ICAM)-1 expressed and secreted by 
LSEC; F(2) release ofcyclooxygenase-2 (COX-2)-dependent IL-1-stimulating factor(s) by cancer cells 
enhancing LSEC-derived IL-1 by 2-fold; and (3) widespread increase of ManR expression and function 
in LSEC induced by paracrine IL-1, leading to decreased anti-tumor cytotoxicity and interferon-gamma 
secretion by liver sinusoidal lymphocyte. ICAM-1-induced tumor COX-2 activity led to the inhibition of 
regional anti-tumor immunity during hepatic colon carcinoma metastasis via IL-1-dependent endothelial 
ManR.  
ManR may constitute a common mediator for prometastatic effects induced by IL-1, COX-2 and 
ICAM-1. The finding that antitumor hepatic immune response activation occurs via ManR deactivation 




INNATE IMUNITY IN ALCOHOLIC LIVER DISEASE: ROLE OF KUPFFER CELLS 
 
L.E. Nagy 
Cleveland Clinic Foundation, Cleveland OH 44195, USA 
 
Alcoholic liver disease (ALD) develops in approximately 20% of all alcoholics and is a complex process 
involving both parenchymal and non-parenchymal cells resident in the liver, as well as the recruitment of 
other cell types to the liver in response to damage and inflammation.  Components of the innate immune 
response, including NK and NKT cells, Kupffer cells (resident hepatic macrophages) and the 
complement system, as well as T-cells and antibody-dependent adaptive immune responses, contribute 
to the pathophysiology of ALD.   
 
Activation of the innate immune response in the liver during chronic ethanol exposure is associated with 
increased production of pro-inflammatory cytokines and chemokines, as well as reactive oxygen species 
(ROS).  Kupffer cells are critical to the onset of ethanol-induced liver injury.  Ablation of Kupffer cells 
prevents the development of fatty liver and inflammation, early stages in the progression of ethanol-
induced liver damage, in rats chronically exposed to ethanol.  Endotoxin/ lipopolysaccharide (LPS), a 
component of gram-negative bacterial cell walls, is an important activator of Kupffer cells. LPS 
concentration is increased in the blood of alcoholics and animals exposed to ethanol, probably due to 
impaired barrier function of the intestinal mucosa.  
 
 In addition to increasing the exposure of Kupffer cells to LPS, chronic ethanol also sensitizes Kupffer 
cells to activation by LPS, leading to increased production of ROS and inflammatory cytokines, 
including tumor necrosis factor α (TNFα). The mechanisms for this ethanol-induced sensitization of 
Kupffer cells is not well understood, but recent data suggest that decreased expression of adiponectin, an 
adipokine with anti-inflammatory properties, during ethanol exposure contributes to a more robust 
inflammatory response by Kupffer cells.  Studies in our laboratory have investigated the molecular 
mechanisms by which ethanol and adiponectin interact to modulate Kupffer cell sensitivity to LPS.  LPS 
rapidly increases ROS production in Kupffer cells, with ROS production 2.5-fold greater in ethanol-fed 
compared to pair-fed.  Pre-treatment with diphenyleneiodonium (DPI), which inhibits NADPH oxidase, 
normalizes ROS production in Kupffer cells from ethanol-fed rats.  LPS rapidly increases the quantity of 
GTP bound-Rac1 and p67phox translocation to the plasma membrane in Kupffer cells from pair-fed rats; 
these responses are enhanced in Kupffer cells from ethanol-fed rats. These results demonstrate that 
chronic ethanol feeding increases LPS-stimulated NADPH oxidase activity in Kupffer cells. Treatment 
of Kupffer cells with adiponectin restores LPS-stimulated TNFα production to control values; this 
normalization is associated with decreased GTP bound-Rac1, as well as decreased LPS-stimulated ROS 
production.  Adiponectin also normalizes the expression of p47phox mRNA and protein after ethanol 
feeding.  Taken together, these data suggest that increased LPS-stimulated NADPH oxidase activity 
contributes to the sensitization of Kupffer cells to LPS and that adiponectin, a critical anti-inflammatory 
modulator, can specifically ameliorate these ethanol-induced changes in the TLR4 signaling cascade.  




KINETICS AND REPLACEMENT OF KUPFFER CELLS AFTER BONE MARROW 
TRANSPLANTATION IN MICE AND RATS 
 
Takashi Yamamoto1, Hiroki Kawamura2, Takashi Oite3, Makoto Naito1 
1 Department of Cellular Function, Division of Cellular and Molecular Pathology, 2 Department of Immunology, 3 
Department of Cellular Physiology, Institute of Nephrology, Niigata University Graduate School of Medical and 




Kupffer cells were thought to be derived from bone marrow precursors via blood monocytes. In this 
present study, we examined replacement of Kupffer cells after bone marrow transplantation (BMT) using 
CD45 congenic mice, and GFP rats. Until 6 months after BMT, numbers of Kupffer cells did not change 
in the liver of mice after BMT. In rats, replacement of ED1-positive Kupffer cells occurred gradually 
until 6 months after BMT as previously reported, and the percentage of GFP-positive Kupffer cells was 
not more than 40% even 6 months after BMT. However, ED1-positive Kupffer cells gradually decreased 
in the liver of rats after BMT. In order to clarify the difference of numbers of Kupffer cells between rats 
and mice, we applied liposome encapsulated dichloromethylene diphosphonate (lipo-MDP) to the mice 
just before BMT. Repopulation of Kupffer cells was completed by 2 weeks in mice after lipo-MDP 
injection. In mice after simultaneous treatment with BMT and lipo-MDP, Kupffer cells repopulated 
within 4 weeks after BMT, however, the numbers of Kupffer cells gradually decreased until 6 months 
after BMT. Furthermore, long term observation of lipo-MDP injected mice without BMT revealed that 
Kupffer cells decreased gradually after repopulation. These results suggested that Kupffer cells were 
surely replaced by blood precursors, however, they could not be maintained only by the influx of bone 
marrow precursors, and they were supposed to be maintained by self proliferation. The difference of 
numbers of Kupffer cells between mice and rats after BMT might be dependent on their survival time.   
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Abstract #19
HIGH FAT FEEDING INDUCES HEPATIC INSULIN RESISTANCE AND 
PREFERENTIAL DISTRIBUTION OF KUPFFER CELLS AROUND LIPID LOADED 
HEPATOCYTES 
 
N. Lanthier1, N. Van Hul1, J. Abarca-Quinones1, V. Lebrun1, M. Petit1, C. Sempoux2, P. Stärkel1, 
Y. Horsmans1, I.A. Leclercq1 
1 Laboratory of Gastroenterology, Faculty of Medicine, Université Catholique de Louvain (UCL), Brussels, 
Belgium. 
2 Department of Pathology, Faculty of Medicine, Université Catholique de Louvain (UCL), Brussels, Belgium. 
 
Introduction: 
Inflammation and macrophage infiltration of the adipose tissue have been causally associated with the 
development of insulin resistance.  
We formulate the hypothesis that Kupffer cells, the hepatic resident macrophages, are implicated in the 
pathogenesis of hepatic insulin resistance. The aim of the study is to analyse the Kupffer cell distribution 
in a model of hepatic insulin resistance and steatosis induced by high fat feeding.  
Materials and methods:  
Male C57BL6 mice of 5 weeks of age (n=24) were fed a high fat diet (60% energy as fat, principally 
saturated) or a regular chow (10% energy as fat) for 3 days preceded or not by a 24h fasting period. This 
short term exposure to the high fat diet was chosen to preferentially induce hepatic insulin resistance. 
The fasting period was applied to enhance hepatic de novo lipogenesis and hepatic fat accumulation. 
Body weight gain, liver weight, blood plasma glucose and insulin levels were studied. A separate group 
of mice was used to assess the hepatic insulin signaling cascade. Hepatic steatosis was evaluated on 
hepatic lipid content and liver histology. Kupffer cell distribution was studied by immunohistochemistry 
using F4/80, a cell surface glycoprotein expressed on a wide range of mature tissue macrophages. Real-
time PCR was used to examine mRNA expression of TNF-alpha and phosphoenolpyruvate 
carboxykinase (PEPCK).  
Results and conclusions:  
Mice fasted for 24h and refed a high fat diet exhibit the most impressive changes. Compared with mice 
refed the control diet, mice refed the high fat diet for 3 days gain more weight (p=0.005), have increased 
liver weight (p<0.001) and hepatic lipid content (56.2 ± 11.5 versus 11.9 ± 3.6 mg/100 mg liver, 
p<0.001). 
Fat accumulates as lipid vacuoles predominantly in the hepatocytes of the intermediate and the periportal 
lobular zones. The majority of F4/80 positive cells is found in these zones in close proximity of fat 
loaded hepatocytes contrasting with the diffuse panlobular distribution in controls. A trend in 
upregulation of TNF-alpha is observed.  
In this model, fat accumulation is associated with insulin resistance. Plasma insulin levels (2.9 ± 1.5 
versus 1.1 ± 0.4 µg/l, p=0.02) and glucose (187.0 ± 17.5 versus 121.7 ± 22.2 mg/dl, p<0.001) are 
significantly higher than in controls. Moreover mRNA levels of phosphoenolpyruvate carboxykinase 
shows an increased gluconeogenesis in the high fat group and Western blot analysis of liver proteins 
demonstrates a decreased expression of insulin receptors (p=0.002) as well as an impaired insulin-
stimulated receptor phosphorylation. 
Our data provide evidence that the fast/high fat refed model induces steatosis and insulin resistance. 
Cytokines or other soluble mediators released by Kupffer cells in the vicinity of hepatocytes may play a 
role in the development of steatosis and hepatic insulin resistance. This relationship is being further 
examined in Kupffer cell depletion experiments. 
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Abstract #20
ARACHIDONATE 5-LIPOXYGENASE MODULATES HEPATOCYTE FATTY ACID 
UPTAKE AND MICROSOMAL TRIGLYCERIDE TRANSFER PROTEIN ACTIVITY.   
 
J. Clària 
Department of Biochemistry and Molecular Genetics, Hospital Clínic, IDIBAPS, University of Barcelona, 
Barcelona, Spain 
 
The 5-lipoxygenase (5-LO) pathway generates lipid mediators from arachidonic acid with 
potent pro-inflammatory and pro-fibrogenic properties. Recent studies have found that the 5-
LO pathway is overexpressed during experimental liver injury and that among the different liver 
sinusoidal cells, Kupffer cells are the only cell type endowed with the complete enzymatic 
machinery for the biosynthesis of 5-LO products (i.e. leukotrienes (LTs)). These Kupffer cell-
derived eicosanoids display potent pro-fibrogenic properties by activating hepatic stellate cells 
in a paracrine fashion. In fact, a remarkable protection against carbon tetrachloride (CCl4)-
induced necro-inflammation and fibrosis is observed in vivo following the blockade of the 5-
LO pathway with either a selective 5-LO inhibitor (CJ-13, 610) or a potent 5-LO-activating 
protein (FLAP) inhibitor (Bay-X-1005). In light of recent findings postulating an emerging role 
for the 5-LO pathway in obesity and insulin resistance, we hypothesized that this pathway may 
also be implicated in the pathogenesis of hepatic steatosis. In the current study, we provide 
evidence that the hepatic formation of 5-LO products is increased in ob/ob mice, an 
experimental model of obesity-related steatohepatitis. In this model, inhibition of 5-LO 
pathway results in down-regulation of genes involved in hepatocyte fatty acid uptake (i.e. L-
FABP and FAT/CD36) and normalization of PPARα and acyl-CoA oxidase expression. No 
changes in the lipogenic genes, FASN and SREBP-1c, were observed. In addition, 5-LO 
inhibition restored the hepatic activity of microsomal triglyceride (TAG) transfer protein 
(MTP). Consistent with these findings, direct addition of 5-LO products such as LTB4 and 
LTD4 to hepatocytes in culture triggered cytosolic TAG accumulation by reducing MTP 
activity and TAG secretion. The functional consequence of 5-LO inhibition was a remarkable 
protection from hepatic steatosis as revealed by decreased oil red-O staining and hepatic TAG 
concentrations. Interestingly, 5-LO-deficient mice exhibited a protection against liver injury and 
a differential expression of a number of lipid metabolism-related genes including C/EBPbeta, 
SCD2, Acly and Elovl3/6. Taken together, these findings identify a novel role for arachidonate 
5-LO in the regulation of fatty acid uptake and TAG transport in hepatocytes.  
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Abstract #21
CROSS TALK BETWEEN PGE2- AND IL-6-MEDIATED SIGNALLING PATHWAYS IN 
CULTURED RAT KUPFFER CELLS 
 
Daniela Gärtner and Gerhard P. Püschel 
University of Potsdam, Department of Nutritional Biochemistry, Arthur-Scheunert-Allee 114-116, 14558 Potsdam
   
 
Introduction: Kupffer cells (KC) are tissue specific resident macrophages of the liver.  During local and 
systemic inflammation KC release inflammatory mediators like cytokines (e.g. IL-6), prostaglandins 
(e.g. PGE2) and nitric oxide (NO). These mediators can act on nearby hepatocytes in a parakrine mode to 
elicit an acute phase response, but they also can act back on KC in an autokrine loop. IL-6 operates via a 
tyrosine kinase associated receptor that phosphorylates and activates a transcription factor “signal 
transducer and activator of transcription 3” (STAT3).  Among its target genes is the inducible form of 
NO synthase and the inducible PGH synthase (COX2) resulting in enhanced NO and PGE2 production. 
PGE2 acts on Gs-protein coupled EP-receptors (EP2-R/EP4-R) that increase the intracellular cAMP-
concentration. Since IL-6 and PGE2 are released concomitantly from KC, it was the purpose of the study 
to analyze whether a signal cross talk exists between IL-6- and PGE2 -pathways and if, therefore, PGE2 
could modulate the IL-6 dependent iNOS and COX-2 induction? 
  
Material and methods: primary KC from male Wistar rats were cultured for 72 h. At the end of this 
culture period they were stimulated with IL-6, PGE2, forskolin (direct activator of adenylate cyclase) and 
RPcAMPs (direct inhibitor of protein kinase A) for 2 h. Cell were lyzed and lysates were used for 
Western Blots with antibodies against phosphorylated and total STAT3, COX-2 and iNOS. cAMP was 
determined by RIA. The KC-supernatant was collected to measure NO by Griess assay and IL-6 by rat 
IL-6-ELISA. 
 
Results and discussion: In Kupffer cells, a combination of PGE2 and IL-6 strongly increased NO-
formation while either stimulus alone increased NO formation only slightly or not at all, respectively. In 
accordance with this observation, a combination of PGE2 and IL-6 induced the inducible form of NO 
synthase 4-fold, while PGE2 alone cause a 2-fold induction and IL-6 alone merely a 1,5-fold induction. A 
similar synergism between PGE2 and IL-6 was observed with the induction of COX2. Both genes are 
regulated by the transcription factor STAT3, which is a downstream target of the IL-6 receptor signal 
chain that gets activated through phosphorylation. As expected, the ratio between phosphorylated 
STAT3 (pSTAT) and total STAT3 was increased about 2-fold in IL-6-treated Kupffer cells. 
Surprisingly, PGE2 alone also increased STAT phosphorylation about 1,5-fold. IL-6 and PGE2 
synergistically increased STAT3 phosphorylation about 4-fold. PGE2 induced IL-6 production in 
Kupffer cells, however, the amount produced was 3 orders of magnitude lower than the exogenously 
added concentration and thus most likely did not contribute to the synergism observed. Experiments with 
receptor subtype specific agonists indicated that the Gs-coupled EP2 receptor mediated the PGE2-
dependent STAT3 phosphorylation, however, this effect appeared to be independent of the EP2-
mediated increase in cAMP formation because neither could direct activation of adenylate cyclase with 
forskolin mimic the PGE2-dependent STAT3 phosphorylation nor could inhibition of adenylate cyclase 
with RPcAMPs abolish it. In conclusion, simultaneous release of PGE2 and IL-6 from Kupffer cells in 
the course of local or systemic inflammation may synergistically enhance the release of proinflammatory 
mediators from Kupffer cells through a STAT3-dependent, cAMP-independent signaling pathway. 
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Abstract #22
THE INFLAMMATORY RESPONSE DURING DRUG-INDUCED LIVER INJURY: 
TOXICITY VERSUS REGENERATION 
 
Jaeschke, H., Saito, C., Lebofsky, M., Yan, H.M., and Bajt, M.L. 
Department of Pharmacology, Toxicology & Therapeutics, University of Kansas Medical Center, Kansas City, KS 
66160, USA. 
 
Acetaminophen (APAP), a widely used analgesic, is generally considered a safe drug at therapeutic 
levels but can induce centrilobular necrosis and even liver failure at higher doses. Although most studies 
still focus mainly on the intracellular signaling mechanisms of cell death in hepatocytes, there is an 
increasing interest in the role of hepatic nonparenchymal cells (Kupffer cells, NK- and NKT cells) and 
infiltrating leukocytes (neutrophils, monocytes) in the pathophysiology. For each cell type there is 
experimental evidence in the literature suggesting a contribution to the mechanism of toxicity. However, 
the validity of several of these conclusions has been questioned recently. The focus of our investigations 
is to elucidate the role of neutrophils in APAP-induced liver injury and regeneration. 
 
Treatment of fasted C57Bl/6 mice with 300 mg/kg APAP resulted in substantial liver injury as indicated 
by the increase of plasma ALT activities between 3 and 12 h, and the development of extensive 
centrilobular necrosis. Plasma ALT activities declined to baseline levels within 48 h and the injury was 
completely repaired by removal of necrotic cells and replacement by newly regenerated hepatocytes by 
96 h. Neutrophil progressively accumulated in the liver after the initiation of cell injury (ALT release). 
Most of the leukocytes were present in sinusoids throughout the liver lobes and only a smaller fraction 
was found extravasated into the parenchyma of the necrotic area during the first 24 h. However, the 
neutrophils in sinusoids disappeared and a massive accumulation of neutrophils and also macrophages 
was observed in the necrotic areas by 48 -72 h. The area of necrosis disappeared together with 
neutrophils and macrophages in the liver by 96 h. A number of interventions against neutrophils and 
macrophages (phox91 or ICAM-1 knock-out mice; NADPH oxidase inhibitors DPI and apocyanin) 
showed no protective effect against APAP-induced liver injury, oxidant stress or DNA fragmentation. 
On the other hand, pretreatment with the neutropenia-inducing antibody Gr-1 for 24 h before APAP 
caused protection. However, this effect was not due to the absence of neutrophils but was caused by 
upregulation of inflammatory and cytoprotective genes, e.g. metallothionein (MT), heme oxygenase-1 
(HO-1), triggered by Kupffer cell activation during the phagocytosis of antibody-tagged neutrophils in 
sinusoids. Selective induction of metallothionein gene expression by ZnCl2 treatment confirmed the 
protective effect of MT induction in this model. Conclusions:  Neutrophils are systemically activated 
during APAP-induced necrosis and accumulate first in sinusoids and later, together with liver 
macrophages, in the area of necrosis. There is no reliable evidence to suggest that neutrophils (or 
macrophages) contribute to APAP-induced liver injury. However, neutrophils and macrophages are 
responsible for removal of necrotic tissue. This inflammatory response creates the space for regenerating 
hepatocytes to restore the original liver mass. 
Supported in part by National Institutes of Health Grants R01 DK070195 and R01 AA12916, and by 
grants P20 RR016475 and P20 RR 021940 from the National Center for Research Resources (NCRR), a 
component of the National Institutes of Health. 
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CECAL LIGATION AND PUNCTURE SEPSIS IS ASSOCIATED WITH A SHIFT IN 
ADENYLYL CYCLASE EXPRESSION IN SINUSOIDAL LIVER CELLS  
 
Una Ryg1, Petter K. Risøe1, Yun Yong Wang1, Bård Smedsrød2, Thoralf Christoffersen3 Jacob E. 
Wang1, Ansgar O. Aasen1 and Maria K. Dahle1  
 1Institute for Surgical Research, University of Oslo and Rikshospitalet, 0027 Oslo, Norway  
2Dept of Cell Biology and Histology, University of Tromsø, 9037 Tromsø, Norway 
3 Institute of Pharmacology, University of Oslo and Rikshospitalet, 0027 Oslo, Norway 
 
Introduction:  One reason for the fatal inflammatory response causing organ injury and death in sepsis is 
the loss of immune modulatory mechanisms. The intracellular signaling mediator cyclic adenosine 
monophosphate (cAMP) is a potent modulator of innate immune cell activation, and elevation of cAMP 
by phosphodiesterase inhibitor treatment can increase survival in endotoxemia.  We have previously 
demonstrated that expression of cAMP-producing adenylyl cyclases (AC) are attenuated by bacterial 
lipopolysaccharide (LPS) in vivo and in Kupffer cell cultures. Here we explore AC gene expression and 
regulation in a rat model of cecal ligation and puncture (CLP) sepsis and in liver cells isolated from this 
model.  
 
Methods: Wistar rats were subjected to CLP procedure or sham operated, and after 10 or 18 hours organs 
were removed. Hepatocytes, liver sinusoidal endothelial cells (LSEC) and Kupffer cells were isolated 18 
hours after CLP/sham-operation. RNA was isolated and analysed for AC mRNA expression.  
 
Results: We found significantly attenuated liver expression of AC6 (P ≤ 0.0336) and AC9 (P ≤ 0.0144) 
mRNAs in CLP animals compared to sham, an attenuation also found in Kupffer cells (AC6 P≤0.0134; 
AC9 P≤0.0623) isolated from the model. AC9 was also attenuated in spleen (P≤ 0.0154) and kidney (P≤ 
0.0091) after 18 hours. AC7 mRNA was only attenuated in spleen (P≤ 0.0183, 18h), and appeared to 
increase in kidney, liver and LSEC.  
 
Conclusion: CLP sepsis is associated with reduced AC mRNA expression in spleen, kidney, liver and 




SPLENCHNIC VITAMIN A-STORING CELL SYSTEM AND ORGAN FIBROGENESIS 
 
Kawada N, Shiga R 
Department of Hepatology, Graduate School of Medicine, Osaka City University, 1-4-3, Asahimachi, Abeno, 
Osaka 545-8585, JAPAN (kawadanori@med.ossaka-cu.ac.jp) 
 
   Organ fibrogenesis is a complex and dynamic pathological process that is controlled by the synthesis 
and degradation of extracellular matrix materials including fibril-forming collagens and by the 
proliferation and apoptosis of fibroblastic cell populations. It has been proven that hepatic stellate cells 
(HSCs) that comprise the hepatic sinusoidal wall play multiple roles in the hepatic fibrotic process. 
Transformation of HSCs from the vitamin A-storing phenotype to the “myofibroblastic” phenotype 
closely correlates with hepatic fibrogenesis during chronic liver trauma. Recent reports indicate that 
vitamin A-storing cells are not liver-specific and exist in all splanchnic organs as stroma-constituent 
cells. Pancreatic stellate cells are one of them, which are now evident to contribute to fibrotic process in 
chronic pancreatitis. The molecular analyses of the phenotypic change of these stellate cell lineages, so 
called “activation”, have made great progress, in particular, in the field of intracellular signal 
transduction of transforming growth factor-beta (TGF-beta) and platelet-derived growth factor-BB 
(PDGF-BB) and collagen gene expression. Accumulation of information on stellate cell activation would 
shed light on the establishment of a novel therapeutic strategy against organ fibrosis. 
   In order to promote a better understanding of molecular dynamics associated with stellate cell 
activation, we performed proteomics approach that compares comprehensive protein expression pattern 
between vitamin A-storing phenotype of HSCs and activated myofibroblasts. This approach has clarified 
the induction of actin-binding proteins, several types of collagens, neural cell adhesion molecule and 
galectins in the course of cell activation process. We additionally discovered cytoglobin (Cygb) that has 
amino acid homology with vertebrate myoglobin (Mb), hemoglobin (Hb), and neuroglobin (Ngb), a 
globin expressed in neuronal cells.  
   Unlike Hb, Mb and Ngb, Cygb is uniquely localized in fibroblast-like cells in splanchnic organs, 
namely vitamin A-storing cell lineage, but neither in epithelial cells, endothelial cells, muscle cells, 
blood cells, macrophages, nor dermal fibroblasts. Cygb-positive cells in the extrahepatic organs include 
pancreatic stellate cell, reticular cells in the spleen, and mesangial cells in the kidney. That is, Cygb is a 
useful molecular marker of splancnic vitamin A–storing cells. Expression of Cygb is upregulated in 
fibrotic lesions of pancreas and kidney in which activated fibroblast-like cells or myofibroblasts increase 
in number. Cygb is co-localized with HSP47, a collagen-specific molecular chaperon. 
   The X-ray crystal structure of recombinant human Cygb is dimerized through two intermolecular 
disulfide bonds between Cys38 (B2) and Cys83 (E9). The overall backbone structure of the Cygb 
monomer exhibits a traditional globin fold with a three-over-three helical sandwich. The His81(E7) 
imidazole directly coordinates to the heme iron as a sixth axial ligand to form a hexacoordinate heme, 
like Ngb and rice Hb. Cygb may be involved in currently unknown physiological actions through a 
mechanism that is linked to conformational changes in the protein upon O2 binding. 
   Molecular function of Cygb and, in particular, its role in organ fibrogenesis will be discussed in the 
lecture.        
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Abstract #25
MODULATION OF HUMAN HEPATIC STELLATE CELLS CHEMOTAXIS BY 
INTRACELLULAR ROS GENERATION AND c-JUN N-TERMINAL KINASE 
ACTIVATION  
 
E. Novo*, L. Valfrè di Bonzo*, S. Cannito*, C. Bertolani°, D. Povero*, C. Busletta*, A. 
Compagnone*, S. Colombatto*, F. Marra°, M. Pinzani°, M. Parola*. 
* Dip. Medicina e Oncologia Sperimentale & Centro Interuniversitario di Fisiopatologia Epatica, University of 
Turin, Italy; ° Dip. Medicina Interna-Centro di Ricerca, Trasferimento e Alta Formazione “DENOThe”, University 
of Florence, Italy.  
 
Background & Aims. Liver fibrogenesis, occurring in conditions of chronic liver diseases of different 
aetiology, is modulated and sustained by myofibroblasts-like cells that may originate from activated 
hepatic stellate cells or HSC/MFs, portal (myo)fibroblasts and, as proposed in recent years, from bone-
marrow derived mesenchymal stem cells or MSC. Since activated HSC/MFs play a major role in 
fibrogenesis and migrate in response to several stimuli, here we investigated whether PDGF-BB and 
other polypeptide factors able to stimulate migration/chemotaxis of human HSC/MFs may act with a 
common signaling pathway involving intracellular generation of reactive oxygen species (ROS) and 
activation of c-Jun N-terminal kinase isoforms (JNKs).  
Methods. Experiments were performed on activated human HSC/MFs displaying antigen repertoire of 
interface myofibroblasts, and on HSC cell extracts obtained from liver of rat sacrificed after acute CCl4 
administration. In vitro and in vivo signal transduction were evaluated by performing both cell and 
molecular biology techniques; non-oriented migration and chemotaxis by using the wound healing assay 
and the modified Boyden’s chamber assay, respectively. 
Results. Exposure of human HSC/MFs to PDGF-BB, MCP-1, AT-II, VEGF and extracellular 
superoxide anion induced both chemokinesis and chemotaxis. These phenotypic responses were 
abolished by pre-treating cells with SP-600125 or diphenylene-iodonium (DPI), pharmacological 
inhibitors of JNK-1/2 and NADPH-oxidase, respectively, as well as by employing siRNAs able to 
silence JNK1/2. The involvement of JNKs and intracellular ROS generation in modulating HSC/MFs 
migration was further confirmed by: 1) activation of JNK1/2 and up-regulation of heme oxygenase I in 
extracts obtained from HSCs isolated from rat livers 24 and 48 hrs after acute CCl4 administration; this 
was concomitant with increased in vivo generation of ROS; 2) only some stimuli such as extracellular 
superoxide and PDGF-BB (used as positive stimuli) but not other, like TGFbeta1 (ineffective on 
migration) were able to activate JNK-1/2; 3) intracellular generation of superoxide or hydrogen peroxide 
by using menadione (MEN) or dimethyl-naphtoquinone (DMNQ), respectively, was sufficient to induce 
JNK activation and migration; 4) migration observed after PDGF-BB, MEN and DMNQ treatment also 
involved activation of ASK-1, an oxidative-stress sensitive upstream kinase for JNK1/2 and was 
prevented by either DPI and pegylated – superoxide dismutase (PEG-SOD, a cell permeable form of 
SOD). 
Conclusions. Migration/chemotaxis of human HSC/MFs critically requires activation of JNK isoforms 
and is positively modulated by NADPH oxidase - dependent  intracellular generation of ROS.    
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CYSTEINE CATHEPSINS IN HEPATIC STELLATE CELLS 
 
Maubach, G., Lim, M.C.C., Kumar, S. and Zhuo, L. 
Institute of Bioengineering and Nanotechnology, 31 Biopolis Way, The Nanos #04-01, Singapore 138669 
 
Acute or chronic injury to the liver leads to fibrosis and subsequently to cirrhosis or hepatocarcinoma. 
Activation of hepatic stellate cells (HSCs) during liver fibrosis is a major event associated with an 
increase in extracellular matrix deposition. Not only the amount of secreted ECM molecules, but also the 
composition of the collagens is changed during HSC activation. Consequently, the increase in ECM 
stiffness impairs the normal function of the hepatocytes. HSCs are recognized as one of the major targets 
in the process of matrix deposition, although recent findings suggest the participation of other cell types.  
The role and function of cysteine cathepsins in HSCs have so far not yet been studied. Cysteine 
cathepsins are lysosomal cysteine proteases, whose main function is the terminal degradation of proteins 
in the lysosomes. Some are ubiquitously expressed (B, L and F), while others (cathepsin S, K and W) are 
tissue- or cell type-specific. Cathepsins are implicated in several diseases for example pycnodysostosis, 
rheumatoid arthritis and different forms of cancer. In addition, the involvements of cathepsin K in lung 
fibrosis and dermal scar formation, and the association of cathepsin B with liver fibrosis have been 
demonstrated. Thus far, we have studied the cathepsins S and F in HSCs. 
HSCs have been shown to be professional antigen presenting cells.Treatment with IFN-γ leads to an 
upregulation of surface molecules essential for the process of antigen presentation. On the molecular 
level, we show that the class II transactivator (CIITA), the invariant chain (CD74), the MHC class II 
molecules (RT1-B, RT1-D), as well as cathepsin S, molecules which are responsible for the initial steps 
of successful antigen presentation, are expressed in activated rat HSCs. We determine that IFN-γ 
upregulates the mRNA and the protein expression of CIITA, CD74, MHC class II molecules and 
cathepsin S in activated HSCs. More importantly, IFN-γ increases cathepsin S activity, suggesting a 
possible involvement of this protease in CD74 processing.  
In another study, we have identified a nuclear cysteine protease activity partially attributed to cathepsin 
F, which co-localizes with nuclear speckles. Treatment with retinol/palmitic acid for 48 hours leads to a 
decrease in nuclear cathepsin F activity, which is coupled to an increase in cystatin B and C transcripts. 
The inhibition of the cathepsin F activity by a cysteine protease inhibitor and siRNA results in a 
differential regulation of smooth muscle alpha actin (SMAA) and collagen type I transcripts. These 
findings indicate a possible link between nuclear cathepsin F activity and the transcriptional regulation 
of HSC activation markers. 
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CANONICAL WNT SIGNALING AND HEPATIC STELLATE CELLS 
 
Hide Tsukamoto, Jason H. Cheng, Hongyun She, Yuan-Ping Han, and Kinji Asahina 
Research Center for ALPD and Cirrhosis and Departments of Pathology and Surgery, Keck School of Medicine of 
the University of Southern California; Department of Veterans Affairs Greater Los Angeles Healthcare System, 
Los Angeles, CA, USA 
 
Our research has demonstrated the importance of adipogenic transcriptional regulation in the 
maintenance of hepatic stellate cell (HSC) quiescence (J Biol Chem 279:11392, 2004; 280:4959, 2005; 
280:40650, 2005).  This concept has an eminent implication because molecules that render anti-
adipogenic effects may now need to be considered as pro-fibrogenic mediators.  Indeed, many known 
inhibitors of adipogenesis such as leptin, TGFβ, TNFα, and β-adrenergic agonists, activate HSCs. One 
notable class of anti-adipogenic mediators is the Wnt family of proteins. Wnts bind to their Frizzled (Fz) 
receptor-LRP co-receptor complexes to transduce canonical Wnt signaling which culminates to β-
catenin stabilization and nuclear translocation, and β-catenin-Tcf dependent transcriptional activation. In 
this study, we tested the roles of Wnt signaling in HSC activation in vitro and in vivo.  Real-time PCR 
screening demonstrates 3~12 fold induction of canonical (Wnt3a and 10b) and non-canonical (Wnt4 and 
5) Wnts, their receptors (Frz-1 and 2) and co-receptors (LRP6 and Ryk) in rat primary HSCs activated in 
vitro on plastic or in vivo by cholestatic liver fibrosis induced by common bile duct ligation. Activated 
canonical Wnt signaling is demonstrated by increased nuclear β-catenin level, enhanced Tcf binding to 
DNA, and heightened Tcf-promoter activity which is suppressed by ectopic expression of the nuclear β-
catenin antagonist Chibby or the Wnt co-receptor antagonist Dkk-1.  Adenoviral expression of Dkk-1 in 
culture-activated HSCs, causes a reduction in nuclear β-catenin, a morphologic reversal to the quiescent 
phenotype including increased intracellular lipids, represses HSC activation markers such as PCNA and 
α1 (I) procollagen, and more importantly up-regulates two key adipogenic transcription factors, PPARγ 
and C/EBPα. Finally, this viral mode of Dkk-1 transduction in the liver via splenic injection significantly 
attenuates the development of cholestatic liver fibrosis in mice. In summary, these results demonstrate 
that activated canonical Wnt signaling underlies at least in part, the anti-adipogenic mode of HSC 
activation and serves as a potential molecular target for anti-fibrotic modality.  (Supported by NIH grants 
P50AA11999, R24AA12885 and Department of Veterans Affairs). 
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PROLIFERATION OF HEPATIC STELLATE CELLS IN RATS WITH ACUTE HEPATITIS 
IS DEPENDENT ON VAGAL INNERVATION VIA MUSCARINIC ACETYLCHOLINE 
RECEPTOR SUBTYPE 2 
 
Bockx I.1, Sinelli N.2, Vander Elst I.1, Libbrecht L.2, Roskams T.2 and Cassiman D.1 
1Department of Hepatology, 2Department of Pathology, University Hospital Gasthuisberg, Leuven,   Belgium 
 
Background: In galactosamine induced hepatitis, hepatocytes lose their replicative capacity and hepatic 
progenitor cells (HPC) and hepatic stellate cells (HSC) become the driving forces behind liver tissue 
regeneration. The liver receives parasympathetic innervation through the hepatic branch of the vagus 
nerve, whose main efferent neurotransmitters are acetylcholine (ACh) and vasoactive intestinal peptide 
(VIP). We have shown that HPC express M3 and VIP2 receptors and mRNA for several ACh receptors. 
Moreover, we showed that hepatic branch vagotomy (HV) inhibits the proliferation of HPC. To examine 
whether HSC proliferation could also be neurally modulated, we determined the neurotransmitter 
receptor expression profile of HSC and their proliferation in acute hepatitis after surgical and 
pharmacological denervation. 
Methods:  RT-PCR with receptor-specific primers was performed on total RNA from isolated HSC. 
Total rat brain RNA was used as a positive control. Identification of amplification products was achieved 
by sequencing. 
Male Wistar rats were subjected to HV (n=20) or sham operation (n=19). A second group of rats 
received IP injections of atropine (ATR, n=11), mecamylamine (MEC, n=16) or saline (Control, n=20). 
In all rats, acute hepatitis was induced by a single intravenous injection of galactosamine (500mg/kg) 
and lipopolysaccharides (1µg/kg). Rats were sacrificed 12 and 48 hours later, the time points with 
maximal necrosis and maximal numbers of HSC, respectively. Frozen liver tissue sections were stained 
for HSC using polyclonal antibodies against desmin (for periportal HSC) and GFAP (for pericentral 
HSC). Numbers of HSC were quantified using image analysis software (Olympus). 
Results: We found that HSC express mRNA for muscarinic receptor subtype 2, for nicotinic receptor 
subtype α1, α5 and β1, and for VIP1 receptor. HV caused significantly less desmin-positive HSC than 
sham operation at 12 and 48h (p=0,008 and p=0,01 respectively), and significantly less GFAP-positive 
HSC at 48h (p=0,03). Administration of ATR (and thus blocking of muscarinic receptors) also resulted 
in less desmin- and GFAP-positive HSC at both 12h (p= 2,7.E-19 and p=0,008) and 48h (p=0,03 and 
p=0,02), as compared to Control. Blocking of nicotinic receptors by administration of MEC caused less 
desmin-positive HSC at 12h (p=0,009) but not at 48h and for GFAP-positive HSC no differences were 
found between MEC and Control. These results show that inhibition of vagal neurotransmission 
significantly decreases the proliferation of HSC in acute hepatitis. The stimulatory effect of the vagus 
nerve on HSC might occur via the direct action of vagal neurotransmitters on the receptors expressed on 
these cells. Moreover, since the effect of ATR administration seems to be more pronounced than the 
effect of MEC, the vagus nerve might exert its effect on HSC mainly through muscarinic receptors.  
Conclusion: As we previously demonstrated for HPC, intact vagal innervation also appears necessary to 
provoke a proliferative stimulus for HSC, to ensure repair, repopulation and regeneration of liver tissue. 
The latter effect is most likely exerted through direct binding of ACh on muscarinic receptor subtype 2, 
expressed by HSC. 
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Epigenetics literally means “above the genetics” but is now generally used as a term to describe 
changes in genes expression that occur without the need for changes in DNA sequence. Epigenetic 
variation involves chemical modifications of DNA and chromatin of which the most extensively 
studied are DNA methylation and post-translational modifications of histone lysine and arginine tails. 
Other epigenetic mechanisms include the actions of microRNAs and higher order structural 
organisation of chromatin within the nucleus. At the cellular level, modulation of these “epigenetic 
marks” significantly influences the differentiation status and functions of the cell. However, the impact 
of epigenetics extends much further than the cellular level. A major outcome of human and animal 
genome mapping projects was the realisation that the information encoded in DNA is insufficient to 
explain the gross phenotypic differences between species, let alone the more subtle differences seen 
between individuals within the same species. It is now emerging that so-called “epigenetic factors” fine 
tune the genome to shape body form and physiology. More remarkably, we are learning that epigenetic 
marks can become stable phenotypic instructions that not only survive mitosis but are also stable 
throughout meiosis, zygote formation and animal development. Subtle changes to these stable 
epigenetic marks can generate an “epigenetic memory” of past events such as exposure to toxins, 
alterations in dietary conditions and even stress, which are passed on through subsequent generations. 
The consequences can be profound for human physiology resulting in altered susceptibility of the 
individual to the development of heart disease, hypertension, diabetes, alcoholism etc.  
 
The progression of chronic liver disease is not a predictable uniform process, but instead the 
development of cirrhosis and cancer differs enormously between individuals even where the primary 
cause of liver injury is identical. Genetic factors have been described which have the potential to 
impinge on susceptibility to disease progression. However, genetic polymorphisms are alone 
insufficient to explain for example, why only 25% of alcoholics develop cirrhosis. Our group in 
Newcastle are working on the hypotheses that epigenetic factors impinge at the cellular level to 
regulate fibrogenesis but may also operate at a higher level via epigenetic memory to help dictate 
susceptibility to disease progression. 
 
In this lecture, I will explain the basic principles of epigenetic control of gene expression, describe how 
DNA methylation and histone structure influence gene transcription and introduce the some of the key 
epigenetic regulators of these modifications (e.g. methyl-DNA binding proteins, histone 
methyltransferases and chromatin remodelling enzymes). I will place these regulators into 
physiological context using my own work to explain how they control the activity of fibrogenic hepatic 
stellate cells. Finally, I will provide examples to explain the concept of epigenetic inheritance of 




RAT HEPATIC STELLATE CELLS ACQUIRE RETINOID RESPONSIVENESS AFTER 
ACTIVATION IN VITRO 
Mezaki Y, Yoshikawa K, Yamaguchi N, Miura M, Imai K, Senoo H 
Akita University School of Medicine, 1-1-1 Hondo, Akita 010-8543, Japan 
 
Introduction: Activation of hepatic stellate cells (HSCs) is a key process in liver fibrogenesis and 
retinoid loss is a remarkable feature of activated HSCs. However, relevance of retinoid signaling in liver 
fibrogenesis is still in controversy. For example, while several studies reported decreased retinoid 
signaling in activated HSCs both in vivo and in vitro, others reported that HSCs could respond to 
retinoids after activation in vitro. We first questioned why cellular retinol-binding protein I, one of the 
well characterized RAR target genes containing RARE, was up-regulated during HSC activation, in spite 
of the reported diminished retinoid signaling in activated HSC. We show here that retinoid 
responsiveness is increased during rat HSC activation in vitro, presumably through post-transcriptional 
up-regulation of RARalpha gene expression. 
Materials and methods: Male Wistar rat livers were perfused with bacterial collagenase solution, and 
dispersed cells were centrifuged F and pelleted cells were further purified by density gradient 
centrifugation with Percoll/RediGrad. The layer containing HSCs was collected, and cells were seeded 
on uncoated plastic dishes or glass bottom dishes. Protocols for animal experimentation were approved 
by the Animal Research Committee, Akita University School of Medicine. All animal experiments 
adhered to the "Guidelines for Animal Experimentation" of the University. 
Results: By using an RARE-driven reporter assay, we show that retinoid responsiveness is increased 
during rat HSC activation in vitro. Am580, a selective RARalpha agonist, increased the reporter 
response, indicating that the transcriptional activity in activated HSCs was mediated, at least in part, by 
RARalpha subtype. Quantitative RT-PCR of RARalpha, beta and gamma transcripts and Western 
blotting of RARalpha, beta and gamma proteins during HSC activation in vitro showed that the 
increased retinoid responsiveness is ascribed to the post-transcriptional up-regulation of RARalpha, and 
to some extent, beta gene expression. Immunocytochemistry showed that RARalpha proteins were 
mainly distributed as many spots in cytosol throughout the activation period. Addition of ATRA during 
HSC activation lowered cytosolic RARalpha protein levels. Treatment of retinoid antagonist LE540 
alone did not affect both RARalpha protein quantity and localization, but attenuated the effect of ATRA. 
Conclusions: Retinoid responsiveness is increased during rat HSC activation in vitro, through post-
transcriptional up-regulation of RARalpha gene expression. This result can explain previous paradoxical 




INVOLVEMENT OF ADRP AND TIP47 IN LIPID DROPLETS FORMATION OF HEPATIC 
STELLATE CELLS 
 
Kiwamu Yoshikawa, Yoshihiro Mezaki, Noriko Yamaguchi, Mitsutaka Miura, Katsuyuki Imai 
and Haruki Senoo 
Department of Cell Biology and Histology, Akita University School of Medicine, 1-1-1 Hondo, Akita 010-8543, 
Japan 
 
Hepatic stellate cells (HSCs) lie in the perisinusoidal space and play central role in production and 
degradation of extracellular matrix (ECM) components in the liver. The cells also store about 80% of 
total body vitamin A as retinyl esters (RE) in their lipid droplets (LDs) and play key roles in hepatic 
uptake and release of retinoids. Under pathological conditions such as liver fibrosis, the cells proliferate 
rapidly, produce a large amount of ECM components, and lose their LDs and RE. Although the existence 
of the LDs rich in RE is the utmost character of stellate cells, the mechanisms of formation and 
disappearance of them are not well understood. It is reported that LDs in adipocyte harbor PAT proteins 
around them, which were named after perilipin, adipocyte differentiation-related protein (ADRP) and 
TIP47. Although the function of PAT proteins is unclear, it is suggested that they are involved in LDs 
formation and lipid metabolism. In this study, we show that ADRP and TIP47 were localized around 
LDs of HSCs. 
HSCs were separated from male Wistar rat livers with collagenase perfusion followed by Percoll density 
gradient centrifugation. The freshly separated cells were seeded on glass bottom dishes for analyses next 
day (A) or seeded on plastic dishes for activation by subculture. The activated cells were seeded on glass 
bottom dishes and administrated with retinol to induce LDs containing RE (B). LDs were detected with 
BODIPY 493/503 and vitamin A-autofluorescence. ADRP and TIP47 were detected with 
immunofluorescence. ADRP localized around LDs emitting vitamin A-autofluorescence in both A and 
B. TIP47 also localized around the LDs in B. However, it did not localized around the LDs but diffusely 





HEPATIC STELLATE CELLS EXPRESS TIM-2: A POSSIBLE MEDIATOR OF FERRITIN-
INDUCED NFκB ACTIVATION AND PROINFLAMMATORY GENE EXPRESSION. 
 
Richard G Ruddell1, Diem Hoang-Le1, Paolo Santambrogio2, Paolo Arosio2 and Grant A Ramm1. 
1The Hepatic Fibrosis Group, The Queensland Institute of Medical Research, PO Royal Brisbane Hospital, 
Brisbane, AUSTRALIA, 4029. 2Proteomics of Iron Metabolism Unit, Dibit, San Raffaele Scientific Institute, 
Milan, ITALY. 3Dipartimento Materno Infantile e Tecnologie Biomediche, 
University of Brescia, Brescia, ITALY. 
 
Introduction ~ Ferritin is comprised of 24 individual proteins of either heavy (H) or light (L) subtypes. 
The main function of ferritin is the storage or iron in a non-toxic but biologically available form, 
however, during times of inflammation linked to or independent of iron status, serum ferritin is 
significantly elevated. The exact reason for this elevation is unclear but the expression of H and L 
ferritins is known to be regulated by inflammatory mediators such as TNFα and IL-1α. The recent 
discovery that the regulator of Th2 dependent immune responses, T-cell immunoglobulin and mucin 
domain-2 (Tim-2) is a receptor for H ferritin endocytosis further suggests that ferritin may have 
physiological roles other than iron storage. Hepatic Stellate Cells (HSC) express a receptor for ferritin 
that mediates internalisation and we have recently shown that ferritin upregulates a number of 
proinflammatory fibrogenic mediators in HSC, including IL-1β, RANTES, ICAM1 and iNOS. 
Aims ~ This study was designed to (i) examine the kinetics of Tim-2 expression with HSC culture- 
induced activation, (ii) further characterise the signaling cascade activated in response to ferritin, and 
(iii) define the role of Tim-2 in mediating the this proinflammatory signaling event. 
Methods ~ HSC were isolated from rat liver and cultured on plastic culture dishes for up to 6 days. 
Whole cell protein and total RNA were isolated at regular 24 hour time points up to day 6. Activated 
HSC (day 5) were treated with tissue ferritin (iron replete), or the iron-free recombinant human H ferritin 
(rHF) and L ferritin (rLF) molecules, in the absence or presence of various inhibitors targeted at specific 
signaling proteins. Protein expression and phosphorylation status were assessed by western blotting and 
immunoprecipitation assay, and mRNA expression was investigated using quantitative real time PCR. 
Results ~ Real time PCR analysis of total RNA isolated from activating HSC demonstrated that Tim-2 
mRNA is present 24 hours post isolation and is slightly but significantly elevated at day 5 to 2.2-fold 
versus day 1. Tim-2 protein was also present in HSC from quiescence to activation, however, there was 
no significant change in expression over the differentiation period. Western blotting showed marked 
phosphorylation of the PI3-kinase target motif YXXM, as well as PKCz, p42/p44 (MAPK) and IKK, in a 
time-dependent manner following HSC incubation with 10 nM tissue ferritin, rHF or rLF. Tissue ferritin 
induced a 48-fold increase in the expression of the NFκB-regulated gene IL-1β. Pharmacological 
inhibition of PI3-kinase, PKCz, MAPK and IKK was able to significantly inhibit (80-100%) the tissue 
ferritin-induced expression of IL-1β. Immunoprecipitation of proteins containing a phosphorylated 
YXXM PI3-kinase target motif induced following tissue ferritin, rHF and rLF incubation was performed. 
Precipitated proteins were then blotted for the presence of Tim-2. Data demonstrated no observable 
change in the levels of Tim-2 YXXM phosphorylation following HSC incubation with ferritin. 
Conclusions ~ This study demonstrates for the first time the expression of Tim-2 by rat HSC. Our data 
implicates a number of signaling intermediaries induced by tissue ferritin in HSC. As iron-free rHF and 
rLF were able to elicit similar cellular responses to tissue ferritin, this suggests that the effects of ferritin 
on HSC may be independent of ferritin-bound iron. These results provide further support for a role for 
ferritin as a mediator of inflammation in addition to its role as an iron storage protein. Our results also 
suggest that if Tim-2 is mediating the effects of ferritin on HSC it is not through the internal YXXM PI3-
kinase phosphorylation motif. 
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CELLULAR DISTRIBUTION OF LECITHIN: RETINOL ACYLTRANSFERASE (LRAT) 
AND CELLULAR RETINOL BINDING PROTEIN-1 (CRBP-1) IN HUMAN NORMAL AND 
PATHOLOGICAL LIVERS 
 
Keisuke Nagatsuma1, 2, Tomokazu Matsuura3, Ken Tanaka1, Masaya Saito1, Shingo Takikawa1, 
Hisao Tajiri1, Hiroshi Hano2, and Soichi Kojima4 
Division of Gastroenterology and Hepatology, Departments of Internal Medicine1, Pathology2 and Laboratory 
Medicine3, The Jikei University School of Medicine, Tokyo, Japan. 
Molecular Ligand Biology Reserach Team, Chemical Genomics Reseach Group, Chemical Biology Department 
Advanced Science Institute, RIKEN 4, Saitama, Japan. 
 
Background/Aims: In a normal liver, hepatic stellate cells (HSC) store 80-90% of hepatic retinoid in 
characteristic lipid droplets as fat-storing cells. HSC are activated and change their phenotype under 
conditions of liver damage, often losing their lipid droplets, promoting liver fibrosis. To examine how 
much HSC contributes to liver fibrosis, it is necessary to develop a structural and functional HSC marker 
for in situ studies. Although several HSC markers have been reported, those are hardly associated with 
particular HSC functions. Lecithin: retinol acyltransferase (LRAT) is a physiological retinol 
esterification enzyme in a liver and its activation is occurred especially in HSC. Cellular retinol-binding 
protein-1 (CRBP-1) also mediates retinoid metabolism and retinol bound CRBP-1 is a substrate of 
LRAT. Therefore interaction between LRAT and CRBP-1 seems to contribute the retinol esterification 
of HSC as fat-storing cells. The present study is to reveal whether co-expression of LRAT and CRBP-1 
could be a potential and relevant tissue marker for HSC. To do this we detected the expression of LRAT 
in HSC during fibrotic/cirrhotic liver disease through correlation with CRBP-1.  
Materials and Methods: An antibody specific to human LRAT was generated on the basis of their 
amino acid sequence. To examine the distribution of LRAT in detail, other antibodies against CRBP-1 
and α-smooth muscle actin were also prepared. These antibodies were used for immunohistochemical 
examination in normal and diseased human liver including chronic hepatitis, alcoholic liver damage, 
non-alcoholic steatohepatitis, and liver cirrhosis. 
Results: In a normal liver, quiescent HSC in sinusoid co-expressed both LRAT and CRBP-1, while 
portal fibroblasts did not. In a fibrotic and a cirrhotic liver, HSC in the space of Disse co-expressed 
both LRAT and CRBP-1 and a part of portal and septal myofibroblasts co-expressed both LRAT and 
CRBP-1. Portal and septal fibrotic fascicles strongly expressed α-smooth muscle actin, whereas they 
did not expressed LRAT.  
Conclusions: Our study demonstrated that LRAT could be an excellent alternative marker to identify 
quiescent HSC as well as CRBP-1 in a normal liver. In a fibrotic/cirrhotic liver, the different pattern of 
expression for LRAT and α -smooth muscle actin enabled to distinguish between various subsets of 
fibroblastic cells involving fibrogenesis. However, we suggest that small amount of cells co-expressing 
LRAT and CRBP-1 in septa in fibrotic liver still maintain original function of quiescent HSC with 





EXPRESSION OF THE TRANSCRIPTION FACTOR, EARLY GROWTH RESPONSE 
(EGR)-1, IS A CRITICAL REGULATOR OF CARBON TETRACHLORIDE-INDUCED 
FIBROSIS IN MICE. 
 
M.T. Pritchard, S. Roychowdhury and L.E. Nagy 
Pathobiology and Gastroenterology, Cleveland Clinic Foundation, 9500 Euclid Avenue, Cleveland, OH 44195 
 
Hepatic fibrosis is a common outcome associated with chronic liver disease, regardless of etiology, and 
is characterized by excessive extracellular matrix deposition.  The transcription factor, early growth 
response (Egr)-1 is an immediate early gene that is both rapidly and transiently induced in response to a 
variety of stressors. Egr-1 has been described as a master regulator of inflammatory disease in animal 
models as it regulates a cadre of genes characteristic of this disease class, such as TNFα, MIP2, and 
ICAM1.  Expression of genes involved in the wound healing response, including bFGF, VEGF, TGFβ, 
PDGF, is also regulated by Egr-1.  Because Egr-1 modulates the expression of inflammatory genes and 
those important for matrix turnover, we hypothesized that Egr-1 would play important roles in both the 
development and resolution of fibrosis.  
 
To determine the contribution of Egr-1 to CCl4-induced hepatic fibrosis, we performed our studies in 
wild type (C57BL/6nTac) and egr-1-/- mice.  In wild type mice, Egr-1 is induced rapidly after a single 
CCl4 exposure peaking at 2h and returning to baseline by 4h post CCl4.  After 5 weeks of biweekly CCl4 
injections to wild type and egr-1-/- mice, Sirius red staining of liver sections demonstrated hepatic 
fibrosis.  In wild type mice, fibrosis was intermittently bridging whereas in egr-1-/- mice fibrosis was 
completely bridging.  In addition, distinct fibrotic septa were present in livers of wild type mice whereas 
collagen deposition was diffuse in the livers of egr-1-/- mice.  The altered distribution of collagen 
deposition in egr-1-/- mice was associated with enhanced and prolonged expression of a smooth muscle 
actin (SMA), a marker of hepatic stellate cell activation, in the liver of egr-1-/- mice compared to wild 
type controls.  Gelatin zymography demonstrated that matrix metalloproteinase (MMP) activity was 
greater in the livers of egr-1-/- mice 7d after cessation of chronic CCl4 exposure and was associated with 
enhanced MMP2 and MMP14 expression measured by real time PCR.  To investigate early events in 
CCl4-induced fibrogenesis, we gave mice a single dose of CCl4 and examined hepatic injury. ALT 
activity was 2-fold and 4-fold greater in the plasma of egr-1-/- mice compared to wild type mice 18h and 
72h after CCl4 exposure, respectively.  Seventy-two hours after CCl4 exposure, there was a greater 
amount of TUNEL positive staining in the livers of egr-1-/- mice compared to wild type mice.  
Collectively, these data suggest that Egr-1 plays a protective role in acute liver injury and fibrosis 




VITAMIN E SUPPRESSED THE PROLIFERATION AND INDUCED APOPTOSIS OF 
“ACTIVATED” HEPATIC STELLATE CELLS.  
 
Noriko Yamaguchi1, Koichi Abe2, Kiwamu Yoshikawa1, Yoshihiro Mezaki1, Katsuyuki Imai1, 
Mitsutaka Miura1, Haruki Senoo1 
1Department of Cell Biology and Histology, Akita University School of Medicine, 1-1-1 Hondo, Akita City, Akita 
010-8543, Japan, 2Vitamin E Information and Technology Section, Eisai Co., Ltd., 4-10-6 Koishikawa, Bunkyo-ku, 
Tokyo 112-8088, Japan 
 
     Hepatic stellate cells are localized in perisinusoidal space of liver. In pathological conditions, such as 
liver fibrosis or liver cirrhosis, they lose lipid droplets, morphologically change to myofibloblast-like 
phenotype and acquire increased proliferation activity. They also become synthesizing relatively large 
amount of matrix components including fibrillar collagens, what is called the “activated” state. Vitamin 
E is composed of eight different forms: alpha-, beta-, gamma- and delta-tocopherols and alpha-, beta-, 
gamma- and delta-tocotrienols. Tocol is lacking methyl groups attached to the chromanol ring and 
utilized for a comparative substance. All vitamin E molecules are well known as antioxidants, however, 
recent research developments demonstrated that they possess powerful cholesterol lowering, platelet 
adhesion inhibition and anti-cancer properties. 
     We have investigated the treatment for liver fibrosis based on the concept of targeting “activated” 
hepatic stellate cells by introducing “non-activated” condition. In this study, four tocopherols and tocol 
were applied to the “activated” hepatic stellate cells and examined the effects on proliferation activity of 
stellate cells. Rat hepatic stellate cells were prepared by collagenase perfusion and the “activated” state 
was induced by culture in vitro and passaged once. Among four tocopherols and tocol, relatively high 
proliferation inhibition effects were detected in delta-tocopherol and tocol. In addition to proliferation 
inhibition, cell detachment and apoptosis were observed in delta-tocopherol treated and tocol treated 
cells in a dose response manner. These data suggest that vitamin E is effective for the treatment of 





BLOOD PLATELETS IN CHOLESTATIC LIVER DISEASE 
 
Witters P1, Freson K2, Hoylaerts M2, Vander Elst I1, Van Pelt J1, Nevens F1, Van Geet C2, Cassiman 
D1 
1Laboratory of hepatology, 2Center for molecular and vascular biology, KULeuven, Leuven, Belgium 
 
Introduction: After the red blood cell, platelets are the most abundant cells of the hepatic sinusoid. 
These cells are increasingly recognized as active players, not only participating in haemostasis but also in 
various disease processes. In a recent study, platelets were shown to contribute to cholestatic liver disease 
by deteriorating microperfusion and assisting in leucocyte recruitment. Blockage of platelet activation or 
platelet depletion could both prevent this, resulting in significantly less liver damage (lower AST and 
ALT). 
In cholestatic liver diseases, platelet function is impaired as evidenced by platelet aggregometry (i.e. the 
gold standard test of platelet function). However, other assays demonstrated a platelet hyperactivity 
(thromboelastography, sonoclot analysis) and intracellular calcium release (the final common pathway to 
aggregation) in platelets is increased in bile duct ligated (BDL) rats. Our aim is to characterize platelet 
function in BDL rats and to compare with thio-acetamide (TAA) induced liver fibrosis. 
Materials and methods: 6 BDL and 6 sham-operated rats at day 14 post-surgery (group1) and 6 TAA 
and 6 controls at week 12 of intoxication (i.e. fibrotic stage; group2), were sacrificed, for liver tests, 
complete blood count, whole blood platelet-aggregometry (stimulation with collagen and ADP), platelet 
electron microscopy, thrombin-antithrombin complexes and liver histology (image analysis of percentage 
sirius red stained surface). A crossover aggregometry experiment with BDL platelets in Sham plasma and 
vice versa was also performed, to distinguish platelet-related from plasma-related effects. 
Results: In group 1: BDL rats versus sham-operated rats showed clearly elevated liver tests (alkaline 
phosphatase, AST, ALT, bilirubin). There was a prominent ductular reaction on histology and liver 
fibrosis (6.57±2.98% sirius red stain versus 0.65±0.36, p=0.002). On whole blood count there was no 
difference in platelet count, but a decreased platelet volume (6.33fl versus 7.85fl, p=0.002) and a marked 
inflammatory state. There was a decreased whole blood aggregability in response to ADP and collagen 
(stimulation with ADP 0.8µM: 50.4±27.2% versus 93.4±7.8% aggregation, p=0.004; stimulation with 
ADP 1.7µM: 93.0±13.1% versus 100±0% aggregation p=0.015; stimulation with collagen 1.25 ng/ml: 
60.0±32.1% versus 94.3±12.9% aggregation, p= 0.015). Thrombin-antithrombin complexes were 
identical and platelet electron microscopy was normal. 
In group 2: TAA rats showed also less abnormal liver tests but equal degree of fibrosis (6.23±2.28%) 
compared to BDL and normal platelet counts and platelet volume compared to controls. Compared to 
controls there was a normal aggregation in response to ADP (stimulation with ADP 0.8µM: 87.8±21.9% 
versus 97.2±3.9% aggregation, p=NS; stimulation with ADP 1.7µM: 99.35±1.6% versus 100±0% 
aggregation, p=NS) and a decreased response to stimulation with collagen 1.25 ng/ml: (63.8±29.4% 
versus 99.7±0.5% aggregation, p= 0.026). The aggregations to ADP were significantly more preserved 
than in the BDL model. Thrombin-antithrombin complexes were not elevated.  
Cross-over experiments using optical platelet aggregometry, showed normal platelet function of BDL 
platelets when resuspended in sham plasma and decreased sham platelet function when resuspended in 
BDL plasma. 
Conclusions: Blood platelets in cholestatic liver disease (BDL) demonstrate normal ultrastructure and 
normal function when resuspended in sham plasma. However, in BDL whole blood aggregation testing, 
the platelet function is clearly inhibited and more so than in other models of liver cirrhosis (TAA). This is 
most pronounced in stimulation with ADP, which is suggestive of a role of the cholestasis-induced 
presence of 5’-nucleotidase, a well-known marker of cholestasis. 




STUDY ON A RABBIT MODEL OF STEATOHEPATITIS THAT DEVELOPS LIVER 
CIRRHOSIS 
 
Ogawa T, Mu YP, Shiga R, and Kawada N 
Department of Hepatology, Graduate school of Medicine, Osaka City University, 1-4-3, Asahimachi, Abeno, 
Osaka 545-8585, JAPAN (e-mail; tomo123@med.osaka-cu.ac.jp)   
 
Introduction: We previously reported a model of non-alcoholic steatohepatitis (NASH) that was 
produced by feeding rabbits with 1.25% cholesterol diet for 8 weeks. The liver of this model exhibited 
steatosis, oxidative stress, inflammation, iron deposition in hepatocytes and macrophages, and fibrosis 
whose characteristics are very similar to human NASH liver. In this study, we have tried to improve this 
model, resulting in the production of an advanced model having cirrhosis of the liver, a life-threatening 
stage of chronic liver disease. 
 
Materials and Methods: Japanese white rabbits were fed 0.75% cholesterol diet including 10% corn oil 
for 9 months. After the sacrifice, the rabbit livers and spleens were removed and used for histological 
evaluations of steatosis, oxidative stress, inflammation, and fibrosis by using H&E staining, Sirius red 
staining, and Sudan III staining. The remaining liver tissues were utilized for evaluating mRNA 
expressions of interleukins 1 and 6, TNF alpha, MCP-1, TGF-beta, collagen 1A1, TIMPs, and MMPs by 
real-time PCR. The level of lipid peroxide and 4-hydroxynonenal in the liver evaluated oxidative stress 
by western blotting and immunohistochemistry. 
 
Results: The livers looked whitish and the surface exhibited irregularity. Steatosis of hepatocytes was 
evident. Staining showed that inflammatory cells including RAM-11-positive macrophages accumulated 
in the sinusoids and the formation of fibrotic septum composed of collagens and activated stellate cells 
crossed over central-central and central-portal veins, indicating the reconstruction of parenchyma. 
Triglyceride, lipid peroxide, and total cholesterol in sera of model rabbits were increased 1.9-, 38-, and 
1277–fold, respectively, compared to the control. Real-time PCR revealed the increase of mRNA levels 
of collagen 1A1 (32-fold), MMP-2 (11-fold) and MMP-9 (170-fold), TIMP-1 (20-fold) and TIMP-2 (21-
fold) and HO-1 (32-fold). The spleens exhibited splenomegaly and the accumulation of foamy 
macrophages. 
 
Conclusions: The livers of this model showed liver fibrosis of stage 3 (bridging fibrosis) or 4 (cirrhosis) 
by Brunt’s staging score. Thus, this rabbit model is useful to study the pathogenesis and molecular 
analysis of human NASH. 
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C-REACTIVE PROTEIN MINIMIZES EXPERIMENTAL HEPATIC FIBROSIS BY 
INHIBITING TRANSACTIVATION OF HEPATIC STELLATE CELLS 
 
Ikejima K, Arai K, Kon K, Aoyama T, Okumura K, Yaginuma R, Takashima M, Yamashina S, 
Watanabe S.  
Department of Gastroenterology, Juntendo University School of Medicine, 2-1-1, Hongo, Bunkyo-ku, Tokyo, 113-
8421 Japan 
 
Background and aims: C-reactive protein (CRP) is an acute phase reactant that participates in 
inflammatory responses involving complement activation. Recently, minimal increment in serum CRP 
levels has been recognized as a sensitive marker of micro-inflammation in atherosclerosis and NASH. In 
the present study, we investigated the direct effect of CRP in transactivation of isolated hepatic stellate 
cells (HSCs), and experimental hepatic fibrogenesis. Methods: HSCs isolated from male Wistar rats 
were cultured in DMEM supplemented with 10% heat-inactivated FBS up to 7 days. Cell proliferation 
was evaluated by BrdU incorporation, and phosphorylation of ERK1/2 and Akt was detected by Western 
blotting. For experiments in vivo, rats were given repeated injections of thioacetamide (TAA, 200 
mg/kg, i.p. 3 times/week) for 6 weeks, simultaneously treated with purified rat CRP (1 mg/kg, i.p.) 
starting from the third week for 4 weeks. Hepatic fibrosis was assessed by picro-sirius red staining and 
smooth muscle α-actin (αSMA) immunohistochemistry. Further, mRNA levels for α1(I)procollagen 
(COL1A1) and TGF-β were detected by Northern blotting. Results: Human CRP blunted PDGF-
induced uptake of BrdU in 3 day-cultured HSCs in a dose-dependent manner, reaching 57% inhibition at 
a concentration of 1 mg/dl (p<0.05, vs. PDGF alone). The similar tendency was observed in 7 day-
cultured, activated HSCs. This anti-proliferative effect was also observed in rat CRP, which lacks 
complement activation capability. PDGF-induced phosphorylation of ERK1/2 was also inhibited by 
CRP; however, phosphorylation of Akt was not decreased by addition of CRP. On the other hand, TAA-
induced hepatic fibrosis was ameliorated markedly when purified rat CRP was given simultaneously for 
4 weeks. Indeed, induction of αSMA in the liver was prevented remarkably, indicating that CRP 
inhibited transactivation of HSCs in vivo. TAA-induced increases in hepatic COL1A1 and TGF-β 
mRNA levels were also blunted significantly. Conclusions: These findings clearly indicated that CRP 
has an anti-fibrogenic property involving direct inhibitory effect on HSC transactivation. The anti-
proliferative effect of CRP on HSCs appears to be independent of complement activation, and most 
likely involves inhibition of the MAP kinase pathway. It is therefore postulated that CRP produced from 
hepatocytes plays a regulatory role in progression of hepatic fibrosis. 
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STUDIES ON DETECTION AND PREVENTION OF HEPATIC FIBROSIS TARGETING 
TGF- ß ACTIVATION REACTION 
 
Kojima S, Arai A, and Teraoka R 
Molecular Ligand Biology Research Team, ASI, RIKEN, Wako, Saitama 351-0198, Japan 
 
      Transforming growth factor (TGF)-ß is the most fibrogenic cytokine that plays a pivotal role in the 
pathogenesis of liver diseases.   It is produced as a high molecular weight latent form, and thus must be 
activated before exerting its biological activities.   TGF-ß activation is the reaction, by which 25 kD 
active TGF-ß molecule is released from the latent complex.   Using animal models, we showed that 
TGF-ß is activated by proteases such as plasmin (PLN) and plasma kallikrein (PLK) during pathogenesis 
of liver fibrosis and impaired liver regeneration, respectively, and that blockage of these activation 
reactions with low molecular weight protease inhibitors prevented the development of the diseases.   
 
      To confirm that a similar activation reaction occurs in human liver disease, we determined that PLN 
and PLK cleaved between K56-L57 and R58-L59 in LAP portion of human latent TGF-ß, respectively, 
and produced antibodies that specifically recognize the neo-epitopes formed by protease degradation, 
namely the cut ends of each cleavage site.  The antibodies against the PLK-cut ends, namely anti-R58 
and anti-L59 antibodies recognized the degradation products of PLK-cleaved latent TGF-ß produced 
during PLK-mediated activation of latent TGF-ß, but did not recognize uncleaved latent TGF-ß and only 
weakly recognized PLN-cleaved latent TGF-ß degradation products.  A similar result was obtained with 
the antibodies against the PLN-cut ends, namely anti-K56 and anti-L57 antibodies.    
 
     We have established a novel sandwich ELISA (sELISA) using a combination of the antibodies 
recognizing LAP and the L59 cut ends containing LAP fragments produced during the process of the 
activation of TGF-ß by PLK.  Using this sELISA and TGF-ß1 Emax ImmunoAssay system, we 
measured parallel generation of LAP degradates and active TGF-ß1 in proportion to the activation of the 
hepatic stellate cells (HSCs).  Furthermore, using this sELISA we measured the concentration of LAP 
degradates released in the serum in rat fibrosis models including bile duct ligation model, and compared 
with hepatic contents of hydroxyproline (HDP).  Serum levels of LAP degradates in the fibrotic animals 
were 3-fold higher than those in the control animals (no treatment or sham operation).  The increase 
showed a good correlation with hepatic HDP levels.  We are now applying this ELISA for patients. 
 
     Next, we produced peptides containing these cleavage sites as well as their decoy peptides in which 
cleavage site amino acids were all mutated to either A or Q, and examined the effect of these peptides 
both in vitro and in vivo.  Western blotting with anti LAP antibody showed inhibition of LAP cleavage 
reaction by these peptides.  TGF-ß ELISA and PCR showed reduced generation of active TGF-ß and 
suppression of HSC activation with these peptides.  Namely, these peptides efficiently suppressed the 
TGF-ß activation reaction and prevented the activation of HSCs in culture.  Furthermore, these peptides 
were effective to prevent TGF-ß-dependent impaired liver regeneration observed in LPS-pretreated 
partially hepatectomized mice.  Histochemical staining with anti-proliferating cell nuclear antigen 
(PCNA) showed the improvement of impaired liver regeneration in animals administered with these 
peptides at 10 mg/kg/day.   
 
     These results suggest that the LAP degradates produced during the TGF-ß activation reaction may be 
a promising novel biomarker for hepatic fibrogenesis, and decoy peptides might be novel new agents 
against liver diseases targeting TGF-ß activation reaction. 
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EXTRACELLULAR MATRIX IN SINUSOIDAL WALL OF FROZEN MAMMOTHS 
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Kiwamu Yoshikawa1, Yoshihiro Mezaki1, Alexei Tikhonov2, Shunji Hattori3, Noriko Yamaguchi1, 
Mutsunori Fujiwara4 
1Department of Cell Biology and Histology, Akita University School of Medicine, 1-1-1 Hondo, Akita City, Akita 
010-8543, Japan, 2Russian Academy of Sciences, St. Petersburg, Russia, 3Nippi Biomatrix Research Institute, 
Tokyo, Japan, 4Division of Pathology, Japanese Red Cross Medical Center, Tokyo, Japan. 
 
To examine characteristics of extracellular matrix (ECM) components supporting sinusoidal wall 
(scaffolding function) of the liver, we analyzed livers of 2 frozen baby mammoths died about 40,000 
years ago and buried in permafrost in Siberia.  
We observed the livers of the 2 mammoths (kept in fixatives in Russian Academy of Sciences in St. 
Petersburg) by light and electron microscopy, scrutinized localization of ECM components by 
immunofluorescence, and analyzed amino acid contents.  
The livers were preserved at gross anatomical and histological levels.  Sinusoidal walls of the liver were 
kept.  Ultrastructure of ECM components, namely fibrillar structure having characteristic pattern of cross 
striation and basement membrane structure, were clearly demonstrated by transmission (TEM) and 
scanning electron microscopy (SEM).  Type I and type IV collagens were shown in ECM components by 
immunofluorescence.  
These results indicate that ECM components including collagen were stable and preserved in the livers 
of these frozen mammoths for 40,000 years.  These findings suggest that three-dimensional structure of 
ECM is important for maintaining gross and histological morphology of the sinusoidal wall in the liver.   
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A STUDY OF MORPHOLOGICAL CHANGES IN LAMPREY LIVER DURING THE 
COURSE OF METAMORPHOSIS WITH SPECIAL REFERENCE TO HEPATIC 
STELLATE CELLS 
 
Mitsutaka Miura*, Katsuyuki Imai*, Kiwamu Yoshikawa*, Yoshihiro Mezaki*, Mayako Morii**, 
Noriko Yamaguchi* and Haruki Senoo** 
Department of Cell Biology and Histology,  **Department of Pediatic Surgery, Akita University School of 
Medicine, 1-1-1 Hondo, Akita 010-8543, Japan 
  
   We have reported that a lamprey (Lampetra japonica), the most primitive vertebrate, has hepatic 
stellate cells (HSCs) storing an abundance of vitamin A in their cytoplasm.  Similar cells storing vitamin 
A were present in the intestine, kidney, gill, and heart (Wold, H. L., et al.: Vitamin A distribution and 
content in tissues of the lamprey (Lampetra japonica).  Anat Rec., 276A, 134-142, 2004).  Lamprey eggs 
hatch in a river, the larva transform into the adult and then migrates to the sea.  The adult lamprey 
becomes a parasite on a big sea fish and obtains nutrients from the body fluid of the fish.  When the 
lamprey enters the spawning migration stage, it leaves the fish and goes up a river without taking food.  
The bile ducts of larval lamprey degenerate and disappear during metamorphosis, so that no bile duct is 
observed in the adult liver.  While the highly regulated nature of lamprey biliary atresia offeres a 
valuable model for studyng liver pathgenesis of human biliary atresia, jaundice and a hepatic dysfunction 
aren't observed in the adult lamprey.  
   We performed microstructural analyses of bile duct degeneration of lamprey in larval and spawning 
stages by transmission electron microscopy.  Furthermore, to estimate the contribution of apoptosis in 
bile duct degenerating process, we examined tissue sections by TUNEL method and immunofluoresent 
staining of activated caspase 3 using confocal laser scanning microscopy.  In larval lamprey, bile 
canaliculi, intra- and extra-hepatic bile ducts, and gall bladder were clearly observed.  The apoptotic cells 
were detected in the epithelium of extra-hepatic bile ducts by the TUNEL method in the latter stage of 
larva.  The convoluted bile ducts were surrounded by fibrous deposits of extra-cellular matrix 
components, where sinusoids were abundant.  The HSCs in perisinusoidal space stored lipid droplets and 
a several liver parenchymal cells constructed bile canaliculi.  In the adult lamprey, the entire biliary 
system and thick periductal fibrosis disappeared.  HSCs with large quantities of vitamin A and hepatic 
parenchymal cells with large amount of lipid droplets were observed, however, hepatic fibrosis and 
cirrhosis have not been accompanied. 
   These results strongly suggested that degeneration and disappearance of bile ducts in lamprey were 
caused by apoptosis of bile duct epithelium during metamorphosis when the larva transformed into the 
adult. HSCs were probably responsible for fibrosis which accompanies the degeneration of bile ducts. 
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CRYOPRESERVATION FOR LONG-TERM STORAGE OF HUMAN PRIMARY 
CULTURED HEPATIC STELLATE CELLS 
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BACKGROUND AND AIMS: Primary cultured cells are very useful for examining the morphologic 
and functional characteristics of the target cells. However, such cells cannot be used repeatedly. This 
study examined whether cryopreservation can be recommended for long-term storage of human primary 
cultured hepatic stellate cells (HSCs). 
METHODS: We used liver tissues obtained by surgical resection from patients with metastatic liver 
cancer or hepatocellular carcinoma. The study protocol was approved by the Institutional Review Board 
of The Kurume University Hospital. HSCs were isolated from the tissues by pronase/collagenase 
digestion, followed by density gradient centrifugation using OPTIPREP. The cells were then seeded in 
DMEM containing 20% fetal calf serum, and cultured. After confluence, half of the cells were frozen, 
and the other half remained in culture at 37° for 1 week. The procedure was repeated once a week for 3 
weeks (the non-frozen HSC group). For the passage of cryopreserved HSCs, the cells were thawed, 
cultured and harvested using 0.05% EDTA trypsin, and seeded for the next passage and cultured for 1 
week. The procedure was repeated once a week for 3 weeks (the frozen HSC group). We examined the 
passaged (passage 0-3) and cryopreserved HSCs (passage 0-3). 1) Identification of the HSC by 
morphological observations using a light microscope, and immunostaining for αSMA and desmin 
expressions 2) Cells proliferation assay (growth curve, MTT assay, PI staining for cell cycle), 3) 
Western blot and Real Time PCR for receptors of PDGF and TGFβ and αSMA expressions. 
RESULTS: 1) The purity of HSCs was over 90% in all passages, and the HSC cultures consistently 
yielded a homogeneous cell population growing to confluence in each passage. The shape of the cells 
was spindle type and fat droplets were visible in the cytoplasm. αSMA positive HSCs were gradually 
increased as passage progressed, and the positive cell rate was almost the same in the two groups. 2) The 
rate of increase in cell number by counting and MTT assay in the frozen HSC group was similar to that 
in the non-frozen HSC group. The ratio of G1, S, and G2 cell cycle stages was almost the same in the 
two groups. 3) PDGF receptorα, TGFβ receptor and αSMA mRNA expressions in HSCs were similar 
among each passage in the two HSC groups.  
CONCLUSIONS: From these results, the establishment of a protocol for cryopreservation of human 
primary cultured HSCs is possible, and the cryopreserved/thawed HSCs in each passage may be useful 




IMMUNOBIOLOGY OF LIVER SINUSOIDAL ENDOTHELIAL CELLS 
 
Percy A. Knolle, MD 
 
The liver is known for its capacity to induce T cell tolerance rather than immunity. We are interested in a 
particular liver-resident cell population, liver sinusoidal endothelial cells (LSEC) that combine 
extraordinary scavenger activity with the capacity to present exogenous antigens to CD4 and CD8 T 
cells. Recently, we have reported that LSEC cross-present circulating antigens to naïve CD8 T cells 
mediating T cell tolerance. Tolerance-induction by LSEC was shown to be important in oral tolerance 
and in the development of tolerance towards tumor cells metastasizing to the liver via the hematogenous 
route thus establishing tumor immune escape. Here, I will discuss the molecular mechanisms that enable 
LSEC to induce tolerance in naïve CD8 T cells through delivery of co-inhibitory signals via the B7-
H1/PD1 receptor ligand interaction. We have discovered that tolerance induction by LSEC involves 
instructional programming of naïve CD8 T cells that is overcome by exogenous IL-2. Furthermore, 
control of IL-2 expression in LSEC-stimulated T cells is critical to assure the correct functional outcome 
of tolerogenic programming. Finally, the initial mechanisms underlying establishment of physical 
interaction of cross-presenting LSEC with circulating naïve CD8 T cells and their relevance for 
subsequent tolerance induction will be discussed.  
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THE PROMETASTATIC ENVIRONMENT OF THE LIVER 
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Department of Cellular Biology and Histology, Basque Country University School of Medicine, Leioa, Bizkaia-
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The liver is a major metastasis-susceptible site and majority of patients with hepatic metastasis die from 
the disease in the absence of efficient treatments. The intrahepatic circulation and microvascular arrest of 
cancer cells trigger a local inflammatory reaction leading to cancer cell apoptosis and cytotoxicity via 
oxidative stress mediators (mainly nitric oxide and hydrogen peroxide) and hepatic natural killer cell-
derived factors. However, certain cancer cells that resist or even deactivate these anti-tumoral defense 
mechanisms still can adhere to endothelial cells of the hepatic microvasculature through 
proinflammatory cytokine-mediated mechanisms. During their temporary residence, some of these 
cancer cells ignore growth-inhibitory factors while respond to proliferation-stimulating factors released 
from tumor-activated hepatocytes and sinusoidal cells, which leads to avascular micrometastasis 
generation in periportal areas of hepatic lobules. Both hepatocytes and myofibroblasts derived from 
portal tracts and sinusoids (activated hepatic stellate cells) are next recruited into some of these avascular 
micrometastases, creating a private microenvironment that supports their development through the 
specific release of both proangiogenic factors and cancer cell invasion- and proliferation-stimulating 
factors. Moreover, soluble factors from tumor-activated hepatocytes and myofibroblasts also contribute 
to the regulation of metastatic cancer cell genes. Therefore, the liver offers a prometastatic 
microenvironment to circulating cancer cells that supports metastasis development. The ability to resist 
anti-tumor hepatic defense and to take advantage of hepatic cell-derived factors are key phenotypic 
properties of liver-metastasizing cancer cells. Knowledge on hepatic metastasis regulation by 
microenvironment opens multiple opportunities for metastasis inhibition at both subclinical and 
advanced stages of the process. In addition, together with metastasis-related gene profiles revealing the 
existence of liver metastasis potential in primary tumors, new biomarkers on the prometastatic 




NERVE GROWTH FACTOR EXPRESSION BY HEPATIC PARENCHYMAL AND NON-
PARENCHYMAL CELLS DURING METASTATIC COLORECTAL DEVELOPMENT IN 
HUMAN AND MURINE LIVER 
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In addition to its contribution to the differentiation and survival of neuronal cells, nerve growth 
factor (NGF) also plays a role in tumor progression and metastasis. In the liver, expression of NGF is 
increased during tissue regeneration and hepatocellular carcinoma development, but its role during 
hepatic metastasis is not well understood.  
We investigated NGF and neurotrophin receptor p75 (p75-NTR) expression by cancer and host 
cells in the hepatic metastasis microenvironment. A tissue-array collection of paraffin-embedded 
colorectal carcinoma metastasis from 24 patients who had undergone hepatic excision of moderately and 
poorly differentiated colorectal adenocarcinoma metastases was used. In vivo, the concentration of NGF 
was determined by ELISA in the hepatic blood from mice affected by hepatic metastases, on the 12th day 
after intrasplenic injection of C26 colorectal carcinoma cells. Anti-NGF monoclonal antibodies were 
used to study in situ NGF expression by cancer and stromal cells in hepatic C26 colorectal carcinoma 
metastases and tumor-unaffected hepatic areas. Finally, primary cultured murine hepatocytes and hepatic 
stellate cells (HSCs) were incubated in the presence of conditioned medium from murine C26 cancer 
cells and the production and effects of recombinant murine and endogenous NGF were studied. 
NGF immunostaining of metastatic colon cancer cells only occurred in 2 out of 24 patients with hepatic 
metastases, while around 80% of studied patients had hepatic metastases with NGF-expressing stromal 
cells. Not statistically significant correlation was demonstrated between NGF immunostaining of tumor-
infiltrated stromal cells and cancer cell immunostaining with anti-ki67 antibodies, suggesting that NGF 
was not involved in the regulation of metastatic cancer cell proliferation. Hepatocytes and hepatic 
sinusoidal cells showed weak NGF immunostaining, while cholangiocytes had a high immunostaining in 
the hepatic tissue unaffected by cancer development. Staining with alpha-smooth muscle actin (alpha-
SMA) confirmed that sinusoidal immunoreactivity was unequivocally localized to HSCs, but not to other 
sinusoidal lining cells. Hepatic C26 colorectal carcinoma metastases had an intense NGF 
immunostaining in those hepatocytes and alpha-SMA-expressing stromal cells located at the invasion 
front of metastases. NGF-expressing hepatocytes were specifically located among cancer cells and had 
phenotypic features suggesting epithelial-to-mesenchymal transition. C26 cancer cells did neither 
express in situ nor secrete in vitro NFG. p75-NTR had a low expression level in normal hepatic tissue, 
but it significantly increased in hepatocytes and HSCs located around and within hepatic metastases, 
while C26 cancer cells were negative. Consistent with these in situ findings, NGF significantly increased 
in the hepatic blood obtained from livers affected by hepatic metastasis development of C26 colorectal 
carcinoma. NGF concentration was 7 times higher in the supernatants from primary cultured HSCs than 
in those from hepatocytes. In addition, it significantly increased in the supernatant of HSCs given C26 
cancer cell-conditioned medium, and in cultured hepatocytes given tumor-activated HSC-conditioned 
medium. Finally, recombinant murine NGF dose-dependent increased chemotactic migration, but not 
proliferation, of HSCs in vitro. Moreover, HSC migration-stimulating activity from tumor-activated 
hepatocyte supernatant was 50% NGF-mediated in vitro. Our results demonstrate for first time that 
hepatocytes and sinusoidal stellate cells express neutrotrophin receptor p75 and secrete NGF in response 
to specific stimulating factors released by cancer cell in the hepatic metastasis microenvironment of 
human and rodent colorectal carcinoma. Thus, NGF may contribute to metastasis progression through 
the specific activation of intratumor stromal cell migration. 
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TUMOR-ASSOCIATED MACROPHAGES IN EXPERIMENTAL MURINE TUMORS 
 
Korolenko T.A., Zhanaeva S.Ya., Alexeenko T.A., Kaledin V.I.1, Belichenko V.M. 
Institute of Physiology RAMS, Institute of Cytology and Genetics RAS1, Novosibirsk, Russia 
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Introduction. The proteolytic enzymes are essential for tumor angiogenesis, invasion and metastases, the 
major defining feature of malignancy (Atkinson et al., 2008). Tumor development is characterized by 
participation of cysteine, aspartic, serine and metallo-proteases, playing the important role both in tumor 
growth and metastazing. In tumor tissue interaction occurs between tumor cells and macrophages 
(Mphs). Tumor-associated Mphs are still poor characterized, and their role in tumor development is 
controversial. Activated Mphs play the important role in the degradation of component of extracellular 
matrix (ECM) due to production and secretion of metalloproteases (MMPs). Mphs  regulate activity of 
MMPs , especially MMP-2 and MMP-9 (gelatinases), MMP-12  (metalloelastase) and MMP-7 
(matrilisin) and in certain conditions – they induce the release of collagenases MMP-1 and MMP-13. 
TIMPs are the main regulator of MMPs fuctions. 
The aim of the study – to investigate tumor-associated Mphs phagocytic function and MMPs / TIMP-1 
ratio during tumor growth and metastazing.  
Materials and Methods. Experiments were performed in male CBA mice (Institute of Cytology and 
Genetics RAS, Novosibirsk, Russia). Lewis lung adenocarcinoma, metastazing into lung was used in our 
study. Intravenous injection of gadolinium (Gd) chloride  (10 mg/kg, single) was used as a model of 
selective liver Mph depression, whereas Gd in the doses of 14 and 28 mg/kg  induced depression of liver 
and lung Mph pools. Uptake and intralysosomal accumulation of Gd  by tumor, lung and liver was 
assayed in tissues by adsorptive spectroscopy method. Gd concentration was measured  on a JI-70 
spectrometer, Jober Ivon (Catalist, Novosibirsk). MMP activity was determined against fluorogenic 
subsrate MCA-Pro-Leu-Gly-Leu-Dpa-Ala-Arg-NH2 (Nagase et al., 1994). TIMP-1 concentration in 
liver, lung and tumor homogenates of mice was measured with help of commercial ELISA kits for mice 
(Ray Biotech, USA), MMP-2 concentration –by ELISA kits for human/rat/mice (R&D, USA).  
Results and conclusions. Uptake of lysosomotropic Gd by liver cells, mainly by Mphs (up to 70% of the 
injected dose) of intact mice was shown at 12- 24 hrs after injection, followed by long-term 
accumulation of Gd in liver cells up to 60 days and increased secretion of lysosomal enzymes – β-D-
glucuronidase and β-D-galactosidase (at days 2-5, when liver Mph repopulation was noted). Gd (14, 28 
mg/kg) significantly decreased the number of metastases into lung when it was administered to mice at 
dissemination stage (at 8th  day after tumor transplantation). In tumor bearing mice uptake of Gd was 
shown by liver, lung and tumor (less than 10%) tissue Mphs. During tumor growth the total uptake of Gd 
by tumor increased (as well as tumor weight), however the concentration of Gd in tumor even had a 
tendency to decrease. Gd uptake by liver cells of intact mice did not influence on serum TIMP-1 
concentration and MMP activity in liver; TIMP-1 concentration increased in liver tissue. Total MMP 
activity was highest in lung (lung>liver>tumor tissue). Tumor growth was followed by increased serum 
TIMP-1 concentration, but in less degree as compare to mice with tumor pretreated by Gd chloride. 
Metastases development induced decreasing of lung MMP activity, and Gd pretreatment had no effect on 
lung MMP activity in tumor bearing mice.  
One can conclude, that Gd–induced depression of lung macrophages had protective effect during 
dissemination phase of metastases into lung.  Tumor-associated Mphs were able to phagocytose Gd 
during all period of tumor growth. Increased serum TIMP-1 concentration in tumor bearing mice 














THE EFFECTS OF RESVERATROL ON HEPATIC PSEUDOCAPILLARIZATION IN 
AGING MICE FED A HIGH FAT DIET 
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     Age-related changes in the hepatic microcirculation called pseudocapillarization include reduction 
in the number and diameter of pores in the liver sinusoidal endothelial cells called fenestrations (1, 2, 
3). Reduction of the porosity of fenestrations causes impaired lipoprotein uptake by the liver and 
potentially contributes to age-related atherosclerosis (4). The sirtuin agonist, resveratrol, increases 
longevity in mice fed high fat diets, in association with improved lipid profiles and reduction in 
vascular disease (5). Here we studied the effects of high and low dose resveratrol in high fat-fed mice 
on aging changes in the hepatic microcirculation using electron microscopy in fixed livers from mice 
aged 22 months. Resveratrol was associated and greater diameter of fenestrations (61±3 nm high dose 
resveratrol; 57±3nm low dose resveratrol; 49±2 nm controls, P=0.008, approx 1000 fenestrations and 3 
mice per group). There was a non-significant trend towards increased porosity (1.4±0.1% high dose 
resveratrol; 1.3±0.2 low dose resveratrol; 1.1±0.1% controls). However there was no effect of 
resveratrol on other changes in the hepatic sinusoid commonly seen in old age such as fenestration 
frequency, endothelial thickness, basal lamina formation, collagen deposition and inactive fat-filled 
stellate cells. On electron microscopy, the resveratrol-treated animals had less hepatocyte steatosis, 
confirming previous light microscopy findings. In summary, resveratrol was associated with increased 
diameter of fenestrations in fat fed old mice, which provides one plausible mechanism for the 
improved lipid profiles and vascular health seen with resveratrol that is independent of its widespread 
effects on ageing and bioenergetics seen in other cell types. 
 
1. Le Couteur et al. Hepatology 33:537, 2001 
2. Ito et al. Exp Gerontol 48:789-797, 2007 
3. Warren et al. Exp Gerontol 40:807-812, 2005 
4. Hilmer et al. Hepatology 42:1349-1354, 2006 




STABILIN-1 AND -2 RECOGNIZE AND MEDIATE ENDOCYTOSIS OF OXIDIZED LDL 
 
Oteiza, A.*, Li, R.*, Sørensen, K.K., McCourt P.A, Smedsrød, B.H., Svistounov, D. 
Department of Cell Biology and Histology. University of Tromsø, 9037 Tromsø, Norway 
*Authors equally contributed to this study 
  
Background and aim of study - Oxidized low density lipoproteins (Ox-LDL) are found in increased 
amounts in atherosclerotic plaques, and are implicated in the pathogenesis of the disease. Liver 
sinusoidal endothelial cells (LSEC) mediate the clearance of vast array of waste macromolecules 
including Ox-LDL from blood via scavenger receptors (SR) mediated endocytosis.  
Stabilin-1 and -2 receptors are major members of the SR family expressed in LSEC. Stabilin-1    and -2 
recognize most of known SR ligands including acetylated LDL (Ac-LDL). However this form of Ac-
LDL represents only a research model for modified LDL and is not formed in vivo. The ability of 
stabilin-1 and -2 to recognize and mediate endocytosis of OxLDL still remains controversial.   
The purpose of this study was therefore to determine the role of Stabilin receptors in the recognition of 
oxLDL. 
Methods - LDL was isolated from fresh plasma by density gradient ultracentrifugation. Ox-LDL with 
different degrees of modification was prepared by incubation with copper sulfate for different lengths 
of time: 3 h (3hOxLDL) 6 h (6hOxLDL) and 24 h (24hOxLDL). Ligand competition studies were 
carried out in mouse stabilin-1 transfected HEK 293 cells (mS1-HEK). The uptake of radiolabelled 
formaldehyde treated serum albumin (125I-FSA) (a known ligand for stabilin-1) by mS1-HEK was 
conducted in the presence or absence of excess amounts of native LDL and OxLDLs with different 
degrees of oxidation. 
Results - The uptake of 125I-FSA by mS1-HEK was inhibited by the 3 forms of OxLDL: 3hOx-LDL, 
6hOx-LDL and 24hOx-LDL (50,6%, 58,5%, and 87% respectively).  Inhibition by native LDL was not 
observed. 
Conclusion - We conclude that stabilin-1 recognizes OxLDL. The ability of stabilin 1 to recognize 
OxLDL oxidized as briefly as 3h may suggest that this receptor may mediate uptake of in vivo formed 
OxLDL as well.   
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CLEARANCE OF TFPI WITH AND WITHOUT HEPARIN ADMINISTRATION  
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Introduction: Tissue factor pathway inhibitor (TFPI) is the only endogenous serine protease inhibitor 
of tissue factor (TF)-induced blood coagulation. It exerts its action by neutralizing the catalytic activity 
of factor Xa (FXa) by forming a TFPI-FXa complex, and by feedback inhibition of the factor VIIa-TF 
complex in the presence of FXa. Infusions of bacterial TFPI was shown to be taken up by the liver and 
kidneys in animal studies. Prolonged administration of unfractionated heparin (UFH) is known to cause 
depletion of intravascular TFPI, even though UFH increase synthesis and release of TFPI from 
endothelial cells. Experimental studies have shown that bacterial TFPI binds to the LRP-receptor on 
hepatocytes with subsequent endocytosis. 
Aim of the study: To investigate the effect of heparin treatment on the clearance of recombinant 
bacterial TFPI (r-TFPI) from E.coli and mammalian TFPI (rg-TFPI) from BHK cells.  
Materials and Methods: rg-TFPI and r-TFPI radiolabeled with 125I was used for in vivo and in vitro 
studies in Sprague-Dawly rats.  
Results: Both rg-TFPI and r-TFPI showed a biphasic elimination curve with a fast t½ α-phase. Almost 
50% of the injected radiolabelled TFPI was eliminated during the α-phase and the clearance was 
significantly faster for r-TFPI than for rg-TFPI (p<0.001). Administration of 100 IU/kg UFH reduced 
significantly the circulatory survival of rg-TFPI (p<0.001) without affecting survival of r-TFPI. 
Anatomical distribution of radiolabelled-ligand revealed that r-TFPI was mainly found in the liver, 
whereas rg-TFPI was equally found in liver and kidneys. Fluorescence microscopy on liver sections 
showed accumulation of FITC-labelled rg-TFPI in both parenchymal cells and in cells lining the liver 
sinusoids. In kidneys, the fluorescence was observed mainly in the cells of the proximal convoluted 
tubules. Hepatocellular distribution of radiolabelled TFPI revealed that parenchymal cells were the 
main cells responsible for the uptake of both types of TFPI. In vivo administration of 100 IU/kg UFH 
switched the uptake of r-TFPI from parenchymal cells towards the non-parenchymal cells, without 
affecting the cellular distribution of rg-TFPI. In vitro studies revealed that liver sinusoidal endothelial 
cells (LSECs), besides parenchymal cells, are involved in the uptake and degradation of both types of 
TFPI.  
Conclusions: Parenchymal cells play a pivotal role for clearance of both mammalian and bacterial 
TFPI, but LSECs also contribute significantly to the TFPI clearance. Heparin treatment increased the 
elimination rate for rg-TFPI and switched the uptake of r-TFPI towards non-parenchymal cells, 
probably due to heparin-TFPI complexes. These observations may represent the underlying mechanism 




INVESTIGATION OF CLEARANCE OF HUMAN FACTOR VIIA AND A PEGYLATED 
VARIANT IN A PERFUSED RAT LIVER MODEL 
 
Rupa Shree Appa1, Brit Binow Sørenson2, and Michael Soeberg Christensen3  
1 Exploratory ADME, Biopharmaceuticals Research Unit, Novo Nordisk A/S, Maaloev, Denmark 
2Hemostasis Biology, Biopharmaceuticals Research Unit, Novo Nordisk A/S, Maaloev, Denmark 
3 DMPK and Bioanalysis, Preclinical Development, Novo Nordisk A/S, Maaloev, Denmark 
 
 
The metabolism of human recombinant activated coagulation factor VII (rFVIIa, NovoSeven®) remains 
largely unknown. However, tissue distribution studies (1,2) suggest that the liver may play a role. 
Consequently, rFVIIa metabolism was explored in perfused rat livers. 
 
Proteins were produced at Novo Nordisk. Rat livers were cannulated via the portal vein and vena cava 
to generate an ex vivo recirculating liver perfusion model. Perfusions were performed between 1- 2 
hours and samples from the perfusate and bile were collected at several timepoints and analysed for 
FVIIa activity and antigen concentration.  
 
The perfusion studies showed that rFVIIa uptake appears to be biphasic in the absence of plasma 
proteins. Approximately 35% of rFVIIa activity is cleared by the liver within the first 30 min, while 
only an additional 5-10% is cleared during the remaining 95 min. A small percentage of rFVIIa was 
also seen in the bile lending support to the existence of an active protein uptake mechanism. 
Previously, studies to understand the biphasic uptake of rFVIIa suggested a subpopulation of rFVIIa 
was being cleared (3). It was of interest to see if this subpopulation existed for a GlycoPEGylated 
variant of rFVIIa (FVIIa-10K). All liver perfusions were performed at a concentration of 10nM. The 
clearance for pegylated rFVIIa was significantly reduced in comparison to rFVIIa. Since clearance was 
drastically reduced. This reduction in uptake from the perfusate was also mirrored in a reduced amount 
of pegylated protein secreted in the bile.  
 
Together, these studies showed that in the absence of plasma proteins, the liver is active in the uptake 
of rFVIIa in a physiologically relevant model. Data also showed that the pegylated rFVIIa derivative 
was cleared by the liver to lesser extent than that observed with rFVIIa. The perfused liver model could 
be useful for mechanistic studies of the clearance of proteins and their analogues. The type of liver cells 
involved and the exact mechanism of liver clearance of rFVIIa and the 10K-pegylated variant is still to 
be investigated, as well as, the relevance of the liver in total clearance of rFVIIa in vivo. 
 
 
1. Thomsen MK: Thromb Haemost, Vol. 70 (3), 458-464, 1993 
2. Beeby TL: Thromb Haemost, Vol. 70 (3), 465-468, 1993 
3. Appa, R.S., Nicolaisen, E.M., Christensen, M.S., International Society of Thrombosis and 




PROTECTIVE EFFECT OF NITRIC OXIDE (NO) INDUCED BY ISCHEMIC 
PRECONDITIONING (IP) ON COLD ISCHEMIC REPERFUSION INJURY OF RAT 
LIVER GRAFT: AN EXPERIMENTAL STUDY 
 
Cheng Ming-xiang*, Zhang Yi-bin*, Chen Zhen-zhen*, Hao Rong-tao*, Tu Bing*  
* Chongqing Key Laboratory of Hepatobliliary Surgery and department of Hepatobiliary Surgery, Second 
Affiliated Hospital, Chongqing Medical University, Chongqing, P.R.China. 
 
Background: To investigate the protective effect of nitric oxide (NO) induced by ischemic 
preconditioning (IP) on ischemic reperfusion injury (IRI) of rat liver graft. 
Methods: Male Sprague Dawley rats were used as donors and recipients of orthotopic liver 
transplantation. One hundred and twenty-eight rats were randomly divided into 4 groups (n=32): 1) 
administering heparin before ischemic reperfusion (IR) (control group), 2) IPC with 10 min ischemia 
and 10 min reperfusion before IR (IP group), 3) administering adenosine before IR (Ade group), 4) L- 
NAME (Nω-nitro-L-arginine methyl ester)+IP before IR (NAME group). One half of each group were 
used to investigate one week survival rate of recipients, and another half of each group were used to 
take sample of blood and hepatic tissue after 2 h reperfusion. Differences between the groups were 
analyzed by q-test, log-rank test was performed for the survival study.  
Results: One week survival rate, bile production, serum NO and activity of anti-oxidase levels were 
higher in IP group and Ade group than those in control group (P<0.05): meanwhile, serum ALT, TNF-
α and superoxide levels in hepatic tissue were lower in IP group and Ade group than those in control 
group (P<0.05). Sinusoidal endothelial cells were the principal target of reperfusion injury and their 
deaths were caused by apoptosis. Sinusoidal endothelial cells in IP group and Ade group showed less 
injury than those in control group. All findings in NAME group showed similar results to those in 
control group (P>0.05). 
Conclusion: Through the stimulation of endogenous NO, IP can protect sinusoidal endothelial cells 
from injury during the early phase of reperfusion and improve the microcirculation and function of rat 
liver graft. 
Key words: Nitric oxide; Ischemic preconditioning; Rat; Liver graft; Ischemic reperfusion injury 
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Abstract #52
PROTECTIVE ROLE OF SHENFU INJECTION IN ISCHEMIA-REPERFUSION INJURY 
OF RAT LIVER GRAFT 
 
Cheng Ming-xiang, zhang yi-bin, Liu Chang-an, Chen Zhen-zhen, Hao Rong-tao, Tu Bing, Gong 
Jian-ping  
 
Aims: To investigate the protective role of Shenfu injection (SF) in ischemia-reperfusion injury (IRI) 
of rat liver graft.  
Methods: Ninety-six male Sprague Dawley (SD) rats were used as donors(48 rats) and recipients(48 
rats) of orthotopic liver transplantation, and randomly divided into two groups: in control group, donor 
livers were injected saline immediately after hepatic blood recovering through portal vein; in SF group, 
donor livers were injected shenfu instead of saline. Each group was further divided into 3 groups 
equally to take sample of blood and hepatic tissue at 2h, 4h and 6h after reperfusion.  
Results: At each phase in SF group, bile production was significantly higher (P<0.05) and serum levels 
of ALT and TNF-α, NF-κB expression in hepatic tissue were obviously lower (P<0.05) than those in 
control group. In SF group, hepatic tissues showed less injury compared with control Group  
Conclusion: Shenfu injection can protect hepatocyte from injury during the early phase of reperfusion 
and improve the function of rat liver graft. 
[Key words]  SF injection; Liver transplantation; Ischemia-reperfusion injury 
68
Abstract #53
EHD3: FUNCTIONAL ANALYSIS OF A LIVER SINUSOIDAL ENDOTHELIAL CELL 
SPECIFIC PROTEIN INVOLVED IN ENDOCYTOSIS 
 
Francis Peyre1, Diana Klein1, Kai Schledzewski1 Alexandra Demory1, Cyrill Géraud1, Han 
Moshage2, Sergij Goerdt1 
1Department of Dermatology, University Hospital Mannheim, Medical Faculty Mannheim, University of 
Heidelberg, Germany. and 2Department. of Pathology and Laboratory Medicine, Medical Biology Section, 
University of Groningen, The Netherlands 
 
Endothelial cells are heterogeneously differentiated along the different segments of the vascular tree as 
well as in the vascular beds of different organs. Vis à vis normal continuous blood vascular endothelial 
cells, non-continuous endothelial cells such as lymphatic endothelial cells, liver or lymph node 
sinusoidal endothelial cells and tumor endothelial cells serve specialized functions; they are involved in 
scavenging processes for macromolecules such as hyaluronan, they exert an active sieve function for 
cellular debris and microorganisms, and they mediate tumor metastasis as well as antigen presentation 
and induction of immune tolerance.  
To identify genes specifically expressed by non-continuous liver sinusoidal endothelial cells (LSEC) 
we established a method to purify rat liver sinusoidal endothelial cells by using monoclonal antibodies 
against LSEC specific surface molecules (Stabilin-2, SE-1) followed by magnetic activated cell sorting 
(MACS). By gene profiling (Affymetrix Rat genome 230 2.0 DNA chips) of LSEC against CD31 
sorted rat lung microvascular endothelial cells (LMEC), we identified over-expression of approx. 300 
genes in diverse functional groups. Among them, we found well known LSEC specific genes like 
Stabilin-1, Stabilin-2, and LYVE-1. By gene ontology (GO)-analysis, a major group of differentially 
expressed genes is involved in processes referred to endocytosis and trafficking. The protein EHD3 
was significantly over expressed in LSEC as compared to LMEC. EHD3 belongs to the eps15 
homology domain (EHD) containing protein family. It was described to be localized close to endocytic 
vesicles indicating that EHD3 shuttles within the endocytic recycling compartment. To verify the gene 
profiling data of EHD3 in LSECs, we first confirmed the differential expression on the mRNA (RT-
PCR) as well as protein (Western blot) level. To address the question of endocytic activity, we showed 
co-localization of EHD3 with endocytosed ligands as well as other components localized to the 
endocytic machinery (e.g. EEA-1, Stabilin-1, and Stabilin-2). By confocal microscopy we showed that 
Stabilin-1, but not Stabilin-2 co-localise with EHD3 suggesting that these two receptors follow 
different pathways after internalisation. The functional relevance of EHD3 on endocytosis of different 
ligands (acetylated LDL, hyaluronan, AHGG, Transferrin, EGF, and AGE-BSA) of LSEC-associated 
scavenger receptors is currently studied using quantitative endocytosis assays and si-RNA to modulate 
EHD3 expression.  
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Abstract #54
INVOLVEMENT OF NITRIC OXIDE IN THE CONTROL OF THE HEPATIC 
MICROCIRCULATION OF THE STEATOTIC LIVER OF THE OBESE ZUCKER RAT 
 
AM Wheatley and CK Sun,  
Microcirculation Research Laboratory, Department of Physiology, University of Otago, Dunedin. 
 
Nitric oxide (NO) is known to play an important role in the maintenance of hepatic 
haemodynamics in normal liver. Its role in the control of the haemodynamics of steatotic (fatty) liver is 
less well understood. This current study was designed to evaluate the involvement of NO in the control 
of the hepatic microcirculation of the steatotic liver of the obese Zucker rat.  
 
Obese (n=13, 724±27g) and lean male Zucker rats (n=13, 464±5g) were anaesthetised with 
sodium pentobarbital (50mg/kg i.p.). Seven animals in each group were administered the nitric oxide 
synthase (NOS) inhibitor, L-NAME (10mg/kg, i.a.), 6 animals received saline. The hepatic 
microcirculation was investigated using intravital fluorescence microscopy (IVFM). IVFM and 
haemodynamic parameters were measured before and after administration of L-NAME.  
 
L-NAME caused a significant rise in MAP in obese and lean rats. Portal pressure fell to the 
same extent in both groups after NOS inhibition. Basal portal venous blood flow (PVBF) was 
significantly lower in obese animals. NOS inhibition caused a fall in PVBF in both groups. Hepatic 
arterial blood flow rose in the lean but not the obese rats. Basal hepatic microcirculatory perfusion was 
higher in non-steatotic liver but fell to the same extent as in steatotic liver (obese animal) after NOS 
inhibition. L-NAME caused a significant drop in lobular perfusion index in the steatotic liver (obese 
animal). Basal sinusoidal erythrocyte velocity ~250 mm/sec in both groups with similar velocity 
profiles. NOS caused a significant drop in velocity and a left-hand shift in velocity profile in both 
groups. Likewise NOS inhibition led to a significant fall in sinusoidal diameter in both non-steatotic 
and steatotic livers. 
 
We conclude from our results that (i) the hepatic haemodynamics are adversely affected by 
steatosis (ii) NO is involved in the maintenance of hepatic haemodynamics in both the non-steatotic 
and steatotic liver of the rat. 
_____________________________________________________________________  
Study support by the Royal Society of New Zealand Marsden Fund and was performed with the 
approval of the Otago University Animal Ethics Committee  
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Abstract #55
INHIBITORY EFFECTS ON THE ACTIVATION OF KUPFFER CELLS BY LXR α 
THROUGH DOWN-REGULATION OF IRF3-GRIP1 
 
MIAO Chun-mu, WANG Ding, GONG Jian-ping    
Department of hepatobiliary Surgery, The Second Affiliated Hospital of Chongqing University of Medical Sciences, 
Chongqing, 400010, China  
 
Abstract – Objective: To explore the possible mechanism of LXRα for inhibition of 
lipopolysaccharide (LPS) induced Kupffer cells (KCs) activation.   
Methods: The KCs were isolated from 40 KM mice and divided into four groups: the LPS group, the 
LPS-T0901317 (LXRα agonist) group, the T0901317 group, the control group. The LPS group was 
treated with 1μg/ml LPS for 6 h, in the LPS-T0901317 group, T0901317 (10µmol/L) was given 24 h 
before, and the T0901317 group treated with T0901317 for 24h. The mRNA levels and protein 
expression of LXRα, IRF3 and GRIP1 were determined by Real Time-PCR and Western blot 
respectively, and IFNγ levels were detected by enzyme 1inked immunosorbent assay (ELISA).  
Results: The levels of IRF3 and GRIP1 gene and protein were higher in LPS group than in another 
three groups, and also the IFNγ levels (P<0.05).  
Conclusion: Treatment with LXRα agonist on KCs could effectively repress the activation of KCs 
induced by LPS. And one of the reasons for this repression is the expression of IRF3 and GRIP1 could 
be inhibited by LXRα. 
Key words: Kupffer cells; Endotoxins; LXR; IRF3; GRIP1 
_________________________ 
This work was supported by a grant from the National Natural Science Foundation of China (No: 
30772098))  
Author’s brief introduction: MIAO Chunmu. Male. Born in 1982, Graduate student for master degree 




EXPRESSION AND FUNCTION OF FASCIN, AN ACTIN BUNDLING PROTEIN, IN 
HUMAN HEPATIC STELLATE CELLS.  
 
Uyama, N1, Iimuro, Y1, Yanagida, A2, Suzumura, K1, Satake, M1, Hirano, T1, Kuroda, N1 
Yamanaka, J1 Fujimoto, J1  
1) Hyogo College of Medicine Department of Surgery  2) Kyoto University Graduate school of Medicine. 
Department of Surgery 
  
(Introduction) Fascin is abundant in tissues such as brain and spleen. At cellular level, it is expressed 
in specific types of cells such as neuronal cells, microcapillary endothelial cells, antigen-presenting 
dendritic cells and several kinds of cancer cells. Fascin is a member of actin-bundling proteins and 
causes F-actin to aggregate side-by-side into bundles and is localized in structures containing actin 
bundles including filopodia and stress fibers of cultured cells. In some cancer cells, fascin is reported to 
be involved in the proliferation and invasion. Expression and function of fascin in the liver cells has 
not been investigated yet. 
(Materials and Methods) In order to investigate the presence of fascin in the liver, 
immunohistochemistry was performed in human normal liver and fibrotic liver tissues. To reveal the 
cells expressing fascin, serial sections were stained with fascin and HSP47 (a marker of fibroblasts) or 
alpha-SMA. Expression of fascin in LX-2 cells, human hepatic stellate cell line, was examined by 
reverse transcriptase polymerase chain reaction (RT-PCR), western blotting, and 
immunocytochemistry. To reduce the expression of fascin in LX-2 cells, two kinds of siRNAs for 
fascin were transfected. As a control, non-targetting siRNAs were transfected. At 72h after 
transfection, cell morphology cell number cell and cell migration were examined. Cell morphorogy 
was microscopically evaluated, cell number were assayed by CyQuant assay kit, and Cell migration 
was assayed with modified Boyden Chambers consisting of Transwell -precoated Matrigel membrane 
filter inserts with 8 μm pores in 24-well tissue culture plates.     
(Results) In normal liver as well as fibrotic liver, fascin immunoreactivity was found at sinusoid cells. 
Serial staining with HSP47 or alpha-SMA indicate that HSCs in sinusoids express fascin. However, 
fibroblasts in periportal region and fibrotic septa, were fascin negative. In LX-2 cells, expression of 
fascin was detected by RT-PCR, western blot and immunocytochemistry. At 72h after transfection of 
siRNA into LX-2 cells, shape of cells were changed to be more spindle or round, extension area of cell 
body were decreased and attached cell number was significantly lower than control (65% and 71%). 
Migration assay showed that suppression of fascin significantly reduce the migration rate of LX-2 
cells.  
(Conclusion) Fascin is expressed in human hepatic stellate cells, but not in fibroblasts at portal area or 
fibrotic septa. Fascin expression may distinguish hepatic stellate cells from fibroblasts at portal area or 




HEPATOCYTES, HEPATIC STELLATE CELLS AND KUPFFER CELLS: AN UNBIASED 
ESTIMATION OF THEIR NUMBER USING DESIGN-BASED STEREOLOGICAL 
METHODS 
 
Marcos R., Santos M., Santos N., Malhão F., Monteiro R.A.F., Rocha E. 
Laboratory of Histology and Embryology, Institute of Biomedical Sciences Abel Salazar (ICBAS), University of 
Porto (UPorto), Lg. Prof. Abel Salazar no. 2, 4099-033 Porto, Portugal.  
 
A solid quantitative background of the normal liver is relevant in several circumstances, such as when 
monitoring the evolution of inflammatory and fibrotic conditions. Even though advances in cell isolation, 
molecular biology and other have contributed extensively to our current understanding of the role of different 
cells in hepatic injury, morphological studies, by providing visual assessments of the in vivo status, continue to be 
powerful ways by which one can investigate cellular interplays. In recent years we have been using modern 
stereology, like the optical smooth fractionator, in the rat liver. This technique combines the optical disector, a 3D 
probe that samples cells in proportion to their number, with the (smooth) fractionator principle, in which a known 
fraction of the organ is systematically sampled, using random starts for selecting the first unit. Our aim herein 
was to apply a strategy to unbiasedly estimate the total number (N), number per gram (N/g) and % cell 
proportions for hepatocytes, HEP (mono- and binucleated), hepatic stellate cells (HSC) and Kupffer cells (KC). 
We used 3-month old male Wistar rats (n=5), being their liver fixed by perfusion, using 10% buffered 
formalin, and submitted to a systematic random sampled (SRS) cascade with a random start, according to the 
smooth fractionator rules, and providing final sample made of 5 fragments, on average. These were processed for 
paraffin embedding and exhaustively sectioned (30 µm thick) in a motorized rotary microtome. In every 30 
sections, 4 consecutive ones were SRS and used for immunohistochemistry against: 1) glial fibrillary acidic 
protein, for HSC; 2) carcinoembryonic antigen, to differentiate mononucleated hepatocytes (MnHEP) from 
binucleated ones (BnHEP), and 3) ED2 for KC. We counted from 445 to 1577 cells per rat, respectively for KC 
and MnHEP estimations. This allowed us to estimate the N, N/g and the cell number proportions. The coefficient 
of error (CE) of the N estimate was calculated, using statistics for systematic sampling. A correlation analysis 
studied the relation between those cells types and the liver and body weight. 
Data are given in Table 1. As to HEP, 26% were BnHEP. A correlation existed between the N of HEP 
and liver weight, the N of HSC and liver weight, and the N of BnHEP and body weight. 
 
Table 1 – Total number (N) and number per gram of liver (N/g) of all the cells (i.e., stromal and parenchymal), 
mononucleated (MnHEP) and binucleated hepatocytes (BnHEP), hepatic stellate cells (HSC) and Kupffer cells 
(KC). Data given as: mean (CV). CE: coefficient of error. 
CELL TYPE       N       N/g CE (N) % OF ALL CELLS 
All liver cells 3.25 x 109 (0.22) 216.8 x 106 (0.14) 0.02       100 
MnHEP 1.44 x 109 (0.23) 96.2 x 106 (0.17) 0.03       44.5 
BnHEP 520 x 106 (0.31) 33.0 x 106 (0.24) 0.05       15.2 
HSC 207 x 106 (0.17) 13.9 x 106 (0.14) 0.04        6.4 
KC 283 x 106 (0.18) 19.4 x 106 (0.25) 0.05        9.0 
  
The latest generation of stereology techniques for number estimation could be implemented in the rat liver, 
providing sound baseline data. The techniques relied on sampling designs (rather than on unrealistic geometrical 
models, as in the past), granting unbiased and precise data, meaning that: 1) the estimations were inherently close 
to the real number; 2) the CE was low, demonstrating the precision; 3) neither assumptions on cell shape, 
irregularity, size, and distribution, nor on the proportion of BnHEP were made. By its evident discriminative 
power, the strategy seems valuable for detecting regenerative and fibrotic responses in the rat liver models, from 
its very early onset. 
Acknowledgments: This work was partially supported by FCT (Grant SFRH/BD/38958/2007). 
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Abstract #58
STUDY INTO THE EXPRESSION OF ADAM17, ADAMTS-1, -4, -5 AND TIMP3 BY 
HEPATIC STELLATE CELL LINE LX-2 AND HEPATOMA CELL LINE HEPG2 
 
Turner SL1, Bird NC2, Mangnall D2, Blair-Zajdel ME1, Bunning RAD1 
1 Biomedical Research Centre, Sheffield Hallam University, Howard Street, Sheffield, UK 
2 Liver Research Group, Clinical Sciences (South), Royal Hallamshire Hospital, Sheffield, UK 
 
Introduction: In the liver, activation of growth factors is required during tumour growth and invasion 
and regeneration to enable cell proliferation and remodelling of the liver extracellular matrix (ECM).  
ADAM17 (a disintegrin and metalloproteinase) is a membrane-bound sheddase, which can release 
membrane-bound proteins including growth factors, such as the epidermal growth factor family of 
ligands. Release of growth factors from normal or transformed liver cells may contribute to tissue 
regeneration or tumour growth. ADAMTS (a disintegrin and metalloproteinase with thrombospondin 
motifs) -1, -4 and -5 are secreted enzymes, which degrade ECM components chondroitin sulphate 
proteoglycans. They have not been extensively studied in the liver, but may participate in remodelling 
liver ECM during invasive or regenerative processes. TIMP3 (tissue inhibitor of metalloproteinases) is 
a major, naturally occurring inhibitor of ADAM17, ADAMTS-1, -4 and -5. 
We have studied the expression of ADAM17, ADAMTS-1, -4, -5 and TIMP3 in human hepatic stellate 
cell line LX-2 and human hepatoma cell line HepG2 at the mRNA and protein level, and their 
modulation by cytokines IL-1β, IL-6 or TNF-α. This work will enable a better evaluation of the 
potential role of ADAM17, ADAMTS-1, -4, -5 and TIMP3 in tissue remodelling and/or invasion. 
 
Methods: ADAM17, ADAMTS-1, -4, -5 and TIMP3 were studied at the mRNA level by real time RT-
PCR in the LX-2 and HepG2 cell lines. Cells were treated with 0, 1, 10 or 100ng/mL IL-1β, IL-6 or 
TNF-α (Peprotech) for 24 hours in serum-free media. RNA was extracted with Tri-ReagentTM (Sigma), 
reverse transcribed and cDNA was amplified by real-time PCR, using the SYBR green detection 
method. Housekeeping gene (β-actin and HPRT) transcript levels were used to normalise gene 
expression. ADAM17 protein expression in LX-2 and HepG2 cells was performed by western blotting. 
Cells were cultured for 48 hours, and protein extracted with CelLyticTM-M (Sigma) with 10% protease 
inhibitor cocktail (Sigma). Proteins (6mg/lane) were fractionated under reducing conditions on 10% 
NuPage gels (Invitrogen) using the SDS-PAGE Laemmli system, and then transferred to Hybond-C 
nitrocellulose membrane (Amersham). ADAM17 was visualised using rabbit polyclonal anti-human 
ADAM17 antibody (Chemicon) and HRP conjugated goat anti-rabbit IgG (Sigma).  
 
Results: Untreated LX-2 cells were shown to express mRNA for ADAM17, ADAMTS-1, -4, -5 and 
TIMP3, whereas HepG2 cells expressed mRNA for ADAM17, ADAMTS-4 and TIMP3. Treatment of 
cells with 1, 10 or 100ng/mL of either IL-1β or IL-6 had no effect on expression of ADAM17, 
ADAMTS-1, -4, -5 or TIMP3. Stimulation of HepG2 cells with TNF-α also did not result in significant 
changes in gene expression. However, TNF-α treatment of LX-2 cells resulted in a decrease of 
ADAM17 (1, 10 & 100ng/mL) and TIMP3 (1 & 100ng/mL), but ADAMTS-1, -4 and -5 were 
unaffected. Western blot data indicates that ADAM17 protein is present in untreated LX-2 and HepG2 
cells. 
 
Conclusions: There is differential mRNA expression of ADAM17, ADAMTS-1, -4, -5 and TIMP3 in 
LX-2 and HepG2 cells. There was very little modulation of gene expression with the cytokines 
investigated. However, in LX-2 cells, TNF-α caused decreased mRNA levels of ADAM17 and TIMP3. 
ADAM17 protein was detected in LX-2 and HepG2 cells, in agreement with the mRNA studies. 
Regulation of ADAM17 by TNF-α in hepatic stellate cells may facilitate the ECM remodelling phase 
of hepatic regeneration and also the growth of colorectal liver metastases into the liver parenchyma. 
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Abstract #59
APOPTOSIS INDUCED IN THE MOUSE LIVER INTOXICATED WITH 
LIPOPOLYSACCHARIDE AND D-GALACTOSAMINE AND ITS INHIBITION BY 
GLYCYRRHIZIN 
 
Tadayuki Ikeda1, 2, Kazuki Abe3, Noriyuki Kuroda1, Yujiro Kida1, Hideo Inoue3, Kenjiro Wake4, 
Mitsuhiko Morito2, and Tetsuji Sato1    
1Department of Anatomy II and 2Department of Geriatric Dentistry, School of Dental Medicine, Tsurumi 
University, Yokohama, Japan, 3Pharmacological Research Department and 4Liver Research Unit, Minophagen 
Pharmaceutical CO., LTD., Tokyo, Japan 
 
Background/Aims: Glycyrrhizin (GL) has been used as a clinical treatment for chronic hepatitis, but its 
effects on acute hepatic injury have been unclear. Our objective is to evaluate the effect of GL on the 
mouse liver injury induced by an injection of lipopolysaccharide (LPS)/D-galactosamine (D-GalN). 
Methods: Male Balb/c mice were treated with LPS/D-GalN. Serum transaminase, cytokines such as 
tumor necrosis factor-α and interleukin-18 (IL-18), and caspase-1, -3 and -8 were evaluated. We 
submitted tissue sections to immunohistochemistry for in situ immunohistochemical labeling of nuclear 
DNA fragmentation (TUNEL), IL-18, or F4/80. Hepatic lobules were divided into pericentral and 
periportal zones, and the cell number/mm2 of F4/80+ or TUNEL+ cells was quantified. Furthermore, 
cell apoptosis was confirmed using microdissection-system and oligonucleosome-bound DNA ELISA.  
Results: The degree of hepatic injury was associated with a substantial number of hepatocytes 
undergoing apoptosis in the centrilobular area. GL inhibited the elevation in serum levels of 
transaminase and IL-18 but not caspase activities. GL significantly reduced the number of TUNEL-
labeled cells in acute hepatitis induced with LPS/D-GalN-treatment. Furthermore, DNA-ladder was 
clearly documented on agarose gel electrophoresis and confirmed with oligonucleosome-bound DNA 
ELISA. The number of F4/80-immunoreactive macrophages was significantly increased in the liver 
injury. Increase in the number of macrophages after LPS/D-GalN-treatment was relatively reduced by 
intraperitoneal administration of GL, but not significantly. 
Conclusion: These findings demonstrate that the protective role of GL in LPS/D-GalN-induced liver 
injury is performed through the inhibition of hepatic apoptosis. These effects might be accompanied by 




HGF UP-REGULATES SDF-1 ACTIVITY IN FIBROTIC LIVER SUPPRESSING DPPIV 
EXPRESSION AND ACCELERATS RECRUITMENT OF BONE MARROW-DERIVED 
CELLS  
 
Iimuro Y, Asano, Y, Uyama N, Fujimoto J 
Hyogo College of Medicine, Department of Surgery 
 
 Anti-fibrogenic effect of hepatocyte growth factor (HGF) has been well documented, while HGF has a 
variety of biological effects, such as mitogenic, motogenic, anti-apoptotic, angiogenic activities. 
Meanwhile, recruitment of bone marrow-derived cells (BMC) into injured organs and differentiation of 
these cells into organ-specific cells has been reported. In the present study, we investigated how BMC 
is recruited in a remodeling process of carbon tetrachloride (CCl4)-induced liver fibrosis following 
HGF gene transfer. Methods: C57BL/6 J mice were treated with CCl4 for 10 weeks. At week six, the 
mice underwent whole body irradiation (900cGy) and transplantation with bone marrow cells (5x106) 
from syngenic LacZ-transgenic mice. After the transplantation, gene transfer of HGF (HVJ liposomes 
containing 200 mg of human HGF expression vector) into skeletal muscles was performed once a week 
for four weeks. In the control group, sterile saline was injected. Results: HGF gene transfer 
ameliorated the CCl4-induced liver fibrosis, accelerating recruitment of LacZ-expressing cells into the 
liver. This phenomenon was accompanied by increased gelatinase activity in the fibrous area. A large 
number of the LacZ-positive cells expressed markers of vascular endothelial cells, while some of them 
had a marker of macrophages. HGF up-regulated the expression of stromal cell-derived factor (SDF)-1 
in the liver around the injured central veins, recruiting chemokine (C-X-C motif) receptor (CXCR) 4, a 
receptor for SDF-1, -positive cells in this area. The double fluorescent staining showed a close relation 
between SDF-1 and CXCR-4 around the central veins. Expression of dipeptidyl peptidase (DPP) IV 
(CD26), an enzyme inactivating SDF-1, was markedly suppressed around the central veins by HGF 
gene transfer, up-regulating SDF-1 activity in this area. Conclusion: Transplanted BMC participate in 
the HGF-induced remodeling process of liver fibrosis. The roles of HGF in this process include the 
recruitment of BMC, possibly through increased activity of SDF-1, as well as anti-apoptotic, mitogenic 
and antifibrotic activities on liver cells. 
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Abstract #61
PREVENTION OF HEPATIC DISEASES USING TGF-β ACTIVATION INHIBITORY 
DECOY PEPTIDES 
 
Teraoka R1,2, Arai A1, Tsujimoto M1, Kojima S2.  
1 Lab Cell Biochem, ASI, RIKEN, Wako, Saitama 351-0198, JAPAN 
2 Mol Ligand Biol Res Team, ASI, RIKEN, Wako, Saitama 351-0198, JAPAN 
 
TGF-β, the most fibrogenic cytokine, is constitutively synthesized and secreted in a 
biologically latent form and thus must be activated before exerting its biological activities.  TGF-β 
activation is the reaction, by which 25kD active TGF-β molecule is released from the latent complex.  
In the liver, TGF-β is produced by hepatic stellate cells (HSCs) and activated on their surface.  The 
resultant active TGF-β induces hepatic fibrosis and impaired hepatic regeneration.  Thus, HSCs play a 
central role in the pathogenesis of hepatic fibrosis by virtue of their ability to undergo a process termed 
activation under the stimuli of TGF-β. In the liver, TGF-β is known to be activated by proteases such 
as plasmin (PLN) and plasma kallikrein (PLK). Blockage of these activation reactions with low 
molecular weight protease inhibitors prevented the development of disease.   
We determined that PLN and PLK cleaved between K56-L57 and R58-L59 in latency 
associated protein (LAP) portion of human latent TGF-β molecule.  We produced peptides containing 
these cleavage sites as well as their decoy peptides in which cleavage site amino acids were all mutated 
to either A or Q, and examined the effect of these peptides on TGF-β activation and associated 
phenomenon both in vitro and in vivo.  Western blotting with anti LAP antibody shows inhibition of 
LAP cleavage reaction by these peptides. TGF-β ELISA and PCR shows reduced generation of active 
TGF-β and suppression of HSC activation with these peptides.  Namely, these peptides efficiently 
suppressed the TGF-β activation reaction and prevented the activation of HSCs in culture.  
Furthermore, these peptides were effective to prevent impaired liver regeneration observed in LPS-
pretreated partially hepatectomized mice. Histochemical staining with anti proliferating cell nuclear 
antigen (PCNA) shows the improvement of impaired liver regeneration by these peptides.   
These results suggest that these peptides might be novel new agents against liver diseases 




SANDWICH ELISA OF LAP DEGRADATES FOR MEASUREMENT OF HEPATIC 
FIBROGENESIS. 
 
Arai A 1.2, Teraoka R2 , Hara M2, Ogawa S3 , Hirose S1 , Kojima S2  
1Dpt. Biol. Sci., Tokyo Inst. Tech. Japan; 2Mol. Ligand Biol. Res. Team, ASI, RIKEN, Japan; 3Pfizer. Co.,U.S.A. 
 
       Although hepatic fibrosis is an important pathology common in many hepatic diseases, there is no 
good biomarker reflecting fibrogenesis in the liver, which limits producing a good diagnostic method 
and development of new drugs. We have established a novel sandwich ELISA based on our recent 
findings that fibrogenesis accompanies the activation of transforming growth factor (TGF)-ß, the most 
fibrogenic cytokine playing a pivotal role in the pathogenesis of the liver fibrosis. TGF-ß is produced 
as a high molecular weight latent form, and thus must be activated, namely released from the latent 
complex, before exerting its biological activities.  
       Using animal models, we showed that TGF-ß is activated by proteases such as plasmin (PLN) and 
plasma kallikrein (PLK). We determined that PLN and PLK cleaved between K56-L57 and R58-L59, 
respectively, within latency associated protein (LAP) portion of human latent TGF-ß1, produced 
antibodies that specifically recognize the neoepitopes formed by protease degradation, namely the cut 
ends of each cleavage site, and made sandwich ELISA (sELISA) using a combination of the antibodies 
recognizing LAP and the L59 cut end-containing LAP fragments produced during the process of the 
activation of TGF-ß by PLK. 
       In Western Blotting, the antibodies against the PLK-cut ends, namely anti-R58 and anti-L59 
antibodies recognized the degraded fragments of latent TGF-ß, but not uncleaved latent TGF-ß. Next, 
using this sELISA and TGF-ß1 Emax ImmunoAssay system, we measured parallel generation of LAP 
degradates and active TGF-ß1 in proportion to the activation of the hepatic stellate cells (HSCs). 
Furthermore, using this sELISA we measured the concentration of LAP degradates released in the 
serum in rat fibrosis models including bile duct ligation model, and compared with hepatic contents of 
hydroxyproline (HDP). Serum levels of LAP degradates in the fibrotic animals were 3-fold higher than 
those in the control animals (no treatment or sham operation). The increase showed a good correlation 
with hepatic HDP levels. 
       These results suggest that the LAP degradates produced during the TGF-ß activation reaction may 





LECITHIN: RETINOL ACYLTRANSFERASE (LRAT) AND CELLULAR RETINOL 
BINDING PROTEIN-1 (CRBP-1) ARE STRONGLY CO-EXPRESSED IN THE LIVER OF 
POLAR BEARS 
 
Keisuke Nagatsuma1, 2, Tomokazu Matsuura3, Ken Tanaka1, Masaya Saito1, Shingo Takikawa1, 
Hiroshi Hano2, and Haruki Senoo4 
 
Division of Gastroenterology and Hepatology, Departments of Internal Medicine1, Pathology2 and Laboratory 
Medicine3, The Jikei University School of Medicine, Tokyo, Japan. 
Department of Cell Biology and Histology, Akita University School of Medicine4, Akita, Japan. 
 
Background/Aims: Polar bears, which exist on the top of food chain in Arctic animals, are the 
valuable mammals for studying retinoid metabolism. The reasons of their decreasing population are 
suggested due to not only melting the sea ice by global warming but also accumulation of some 
environmental pollutants to their bodies, particularly dioxins. Polar bear is known to have an unique 
retinoid accumulation system in the liver, since hepatic stellate cells (HSC) in polar bear store 20-100 
times high level of vitamin A compare to human or rat. Lecithin: retinol acyltransferase (LRAT) is a 
physiological retinol esterification enzyme in the liver and its activation is occurred especially in HSC. 
Retinol bound cellular retinol-binding protein-1 (CRBP-1) is a substrate of LRAT. In the present study, 
we would like to examine if LRAT has anything to do with CRBP-1 in terms of their expression and 
localization in HSC. We determined the expression level of LRAT in HSC among different weight of 
polar bears through correlation with CRBP-1.  
Materials and Methods: An antibody specific to LRAT was generated on the basis of human LRAT 
amino acid sequence. To examine the distribution of LRAT in detail, other antibodies, CRBP-1 and α-
smooth muscle actin, were also prepared. Immunohistochemical study on HSC was performed in the 
liver of four different polar bears ranging from 100kg to 500kg. 
Results: Enlargement of lipid droplets in HSC was observed correlatively in the order of the bears’ 
weights. Nucleus and cytosol were pushed aside by the large lipid droplets, especially for heavy polar 
bears. Quiescent HSC with lipid droplets in the space of Disse strongly expressed both LRAT and 
CRBP-1 proteins in many fields. The strength of immunostaining for LRAT was also increased 
correlating with a body weight. In portal area, portal fibroblasts strongly expressed α -smooth muscle 
actin, whereas they did not express LRAT. The co-expression of LRAT and CRBP-1 in polar bear liver 
was apparent compared to that in human liver. 
Conclusions: We speculated that interaction between LRAT and CRBP-1 could play an important role 
in unique vitamin A storage function in HSC. The cells expressing both LRAT and CRBP-1 were 




HEPATIC STELLATE CELL ACTIVATION AND FIBROGENESIS ARE INHIBITED BY 
SOLUBLE FACTORS FROM PARASITE EGGS 
 
Barrie Anthony, Stephen Bennett and Jeremy Allen 
Centre for Parasitology & Disease, Biomedical Sciences Research Institute, University of Salford, Manchester, 
M5 4WT, UK 
 
Introduction. Adult worms of the parasite Schistosoma mansoni reside in the human gut mesenteries 
where females produce significant numbers of eggs. More than 50% of eggs are carried to the liver by 
the portal circulation where they become trapped in the liver sinusoids and generate a host immune 
response often resulting in pathology and fibrosis. The aim of this study was to investigate the 
fibrogenic nature of the host-parasite interaction, focusing specifically on that between parasite eggs 
and hepatic stellate cells (HSC). The immortalised human HSC-line (LX-2) is a recently-available 
resource for liver fibrogenesis studies. LX-2 cells retain many primary HSC characteristics but display 
a progressively more activated, myofibroblast-like phenotype after being introduced onto tissue culture 
plastic. Since liver fibrosis requires transdifferentiation of HSC from a quiescent to an active 
myofibroblastic phenotype, we have developed a model in which LX-2 is manipulated to yield either 
phenotype, prior to co-culture with isolated S.mansoni eggs or a homogenised soluble egg antigen 
(SEA) extract.  
 
Methods. HSC were investigated for biomarkers of their activation; by phase contrast imaging for 
morphology and staining with oil-red O for lipids; by immunofluorescence techniques for α-smooth 
muscle actin (αSMA) and F-actin (FA); by realtime PCR techniques for gene expression of pro-
fibrogenic collagen type I (col1A1), connective tissue growth factor (CTGF), αSMA and anti-
fibrogenic peroxisome proliferator-activated receptor (PPAR)γ. HSC were cultured for 7days either in 
DMEM + FBS on cell culture plastic for activation or in DMEM+ FBS + adipogenic factors on cell 
culture plastic for quiescence. HSC were then co-cultured for up to 7 days in the presence of eggs (0-
1,500 per well) or SEA (0-15μg/ml per well). 
 
Results. Quiescent HSC were able to respond to a positive control, transforming growth factor (TGF)-
β, and became activated as expected. HSC exposed either directly to viable parasite eggs or indirectly 
to SEA, adopted a quiescent phenotype according to morphological activation markers. In the absence 
of parasite material, HSC displayed a flat, spread morphology with cells abundantly expressing αSMA 
and FA in a stress fibre-like pattern and showed little evidence of lipid accumulation. In contrast, in the 
presence of eggs or SEA, HSC were reduced in size, exhibited fine cellular processes, reduced their 
expression of actins that were not linked to stress fibres and showed abundant lipid staining. HSC 
exposed either directly to viable parasite eggs or indirectly to SEA, adopted a quiescent phenotype 
according to their expression of fibrogenic genes. Thus, expression of αSMA, CTGF and col1A1 genes 
were all highly downregulated and simultaneously expression of PPARγ was upregulated.   
 
Conclusions. In conclusion, our data indicate that human HSC are directly regulated by S.mansoni 
eggs. HSC exposed directly to viable eggs or to SEA adopted a quiescent phenotype. The identification 
and isolation of soluble factor(s) in parasite eggs with anti-fibrotic activity responsible for this effect 
may have benefits against liver fibrosis.  
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Abstract #65
HEPATIC PROGENITOR CELLS AND FIBROSIS IN THE CHOLINE 
DEFICIENT/ETHIONINE INDUCED MODEL OF CHRONIC LIVER INJURY.  
 
N.Van Hul1, J.Abarca Quinones1, C.Sempoux2, Y.Horsmans1, I.Leclercq1 
1 Laboratoire de Gastro-enterologie, Université Catholique de Louvain, Bruxelles 
2 Laboratoire de Gastro-enterologie, Université Catholique de Louvain, Bruxelles 
 
Background and aims: when severe liver injury coincides with incapacity of the left-over hepatocytes 
to proliferate, activation of dormant rescue cells occurs. These liver progenitor cells (LPCs) are 
believed to repopulate the damaged liver with, at least, hepatocytes and bile duct cells. For this LPC-
aided regeneration, a well orchestrated symphony of secreted cytokines and growth factors, and both 
cell-cell and cell-matrix interactions are necessary. We developed a particular interest in the 
relationship between LPCs and hepatic stellate cells (HSCs), specialized extracellular matrix (ECM) 
producing cells. 
 
Methods: A choline deficient diet, supplemented in ethionin (CDE diet) was given to five- week-old 
C57Bl6 mice. This diet fulfills the two conditions necessitated for the activation of the progenitor 
compartment (i.e. inducing severe liver damage and proliferative incapacity of the remaining 
hepatocytes). After 2 to 3 weeks of administration of the diet, liver histology is investigated and LPC 
number is determined by immunostaining with CK19. Sirius red (SR) staining, to point out excess of 
ECM was also carried out. Morphometrical analysis of the (immuno)histochemistry was obtained and 
the results were confirmed by RT-PCR analysis of mRNA expression of CK19 and several ECM 
components. 
 
Results: We observed in these CDE models a LPC proliferative response, which, in some cases, was 
massive. The morphometrical analysis of CK19 and SR staining demonstrates a parallelism between 
the increasing number of LPCs and growing excess of ECM. Even more, the available data show a co-
localisation, with the LPCs embedded in the ECM. In a  time course experiment (CDE diet for 0 to 14 
days), RT-PCR reveals as soon as day 3, an increase of 7 times the normal value of α-SMA, marker of 
the myofibroblasts.  An increased expression of ECM components collagen 1 and 3, and a minor 
increase of laminin were also noticed. 
 
Conclusion: These preliminary results support the hypothesis that LPCs need a support matrix such as 
fibrotic tissue for migration and anchor in order to differentiate for restitution of the damaged liver. We 
show with our data that already at day 3, the liver is put in a high state of readiness for the upcoming 
proliferation of the LPCs, with first the production of ECM and secondly the appearance of LPCs. 
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Abstract #66
THE TUMOR SUPPRESSOR PROTEIN PTEN INHIBITS RAT HEPATIC STELLATE 
CELL  ACTIVATION 
 
Motoki Takashima, Christopher J. Parsons, Kenichi Ikejima, Sumio Wantanabe, Eric S. White, 
and Richard A. Rippe 
Department of Gastroenterology, Juntendo University School of Medicine, 2-1-1, Hongo, Bunkyo-ku, Tokyo 
113-8421, Japan 
 
Introduction: Following a fibrogenic stimulus, the hepatic stellate cell (HSC) transforms from a 
quiescent to an activated cell type associated with numerous morphological and phenotypic changes 
including increased proliferation, excess collagen synthesis, and expression of smooth muscle β-actin 
(αSMA). PTEN (phosphatase and tensin homolog deleted on chromosome 10), a tumor suppressor 
phosphatase, has been shown to play a role in several nonmalignant diseases. We investigated the role 
of PTEN in HSC activation. 
Materials & Methods: HSCs were isolated from SD rats and cultured for 2 days and 14 days, used as 
quiescent HSCs and activated HSCs, respectively. HSCs were transduced with adenoviruses including 
WT-PTEN which overexpresses PTEN. Morphological changes and associated HSC activation was 
investigated with phase-contrast microscopy. Apoptosis was evaluated by Caspase3/7 assay. The 
phosphorylation status and the expression of proteins related to HSC activation and cell cycle were 
investigated by Western blot analysis.  
Result: In quiescent HSCs, expression of WT-PTEN inhibited morphological changes and αSMA 
expression by 66% compared to transduced control cells, both associated with HSC activation. 
Overexpression of PTEN blocked HSC proliferation with reduced PCNA and cyclin D1 expression by 
96% and 93% compared to transduced control cells, respectively. WT-PTEN also induced apoptosis 
with increased activity of caspase 3/7 4.4-fold in quiescent HSCs compared to the control cells. The 
phospholyration of Akt, p70S6K, and Erk, related to HSC activation was inhibited by WT-PTEN, 
suggesting that these findings were caused by inactivation of these pathways. However, these effects 
were not observed with overexpression of PTEN in activated HSCs.  
Conclusion: PTEN represents an important regulator for the activation of HSCs, suggesting that PTEN 




THE CONTRIBUTION OF ACTIVATED LIVER MYOFIBROBLASTS AND HEPATIC 
STELLATE CELLS IN THE RECRUITMENT AND POSITIONING OF LYMPHOCYTES 
WITHIN THE LIVER. 
 
Haughton, E.L.; Holt, A.P.; Lalor, P.F.; Adams, D.H. 
Liver Research Laboratory, Institute of Biomedical Research, Division of Medical Science, University of 
Birmingham, Birmingham, B15 2TT, United Kingdom 
 
Introduction: The recruitment of lymphocytes to inflamed tissues via the endothelium has been 
extensively studied but less is known about the signals that direct migration of cells within tissues. 
Hepatic stellate cells (HSC) possess several immunological properties including the production of 
cytokines, the expression of adhesion molecules and are positioned below the sinusoidal endothelium 
through which activated lymphocytes are recruited to the damaged liver. Moreover, in chronic liver 
disease, activated liver myofibroblasts (aLMF) are associated with infiltrating lymphocytes at sites of 
damage. Here we investigate whether the myofibroblast population in the liver can direct the migration 
of lymphocytes within the inflamed liver.  
 
Methods: The ability of aLMF isolated from diseased human liver and HSC isolated from normal 
tissue and activated in vitro to promote lymphocyte chemotaxis, adhesion and migration was studied 
using chemotaxis, adhesion and transmigration assays.  
 
Results and Conclusions: In vitro, aLMF secreted a similar profile of cytokines to that observed in 
HSCs, characterised by high levels of IL-6, IL-12, HGF, VEGF and the chemokines CCL2 and 
CXCL8.  In response to proinflammatory cytokine treatment CXCL9, CXCL10, CCL5 and CCL3 were 
secreted. Following treatment with TNFα and IFNγ we also report secretion of IL-17 by both aHSC 
and aLMF. Cell-conditioned supernatants promoted a rapid chemotactic response in blood 
lymphocytes which was increased further upon stimulation with pro-inflammatory cytokines.  This 
response was partially inhibited by pertussis toxin and neutralisation of IL-6, HGF and VEGF 
suggesting both GPCR-dependent as well as independent mechanisms of lymphocyte chemotaxis. 
Lymphocytes bound to aLMF in using ICAM-1 and VCAM-1 and a proportion of the adherent cells 
migrated on and through the fibroblast monolayer.  This migration was only partially inhibited by 
pertussis and was again dependent on HGF and VEGF. Human in vitro activated aHSC and in vivo 
activated aLMF support lymphocyte adhesion and promote lymphocyte migration in-vitro in both 
GPCR-dependent and independent mechanisms. These properties may allow the regulation of the 
recruitment and positioning of lymphocytes in chronic inflammatory liver disease.  
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Abstract #68
PRETRANSPLANT VIABILITY TESTING OF EXTENDED CRITERIA DONOR LIVERS 
DURING HYPOTHERMIC MACHINE PERFUSION 
 
Monbaliu D1, Liu Q1, Heedfeld V1, Wylin T1, Brassil J2, Demuylder P2, Theunis B2, Vercruysse 
J2, Pirenne J1, Vekemans K1 
1Abdominal Transplant Surgery, Catholic University of Leuven Herestraat 49, Leuven, Belgium.  
2 Organ Recovery Systems Europe, da Vincilaan 2, 1935 Zaventem, Belgium 
 
Background: Using extended criteria donor livers (steatotic, very old, donation after cardiac death 
donors) offer the most immediate promise to decrease the critical organ shortage. The growing urge to 
use such livers makes it necessary to improve current preservation techniques and to develop objective 
criteria to assess graft quality prior to transplantation (Tx). Hypothermic Machine Perfusion (HMP) has 
the potential to fulfill these goals. The aim of this study was therefore to test during HMP of extended 
criteria donor liver grafts, certain biochemical parameters that may reflect viability prior to Tx. 
Methods: HMP was conducted on human livers (n=10) initially accepted and allocated for Tx in our 
centre but discarded due to unexpected in vivo findings {>50% steatosis (n=5); other reasons (n=4); or 
failed rescue allocation in case the recipient was found not transplantable (n=1)}. Following a period of 
cold storage of 13h30min ± 5h42min, livers were HMP preserved for 24h with non-oxygenated 4-6°C 
KPS-1™. Release of pH, lactate, glucose, and Aspartate Aminotransferase (AST), was determined in 
KPS-1™ samples obtained during HMP (30min, 1, 6, and 24h). Retrospectively, these parameters were 
compared in 2 different groups: a first group comparing > or <50% steatosis (n=5 in each group), a 
second group comparing livers regarded -in retrospect- as absolutely not (n=7) or potentially well 
transplantable (n=3). 
Results: No differences between the various groups were observed when determining pH, lactate and 
glucose levels. During HMP of >50% steatotic livers, AST release was higher (p<0.05) compared to 
<50% steatotic livers (4672±2049 vs 287±224, 4843±2171 vs 330±255, 7101±3207 vs 455±318, 
8802±5070 vs 791±382 U/L, at 30min, and 1, 6, 24h). AST was higher (p<0.05) when comparing 
livers regarded as absolutely not- vs potentially transplantable, (4672±2049 vs 287±224, 4843±2171 vs 
330±255, 7101±3207 vs 455±318, 6618±5572 vs 547±261 U/L, at 30min, and 1, 6, 24h, respectively). 
In conclusion, this study indicates that AST in the perfusate during HMP is a simple/reliable marker to 
assess the quality of liver grafts prior to Tx and to discriminate transplantable vs non transplantable 
livers, thereby allowing wider and safer use of extended criteria donor livers. 
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Abstract #69
EARLY PROINFLAMMATORY CYTOKINE RESPONSE DURING LIVER 
REGENERATION IN NORMAL, TLR4-MUTANT AND TLR4-DEFICIENT MICE. 
 
Marlini Muhamad 1, Ayako Mabuchi 1, Jacquie Harper 2, Antony M. Wheatley1. 
1 Microcirculation Research Laboratory, Department of Physiology, University of Otago, Dunedin, New  
Zealand. 
2 Malaghan Institute of Medical Research, Wellington, New Zealand. 
 
Introduction: The liver has a remarkable capacity to regenerate following any insult or injury. To date, 
tumour necrosis factor-α (TNF-α) and interleukin-6 (IL-6) are two important cytokines that have been 
identified as being responsible for initiating or triggering this event. The signal that triggers cytokine 
secretion is believed to come from gut-derived lipopolysaccharide (LPS), which is a ligand for toll like 
receptor 4 (TLR4). Liver regeneration is delayed in TLR4-mutant C3H/HeJ mice, indicating that LPS 
and/or TLR4 is involved during liver regeneration. We therefore investigated the proinflammatory 
cytokine response following partial hepatectomy (PH) in normal LPS-sensitive (C3H/HeN, C57BL/6), 
TLR4-mutant (C3H/HeJ) and TLR4-deficient (TLR4-/-) mice. Methods: Male, 8-10 weeks old 
C3H/HeN, C3H/HeJ, C57BL/6 and TLR4-/- mice were used in this study. A 70% PH or sham 
operation was performed in these mice under sodium pentobarbital anaesthesia (50 mg/kg). Bloods 
were collected by axillary exsanguinations and mice were sacrificed at 0 (control), 3, 6, 12 hours, 1, 2, 
3 and 7 days after PH. Serum cytokines (TNF-α, IL-6) were measured using the Bio-plex kit. Liver 
regeneration was assessed by calculating the liver weight-to-body-weight ratio. Results: Restoration of 
normal liver weight-to-body-weight ratio after PH was delayed in the C3H/HeJ but not in the TLR4-/- 
mice when compared to control (C3H/HeN and C57BL6, respectively). Our data showed that the 
production of TNF-α peaked at 3 hours after PH in C3H/HeN mice. This was followed by the peak IL-
6 levels at 6 hours after PH. In C3H/HeJ mice, in which the liver regeneration is delayed, the peaked 
production of TNF-α and IL-6 occurred at later time points (2 days and 12 hours after PH, 
respectively). TNF-α secretion after PH in TLR4-/- mice was depressed, while the peak level of IL-6 
production occurred at 3 hours after PH. Conclusion: In conclusion, proinflammatory cytokines TNF-
α and IL-6 were upregulated at the early phase of liver regeneration in normal, C3H/HeN mice. 
Delayed cytokine production in TLR4-mutant mice might have been the cause of the delay in liver 
regeneration in these mice. Normal restoration of liver mass after PH in the TLR4-deficient mice 
indicates that IL-6, rather than TNF-α is more important during liver regeneration.  
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TOLL-LIKE RECEPTOR 4 IS INVOLVED IN THE MECHANISM OF CONCANAVALIN 
A INDUCED HEPATITIS IN MICE  
 
Ayako Mabuchi1, Beth L Mallard1, Jacquie Harper2, Sachiko Akashi-Takamura3, Kensuke 
Miyake3, Antony M Wheatley1 
1Department of Physiology, University of Otago, Dunedin, New Zealand;  
2Malaghan Institute of Medical Research, Wellington, New Zealand; 3Division of Infectious Genetics, Institute of 
Medical Science, University of Tokyo, Tokyo, Japan 
 
Background: Concanavalin A (Con A) administration in mice leads to T-cell mediated hepatitis, 
which involves cytokines interferon (IFN)-γ and tumor necrosis factor (TNF)-α. The 
lipopolysaccharide (LPS)/TLR4 signaling pathway has been shown to be involved in the underlying 
mechanism in a number of liver pathologies (I/R-induced injury, alcohol-induced hepatitis). 
Involvement of TLR4 in T-cell mediated hepatitis has not been elucidated. In the current study the 
impact of TLR4 gene deletion (TLR4-/- mice) and a defective TLR4 (C3H/HeJ mice) was investigated.  
Methods: Mice with normal TLR4 (C3H/HeN and C57BL/6), C3H/HeJ and TLR4-/- were injected 
with Con A (20 mg/kg). Additional groups were treated with anti-TLR4 mAb (MTS510;100 mg/mouse 
iv). Plasma ALT was measured to assess liver injury. Plasma TNF-α and IFN-γ were measured by Bio-
Plex suspension array system. Results: Following Con A administration, C3H/HeN and C57BL/6 mice 
developed severe liver injury indicated by elevated plasma ALT. However, no ALT increase was seen 
in C3H/HeJ, TLR4-/-, or anti-TLR4 treated C3H/HeN mice. Histological examination confirmed signs 
of necrosis following Con A in the wild-type animals that was absent in the C3H/HeJ, TLR4-/- or anti-
TLR4 mAb treated C3H/HeN mice. TNF-α was significantly elevated at 2 hours post-Con A in 
C3H/HeN (1448 ± 715 pg/mL) and C57BL/6 mice (7302 ± 3500 pg/mL) but not in C3H/HeJ mice 
(347 ± 199 pg/mL). IFN-γ levels were significantly higher in C3H/HeN (770 ± 160 pg/mL) and 
C57BL/6 mice (1113 ± pg/mL) compared to C3H/HeJ mice (330 ± 30 pg/mL). Conclusions: Our 
results show that Con A causes liver injury and proinflammatory cytokine production in mice with 
functional TLR4. In the absence of the TLR4 signaling pathway, cytokine production is attenuated and 
injury is prevented (C3H/HeJ and TLR4-/- mice). Thus we have shown for the first time the 
involvement LPS/TLR4 signaling may play a role in Con A induced hepatitis, probably mediated by 




SINUSOIDAL DILATATION AND PELIOSIS IN INFLAMMATORY 
HEPATOCELLULAR ADENOMAS 
 
Paulette Bioulac-Sage , Hervé Laumonier , Hervé Trillaud , Charles Balabaud 
Departments of Pathology, Radiology, Hepatology, CHU de Bordeaux; GREF Inserm U889, Université Victor 
Segalen Bordeaux 2 Bordeaux France 
 
Hepatocellular adenomes [HCAs] are monoclonal tumors, which have been divided up into three 
subtypes of tumors depending on the molecular alteration detected in the tumors: an acute 
inflammatory response in the tumor (40-50 %), an HNF1α inactivation (30 -35%), α β-catenin 
activation (20% -10% being also inflammatory). These molecular features are closely related to clinical 
and pathological characteristics, and one of the most critical correlations is the higher risk of malignant 
transformation for β-catenin activated HCA cases. 
Inflammatory HCAs are characterized by the presence of inflammatory infiltrates. These nodules 
exhibited additional features such as sinusoidal dilatation found at the periphery of the nodule and 
peliotic cavity more centrally located, dystrophic artries and ductular reaction, and included most of the 
previously described so-called ‘‘telangiectatic focal nodular hyperplasia’’ cases. In these tumors, we 
detected elevated expression of members of the acute phase inflammatory response (serum amyloid A 
protein, and C-reactive protein) at both the mRNA and protein levels.  
The aim of this study was to correlate pathological findings with MRI features.  
We analyzed MRI data from twenty-three inflammatory HCA. It showed:  1) hyposignal or isosignal 
on T1W images, 2) an absence or only focal signal dropout on chemical shift sequence, 3) marked 
hypersignal on T2W sequences, with a stronger signal in the outer part of the lesions, 4) strong arterial 
enhancement, with persistent enhancement in the portal venous and delayed phases. Marked 
hypersignal on T2W sequences associated with delayed persistent enhancement had a positive 
predictive value of 88.5%, a negative predictive value of 84%, a sensitivity of 85.2% and a specificity 
of 87.5% for the diagnosis of inflammatory telangiectatic HCA. A target-like feature was observed for 
a large proportion of these lesions on T2 W images, with a very high-intensity signal forming a rim in 
the outer part of the lesion. A strong correlation was found between these rims and the peripheral 
sinusoidal dilatation. 
For comparison we analysed 15 HNF1α mutated HCA a histologically homogeneous group of 
tumours, characterized by marked steatosis, no inflammatory infiltrate and no abnormal arteries, 
sinusoidal dilatation or peliotic cavities. The corresponding lesions showed 1) hyposignal or isosignal 
on T1W images, with diffuse signal dropout on chemical shift sequence, 2) isosignal or slight 
hypersignal on T2W images, 3) moderate enhancement in the arterial phase, with no persistent 
enhancement in the portal venous and delayed phases. For the diagnosis of HNF1α-inactivated HCA 
the positive predictive value of homogeneous signal dropout on chemical shift images was 100%, the 
negative predictive value was 94.7%, the sensitivity was 86.7% and the specificity was 100%. 
In conclusion, inflammatory HCA the most numerous subgroup of HCA identified on molecular 
criteria present distinct radiological criteria which allows their identification prior resection. The link 
between these highly vascularized tumors with dystroplic arteries, sinusoidal dilatation and peliotic 




EXPRESSION OF NUCLEAR RECEPTORS IN HUMAN AND MURINE LIVER 
 
Naito M1, Takegoshi S1, Iwanari H2, Ohashi R1, Savchenko AS1, Jiang S1,3, Tanaka T2, Go 
Hasegawa1, Hamakubo T2, Kodama T2  
1 Department of Cellular Function, Division of Cellular and Molecular Pathology, Niigata University Graduate 
School of Medical and Dental Sciences, Asahimachi-dori 1-757, Chuou, 951-8510, Niigata, Japan, 2 Laboratory 
for Systems Biology and Medicine, Research Center for Advanced Science and Technology, University of 
Tokyo, Tokyo, Japan, and 3 Perseus Proteomics, Tokyo, Japan. 
 
Introduction: Nuclear receptors (NRs) are transcriptional regulators expressed in a variety of tissues 
and play important roles in embryonic development, organogenesis and metabolic homeostasis. In 
order to investigate the tissue-specific expression pattern of NRs, we generated mouse anti-human 
monoclonal antibodies against various NRs.  
Materials and Methods: Paraffin sections of human and murine liver were immunostained using mouse 
anti-human monoclonal antibodies against NRs (Perseus Proteomics Inc., Tokyo, Japan). Specificities 
of the antibodies were confirmed by immunoblotting using overexpressed proteins. Immunoblotting 
was performed using human and murine tissues and anti-nuclear receptor antibodies. 
Results: Among 32 immunohistochemically examined antibodies against NRs, we observed the 
expression of 14 NRs in hepatocytes of human liver specimens. Different combinations of six NRs 
were expressed in Kupffer cells, endothelial cells, and hepatic stellate cells, while 13 NRs were 
expressed in bile ducts. In the murine liver, immunohistochemical examination indicated that 14 NRs 
are expressed in hepatocytes, 7 NRs in Kupffer cells and hepatic stellate cells, 6 NRs in endothelial 
cells, and 13 NRs in bile ducts, respectively. 
  HNF4α (P1) was expressed in hepatocytes, while HNF4α (P2) was displayed in bile ducts. COUP-
TFII expression was observed only in the endothelial cells and bile ducts. RXRα was expressed both in 
Kupffer cells and hepatic stellate cells, while FXR was expressed in hepatocytes and hepatic stellate 
cells and LXRα expression was observed in Kupffer cells. Immunoblotting using these antibodies 
revealed similar corresponding bands both in human and mouse liver.  
Conclusions: These monoclonal antibodies may serve as powerful tools to detect tissue-specific 
localization of NRs and provide a platform for future studies of NRs in human and murine tissues.  
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Abstract #73
GLYCOGEN, α-SMA AND E-CADHERIN IN MARGINAL HUMAN LIVER GRAFTS 
DISCARDED FOR CLINICAL USE AND PRESERVED BY HYPOTHERMIC MACHINE 
PERFUSION 
 
Vekemans K1, Monbaliu D1, Liu Q1,Komuta M2, Heedfeld V1 and Pirenne J1.  
1Department of abdominal transplant surgery, Catholic University of Leuven (KULeuven), Leuven, Belgium and 
2Department of pathology, Catholic University of Leuven (KULeuven), Leuven, Belgium.  
 
Data on Hypothermic Machine Perfusion (HMP) of human marginal livers are virtually inexistent. 
Superiority of HMP of marginal human livers must be first proven ex vivo before this is applied 
clinically. In this study we aimed to visualize markers for glycogen, the stellate cell activation and the 
intercellular connections. METHODS: Six marginal human livers discarded for clinical transplantation 
were recovered and cold stored in UW during 14 4h. Four livers had >30% steatotis; two had 20-30% 
steatotis and other co-morbidity. These livers were perfused by HMP during 4h via hepatic artery and 
portal vein with oxygenated, 4-6 C KPS-1 using an ORS-HMP-prototype. The livers were then 
rewarmed (36 C) with RS-I and red blood cells (2h). Tissue samples were taken just before HMP (0 ), 
after 1h, and 4h of HMP, at the start of warm reperfusion, and after 1h and 2h of warm reperfusion. 
The tissues were stained with PAS-stain to stain glycogen, for α-smooth muscle actin (α-SMA) (a 
marker for stellate cell activation) and for E-cadherin (a protein in hepatocytes tight junctions). 
RESULTS: PAS-stain revealed a decrease in the glycogen content of the hepatocytes 4h after HMP; 
this decrease was even aggravated after 2h of warm reperfusion. In the pericentral areas the glycogen 
had totally disappeared and at the periportal areas the glycogen was still present but much less than at 
the start of HMP. α-SMA decreased when comparing 0  and 2h of reperfusion. The timing of decrease 
followed 2 distinct patterns: either after 1h of HMP or during the rewarming. E-cadherin decreased in 
the HMP preservation period either after 3h or 4h HMP. At that time point a discontinuity was 
observed in the tight junctions of the hepatocytes. This decrease was even more pronounced during the 
warm reperfusion. CONCLUSIONS: HMP of marginal livers is associated to a substantial reduction of 
glycogen primarily in the pericentral areas. α-SMA decreases during HMP or during the reperfusion, 
suggesting that stellate cells become less activated. That E-cadherin decreases after HMP is intriguing 
and suggests that the intercellular connections are damaged. 
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Abstract #74
EVIDENCE FOR NO RELEVANCE OF ANTI-MICA ANTIBODIES IN LIVER 
TRANSPLANTATION 
 
Mehmet Uzunel1, Haxiaobieke Kasimu2, Xupeng Ge3, Meghnad Joshi2, Marie Jaksch4, Jining 
Liu1, Xu Bo2, Carl Jorns2, Grzegorz Nowak2, and Suchitra Sumitran-Holgersson2 
Divisions of 1Clinical Immunology, 2Transplantation Surgery, Huddinge University Hospital, Karolinska 
Institutet, S-141 86 Stockholm. Sweden, 3Transplant Biology Research Center, Massachusetts General Hospital, 
Harvard Medical School, 4The Burnham Institute for Medical Research, La Jolla, CA .USA 
 
Introduction Little is known regarding the specificity of antibodies directed to tissue-/organ-specific 
antigens in patients receiving liver allografts. Recently, the polymorphic MHC class I-related chain A 
(MICA) is increasingly recognized as a potential target molecule for immune cells during allograft 
rejections. Here, we studied whether MICA is a target antigen for antibodies in liver transplanted (LTx) 
patients.  
Material and Methods Eighty-four patients were investigated for the presence of MICA reactive 
antibodies pre and post-LTx, using MICA transfected cells and flow cytometry. MICA typing was 
performed by PCR. Expression of MICA in liver cells was determined by RT-PCR and Western 
Blotting. Liver biopsy specimens from patients after transplantation were examined for MICA 
expression.  
Results We found a total of 22/84 (26%) pts with MICA abs either pre and/or post-tx. 8/84 (9.5%) 
patients had MICA antibodies in the pre- and 14/84 (17%) in the post-tx period. Overall 43/84(51%) 
patients had rejections. No correlation between rejection frequencies (14/22, 63%) or other clinical 
parameters was observed in patients with MICA Ab as compared to those without MICA Abs (29/62, 
47% p=ns). We found weak mRNA expression for MICA in liver cells, but no protein or cell surface 
expression by western blots or flow cytometry. In addition, no MICA expression in liver biopsy 
sections was observed from LTx patients at any time point including rejections.  
In conclusion we found no causal relationship between the presence of MICA antibodies and liver 




IMPLICATION OF DISCOIDIN DOMAIN RECEPTORS IN THE ACTIVATION OF 
HEPATIC STELLATE CELLS DURING LIVER METASTASIS 
 
Iker Badiola, Beatriz Arteta, Iratxe Basaldua, Fernando Vidal-Vanaclocha, Elvira Olaso. 
University of Basque Country, Leioa, Spain.  
 
Discoidin Domain Receptors DDR1 and DDR2 are two novel tyrosine kinase receptors for collagen 
previously described in aggressive epithelial tumors and their associated stroma. In the metastasized 
liver, stromal areas are populated by tumor-activated stellate cells of myofibroblastic phenotype 
releasing tumor cell proliferation and migration factors. The aim of our study was to elucidate the role 
of DDRs in tumor-activated stellate cells during liver metastasis.  
 
Results: Immunohistochemical analysis of human livers metastasized by colon carcinoma 
demonstrated co-expression of DDR1, DDR2 and the myofibroblast marker alpha-smooth muscle actin 
in stromal hepatic stellate cells (HSC). In vitro, freshly isolated human HScs cultured in the presence 
of media from HT29 human colon carcinoma cells showed enhanced DDR1, DDR2 and alpha smooth 
actin expression than HSCs cultured in basal media. Experimental liver metastases generated by 
intrasplenic injection of MC38 colon carcinoma cells in DDR2-deficient mice developed faster than in 
wild type ones. Immunohistochemical co-localization of desmin and alpha-smooth muscle actin was 3-
fold higher in livers from DDR2-deficient mice than in the wild type, indicating a higher rate of tumor-
associated activated HScs. In vitro, supernatant from primary cultures of DDR2-deficient HScs 
exposed to MC38-conditioned media exerted a 2-fold higher MMP2 activity than wild type ones. Also, 
MC38 cell proliferation and migration was maximal when cultured in the presence of supernatants 
from DDR2-deficient HSCs. Furthermore, real time quantitative RT-PCR analysis showed a 10-fold 
increase in DDR1 mRNA expression of DDR2-deficient HSCs, compared to wild type ones. DDR2-
deficient HSCs transfected with a vector encoding a DDR1-interference RNA showed diminished 
proliferative, adhesive and migratory rates, compared to cells treated with a control vector encoding an 
irrelevant RNA or wild type ones. In vivo silencing of DDR1mRNA by daily intrasplenic 
administration of the appropriate vector resulted in a dramatic reduction in the development of 
experimental liver metastasis by MC38 cells compared to wild type mice. Conclusion: These results 
demonstrate for the first time a direct role of both DDR receptors in the functional behaviour of stromal 
hepatic stellate cells during liver metastasis. Ongoing cDNA microarray analysis will reveal how gene 




NERVE GROWTH FACTOR EXPRESSION BY HEPATIC PARENCHYMAL AND NON-
PARENCHYMAL CELLS DURING METASTATIC COLORECTAL DEVELOPMENT IN 
HUMAN AND MURINE LIVER 
 
Felisa Basaldua1, Aritz Lopategi1, Beatriz Arteta1, Andrés Valdivieso2,  Jorge Ortíz de 
Urbina2,  and Fernando Vidal-Vanaclocha1 
1Department of Cellular Biology and Histology, Basque Country University School of Medicine, Leioa, Bizkaia-
48940, and 2Hepatobiliar Tumor Surgery Unit, Cruces University Hospital, Baracaldo, Bizkaia, Spain; Tel: 34-
94-601-2880; Fax: 34-94-601-3266; fernando.vidal@ehu.es 
 
In addition to its contribution to the differentiation and survival of neuronal cells, nerve growth 
factor (NGF) also plays a role in tumor progression and metastasis. In the liver, expression of NGF is 
increased during tissue regeneration and hepatocellular carcinoma development, but its role during 
hepatic metastasis is not well understood.  
We investigated NGF and neurotrophin receptor p75 (p75-NTR) expression by cancer and host 
cells in the hepatic metastasis microenvironment. A tissue-array collection of paraffin-embedded 
colorectal carcinoma metastasis from 24 patients who had undergone hepatic excision of moderately 
and poorly differentiated colorectal adenocarcinoma metastases was used. In vivo, the concentration of 
NGF was determined by ELISA in the hepatic blood from mice affected by hepatic metastases, on the 
12th day after intrasplenic injection of C26 colorectal carcinoma cells. Anti-NGF monoclonal 
antibodies were used to study in situ NGF expression by cancer and stromal cells in hepatic C26 
colorectal carcinoma metastases and tumor-unaffected hepatic areas. Finally, primary cultured murine 
hepatocytes and hepatic stellate cells (HSCs) were incubated in the presence of conditioned medium 
from murine C26 cancer cells and the production and effects of recombinant murine and endogenous 
NGF were studied. 
NGF immunostaining of metastatic colon cancer cells only occurred in 2 out of 24 patients with 
hepatic metastases, while around 80% of studied patients had hepatic metastases with NGF-expressing 
stromal cells. Not statistically significant correlation was demonstrated between NGF immunostaining 
of tumor-infiltrated stromal cells and cancer cell immunostaining with anti-ki67 antibodies, suggesting 
that NGF was not involved in the regulation of metastatic cancer cell proliferation. Hepatocytes and 
hepatic sinusoidal cells showed weak NGF immunostaining, while cholangiocytes had a high 
immunostaining in the hepatic tissue unaffected by cancer development. Staining with alpha-smooth 
muscle actin (alpha-SMA) confirmed that sinusoidal immunoreactivity was unequivocally localized to 
HSCs, but not to other sinusoidal lining cells. Hepatic C26 colorectal carcinoma metastases had an 
intense NGF immunostaining in those hepatocytes and alpha-SMA-expressing stromal cells located at 
the invasion front of metastases. NGF-expressing hepatocytes were specifically located among cancer 
cells and had phenotypic features suggesting epithelial-to-mesenchymal transition. C26 cancer cells did 
neither express in situ nor secrete in vitro NFG. p75-NTR had a low expression level in normal hepatic 
tissue, but it significantly increased in hepatocytes and HSCs located around and within hepatic 
metastases, while C26 cancer cells were negative. Consistent with these in situ findings, NGF 
significantly increased in the hepatic blood obtained from livers affected by hepatic metastasis 
development of C26 colorectal carcinoma. NGF concentration was 7 times higher in the supernatants 
from primary cultured HSCs than in those from hepatocytes. In addition, it significantly increased in 
the supernatant of HSCs given C26 cancer cell-conditioned medium, and in cultured hepatocytes given 
tumor-activated HSC-conditioned medium. Finally, recombinant murine NGF dose-dependent 
increased chemotactic migration, but not proliferation, of HSCs in vitro. Moreover, HSC migration-
stimulating activity from tumor-activated hepatocyte supernatant was 50% NGF-mediated in vitro. Our 
results demonstrate for first time that hepatocytes and sinusoidal stellate cells express neutrotrophin 
receptor p75 and secrete NGF in response to specific stimulating factors released by cancer cell in the 
hepatic metastasis microenvironment of human and rodent colorectal carcinoma. Thus, NGF may 
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